{
  "meta": {
    "id": "test4",
    "title": "Antenatal Care",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "The cardiovascular examination of a 21 y primigravida at term reveals a split S1, normal S2, S3 easily audible with a 2/6 systolic ejection murmur greater during inspiration and a mildly elevated JVP. You immediately recognize that:",
      "options": [
        {
          "label": "A",
          "text": "The presence of S3 is abnormal",
          "correct": false
        },
        {
          "label": "B",
          "text": "The systolic murmur is unusual in a pregnant woman at term",
          "correct": false
        },
        {
          "label": "C",
          "text": "The combination of a prominent S3 and an elevated JVP is suggestive of an underlying heart disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "All findings are normal changes of pregnancy",
          "correct": true
        }
      ],
      "correct_answer": "D. All findings are normal changes of pregnancy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. All findings are normal changes of pregnancy</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Normal cardiovascular findings in pregnancy are:</li><li>\u27a4 Normal cardiovascular findings in pregnancy are:</li><li>\u27a4 On Examination:</li><li>\u27a4 On Examination:</li><li>\u27a4 Apex beat is shifted to the 4 th intercostal space; 2.5 cm outside the mid-clavicular line. PR increases Mildly elevated JVP Ejection Systolic murmur at apical/pulmonary area (grade 1/2) Rarely (20%): A soft diastolic murmur may be heard Mammary murmur \u2013 left 2 nd and 3 rd intercostal space \u2013 due to increased flow in the internal mammary vessels. S3 \u2013 due to rapid diastolic filling S4 \u2013 rare ECG \u2013 normal pattern; sometimes left axis deviation.</li><li>\u27a4 Apex beat is shifted to the 4 th intercostal space; 2.5 cm outside the mid-clavicular line.</li><li>\u27a4 Apex beat is shifted to the 4 th intercostal space; 2.5 cm outside the mid-clavicular line.</li><li>\u27a4 PR increases</li><li>\u27a4 PR increases</li><li>\u27a4 Mildly elevated JVP</li><li>\u27a4 Mildly elevated JVP</li><li>\u27a4 Ejection Systolic murmur at apical/pulmonary area (grade 1/2)</li><li>\u27a4 Ejection Systolic murmur at apical/pulmonary area (grade 1/2)</li><li>\u27a4 Rarely (20%): A soft diastolic murmur may be heard</li><li>\u27a4 Rarely (20%): A soft diastolic murmur may be heard</li><li>\u27a4 Mammary murmur \u2013 left 2 nd and 3 rd intercostal space \u2013 due to increased flow in the internal mammary vessels.</li><li>\u27a4 Mammary murmur \u2013 left 2 nd and 3 rd intercostal space \u2013 due to increased flow in the internal mammary vessels.</li><li>\u27a4 S3 \u2013 due to rapid diastolic filling</li><li>\u27a4 S3 \u2013 due to rapid diastolic filling</li><li>\u27a4 S4 \u2013 rare</li><li>\u27a4 S4 \u2013 rare</li><li>\u27a4 ECG \u2013 normal pattern; sometimes left axis deviation.</li><li>\u27a4 ECG \u2013 normal pattern; sometimes left axis deviation.</li><li>\u27a4 Ref: Page no 61, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 61, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dcffef71",
      "audio": ""
    },
    {
      "text": "Hemodynamic changes regress to normal after................. weeks of delivery:",
      "options": [
        {
          "label": "A",
          "text": "2",
          "correct": false
        },
        {
          "label": "B",
          "text": "4",
          "correct": false
        },
        {
          "label": "C",
          "text": "6",
          "correct": true
        },
        {
          "label": "D",
          "text": "8",
          "correct": false
        }
      ],
      "correct_answer": "C. 6",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. 6</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Cardiac output returns to normal 2 weeks after delivery Hemodynamic changes completely regress to normal by 42 days (= 6 weeks) post-partum.</li><li>\u2022 Cardiac output returns to normal 2 weeks after delivery</li><li>\u2022 Cardiac output</li><li>\u2022 normal</li><li>\u2022 2 weeks</li><li>\u2022 Hemodynamic changes completely regress to normal by 42 days (= 6 weeks) post-partum.</li><li>\u2022 Hemodynamic</li><li>\u2022 regress to normal</li><li>\u2022 42 days</li><li>\u2022 post-partum.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cardiac output returns to normal 2 weeks after delivery Hemodynamic changes completely regress to normal by 42 days (= 6 weeks) post-partum.</li><li>\u27a4 Cardiac output returns to normal 2 weeks after delivery</li><li>\u27a4 Cardiac output</li><li>\u27a4 2 weeks</li><li>\u27a4 delivery</li><li>\u27a4 Hemodynamic changes completely regress to normal by 42 days (= 6 weeks) post-partum.</li><li>\u27a4 Hemodynamic changes</li><li>\u27a4 regress</li><li>\u27a4 normal</li><li>\u27a4 42 days (= 6 weeks) post-partum.</li><li>\u27a4 Ref: Page no 57-58, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 57-58, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fe6bed3d",
      "audio": ""
    },
    {
      "text": "A healthy 25 y G1 at 40 weeks gestational age comes for a routine antenatal visit. The patient complains that on several occasions she has experienced dizziness, light headedness and feeling as if she is going to pass out when she lies down on her back to take a nap. What is the appropriate plan of management?",
      "options": [
        {
          "label": "A",
          "text": "Do an ECG",
          "correct": false
        },
        {
          "label": "B",
          "text": "Monitor her for 24 h with a Holter monitor to rule out an arrhythmia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Do an arterial blood gas analysis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Reassure her that nothing is wrong with her and encourage her not to lie flat on her back",
          "correct": true
        }
      ],
      "correct_answer": "D. Reassure her that nothing is wrong with her and encourage her not to lie flat on her back",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Reassure her that nothing is wrong with her and encourage her not to lie flat on her back</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The above scenario is of supine hypotension syndrome .</li><li>\u2022 supine hypotension syndrome</li><li>\u2022 Seen in 3 rd trimester Pressure of gravid uterus on the IVC in supine position Hypotension, tachycardia and syncope Patient is asked to lie on one side and not on her back It is especially dangerous during caesarean where spinal anaesthesia causes hypotension . Hence a left lateral tilt needs to be given .</li><li>\u2022 Seen in 3 rd trimester</li><li>\u2022 3 rd trimester</li><li>\u2022 Pressure of gravid uterus on the IVC in supine position</li><li>\u2022 Pressure</li><li>\u2022 gravid</li><li>\u2022 IVC</li><li>\u2022 Hypotension, tachycardia and syncope</li><li>\u2022 Hypotension, tachycardia</li><li>\u2022 syncope</li><li>\u2022 Patient is asked to lie on one side and not on her back</li><li>\u2022 lie on one side</li><li>\u2022 not on her back</li><li>\u2022 It is especially dangerous during caesarean where spinal anaesthesia causes hypotension . Hence a left lateral tilt needs to be given .</li><li>\u2022 dangerous during caesarean</li><li>\u2022 spinal anaesthesia</li><li>\u2022 hypotension</li><li>\u2022 left lateral tilt</li><li>\u2022 given</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Supine Hypotension Syndrome :</li><li>\u27a4 Supine Hypotension Syndrome</li><li>\u27a4 Seen in 3 rd trimester. Pressure of gravid uterus on the IVC in supine position. Hypotension, tachycardia and syncope. Patient is asked to lie on one side and not on her back. It is especially dangerous during caesarean where spinal anaesthesia causes hypotension . Hence a left lateral tilt needs to be given.</li><li>\u27a4 Seen in 3 rd trimester.</li><li>\u27a4 3 rd trimester.</li><li>\u27a4 Pressure of gravid uterus on the IVC in supine position.</li><li>\u27a4 Pressure</li><li>\u27a4 gravid</li><li>\u27a4 IVC</li><li>\u27a4 Hypotension, tachycardia and syncope.</li><li>\u27a4 Hypotension, tachycardia</li><li>\u27a4 syncope.</li><li>\u27a4 Patient is asked to lie on one side and not on her back.</li><li>\u27a4 lie on one side</li><li>\u27a4 It is especially dangerous during caesarean where spinal anaesthesia causes hypotension . Hence a left lateral tilt needs to be given.</li><li>\u27a4 dangerous</li><li>\u27a4 caesarean</li><li>\u27a4 spinal anaesthesia</li><li>\u27a4 hypotension</li><li>\u27a4 left lateral tilt</li><li>\u27a4 Ref: Page no 60, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 60, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c7f57661",
      "audio": ""
    },
    {
      "text": "What is not true about blood volume in pregnancy:",
      "options": [
        {
          "label": "A",
          "text": "Increases by 30-60% of nonpregnant volume",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increases with gestational age and plateaus at 34 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increase is less with low-normal range hematocrit and more with high normal range hematocrit",
          "correct": true
        },
        {
          "label": "D",
          "text": "Increase is 40-80% with multifetal gestation",
          "correct": false
        }
      ],
      "correct_answer": "C. Increase is less with low-normal range hematocrit and more with high normal range hematocrit",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Increase is less with low-normal range hematocrit and more with high normal range hematocrit</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A: Blood volume increases by 30-60% of nonpregnant volume. This is correct. Option B: Blood Increases with gestational age and plateaus at 34 weeks. Option C: The increase in blood volume in pregnancy is more with low-normal range hematocrit and less with high normal range hematocrit Option D: The increase in blood volume is 40-80% with multifetal gestation</li><li>\u2022 Option A: Blood volume increases by 30-60% of nonpregnant volume. This is correct.</li><li>\u2022 Option A:</li><li>\u2022 Blood volume increases</li><li>\u2022 30-60%</li><li>\u2022 correct.</li><li>\u2022 Option B: Blood Increases with gestational age and plateaus at 34 weeks.</li><li>\u2022 Option B:</li><li>\u2022 Blood Increases</li><li>\u2022 gestational age</li><li>\u2022 plateaus at 34 weeks.</li><li>\u2022 Option C: The increase in blood volume in pregnancy is more with low-normal range hematocrit and less with high normal range hematocrit</li><li>\u2022 Option C:</li><li>\u2022 increase</li><li>\u2022 more</li><li>\u2022 low-normal range hematocrit</li><li>\u2022 less</li><li>\u2022 high</li><li>\u2022 normal range hematocrit</li><li>\u2022 Option D: The increase in blood volume is 40-80% with multifetal gestation</li><li>\u2022 Option D:</li><li>\u2022 increase in blood volume</li><li>\u2022 40-80%</li><li>\u2022 multifetal gestation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Regarding blood volume in pregnancy:</li><li>\u27a4 blood volume</li><li>\u27a4 pregnancy:</li><li>\u27a4 Increased vascularity of the enlarging uterus with the interposition of uteroplacental circulation Blood volume raised : 40 \u2013 50% Starts in the 6 th weeks ; maximum at 34 weeks \u2013 then remains static. Higher in multigravida , multiple pregnancy and large babies.</li><li>\u27a4 Increased vascularity of the enlarging uterus with the interposition of uteroplacental circulation</li><li>\u27a4 Increased</li><li>\u27a4 enlarging uterus</li><li>\u27a4 uteroplacental circulation</li><li>\u27a4 Blood volume raised : 40 \u2013 50%</li><li>\u27a4 Blood volume raised</li><li>\u27a4 40 \u2013 50%</li><li>\u27a4 Starts in the 6 th weeks ; maximum at 34 weeks \u2013 then remains static.</li><li>\u27a4 Starts</li><li>\u27a4 6 th weeks</li><li>\u27a4 maximum at 34 weeks</li><li>\u27a4 remains static.</li><li>\u27a4 Higher in multigravida , multiple pregnancy and large babies.</li><li>\u27a4 multigravida</li><li>\u27a4 multiple pregnancy</li><li>\u27a4 large babies.</li><li>\u27a4 Ref: Page no 57, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 57, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fbcea5e1",
      "audio": ""
    },
    {
      "text": "Normal echocardiographic changes in pregnancy include all except:",
      "options": [
        {
          "label": "A",
          "text": "Slight increase in the systolic and diastolic left ventricular dimensions",
          "correct": false
        },
        {
          "label": "B",
          "text": "Moderate increase in the size of the right atrium",
          "correct": false
        },
        {
          "label": "C",
          "text": "Moderate increase in the size of the right ventricle",
          "correct": false
        },
        {
          "label": "D",
          "text": "Moderate decrease in the size of the left atrium",
          "correct": true
        }
      ],
      "correct_answer": "D. Moderate decrease in the size of the left atrium",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Moderate decrease in the size of the left atrium</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 In Echocardiography in pregnancy there is chamber enlargement of all 4 chambers.</li><li>\u2022 Echocardiography</li><li>\u2022 pregnancy</li><li>\u2022 chamber enlargement</li><li>\u2022 4 chambers.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Echo changes in pregnancy Physiologic multivalvular regurgitation (Rt > Left) Chamber enlargement (all 4 chambers) \u2013 secondary to hypervolemia Valvular annular dilatation Small asymptomatic pericardial effusion</li><li>\u27a4 Echo changes in pregnancy Physiologic multivalvular regurgitation (Rt > Left) Chamber enlargement (all 4 chambers) \u2013 secondary to hypervolemia Valvular annular dilatation Small asymptomatic pericardial effusion</li><li>\u27a4 Echo</li><li>\u27a4 pregnancy</li><li>\u27a4 Physiologic multivalvular regurgitation (Rt > Left) Chamber enlargement (all 4 chambers) \u2013 secondary to hypervolemia Valvular annular dilatation Small asymptomatic pericardial effusion</li><li>\u27a4 Physiologic multivalvular regurgitation (Rt > Left)</li><li>\u27a4 multivalvular regurgitation</li><li>\u27a4 Chamber enlargement (all 4 chambers) \u2013 secondary to hypervolemia</li><li>\u27a4 Chamber enlargement</li><li>\u27a4 secondary to hypervolemia</li><li>\u27a4 Valvular annular dilatation</li><li>\u27a4 Valvular annular dilatation</li><li>\u27a4 Small asymptomatic pericardial effusion</li><li>\u27a4 asymptomatic</li><li>\u27a4 pericardial effusion</li><li>\u27a4 Ref: Page no 2346-7, Hurst\u2019s The Heart 14 th edition</li><li>\u27a4 Ref: Page no 2346-7, Hurst\u2019s The Heart 14 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8d51409b",
      "audio": ""
    },
    {
      "text": "The total amount of iron required during pregnancy is:",
      "options": [
        {
          "label": "A",
          "text": "100 mg",
          "correct": false
        },
        {
          "label": "B",
          "text": "1000 mg",
          "correct": true
        },
        {
          "label": "C",
          "text": "500 mg",
          "correct": false
        },
        {
          "label": "D",
          "text": "1500 mg",
          "correct": false
        }
      ],
      "correct_answer": "B. 1000 mg",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. 1000 mg</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Total iron requirement in pregnancy is 1000 mg 500 mg \u2013 red cell mass expansion 300 mg \u2013 placenta and fetus 200 mg \u2013 shed through skin/ GIT/ renal</li><li>\u2022 Total iron requirement in pregnancy is 1000 mg 500 mg \u2013 red cell mass expansion 300 mg \u2013 placenta and fetus 200 mg \u2013 shed through skin/ GIT/ renal</li><li>\u2022 Total iron</li><li>\u2022 pregnancy</li><li>\u2022 1000 mg</li><li>\u2022 500 mg \u2013 red cell mass expansion 300 mg \u2013 placenta and fetus 200 mg \u2013 shed through skin/ GIT/ renal</li><li>\u2022 500 mg \u2013 red cell mass expansion</li><li>\u2022 300 mg \u2013 placenta and fetus</li><li>\u2022 200 mg \u2013 shed through skin/ GIT/ renal</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Total iron requirement in pregnancy is 1000 mg 500 mg \u2013 red cell mass expansion 300 mg \u2013 placenta and fetus 200 mg \u2013 shed through skin/ GIT/ renal</li><li>\u27a4 Total iron requirement in pregnancy is 1000 mg 500 mg \u2013 red cell mass expansion 300 mg \u2013 placenta and fetus 200 mg \u2013 shed through skin/ GIT/ renal</li><li>\u27a4 Total iron</li><li>\u27a4 pregnancy</li><li>\u27a4 1000 mg</li><li>\u27a4 500 mg \u2013 red cell mass expansion 300 mg \u2013 placenta and fetus 200 mg \u2013 shed through skin/ GIT/ renal</li><li>\u27a4 500 mg \u2013 red cell mass expansion</li><li>\u27a4 500 mg</li><li>\u27a4 red cell mass expansion</li><li>\u27a4 300 mg \u2013 placenta and fetus</li><li>\u27a4 300 mg</li><li>\u27a4 placenta and fetus</li><li>\u27a4 200 mg \u2013 shed through skin/ GIT/ renal</li><li>\u27a4 200 mg</li><li>\u27a4 shed through skin/ GIT/ renal</li><li>\u27a4 Ref: Page no 58, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 58, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "69a15735",
      "audio": ""
    },
    {
      "text": "Physiological changes in pregnancy includes all except:",
      "options": [
        {
          "label": "A",
          "text": "Rise in total leucocyte count",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rise in Hemoglobin",
          "correct": true
        },
        {
          "label": "C",
          "text": "Decrease in the peripheral resistance by 50%",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rise in cardiac output by 70%",
          "correct": false
        }
      ],
      "correct_answer": "B. Rise in Hemoglobin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Rise in Hemoglobin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Hb falls in pregnancy due to haemodilution resulting from an unequal increase in blood volume and red cell mass.</li><li>\u2022 Option B:</li><li>\u2022 Hb falls</li><li>\u2022 due to haemodilution</li><li>\u2022 unequal increase in blood volume</li><li>\u2022 red cell mass.</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A: Rise in TLC : This is normally seen in pregnancy Option C: The peripheral resistance decreases by 50% Option D: Rise in cardiac output by 70% is normal in pregnancy</li><li>\u2022 Option A: Rise in TLC : This is normally seen in pregnancy</li><li>\u2022 Option A:</li><li>\u2022 TLC</li><li>\u2022 pregnancy</li><li>\u2022 Option C: The peripheral resistance decreases by 50%</li><li>\u2022 Option C:</li><li>\u2022 peripheral resistance decreases</li><li>\u2022 50%</li><li>\u2022 Option D: Rise in cardiac output by 70% is normal in pregnancy</li><li>\u2022 Option D:</li><li>\u2022 Rise in cardiac output</li><li>\u2022 70%</li><li>\u2022 pregnancy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hb falls in pregnancy due to haemodilution resulting from an unequal increase in blood volume and red cell mass.</li><li>\u27a4 Hb falls</li><li>\u27a4 due to haemodilution</li><li>\u27a4 unequal increase in blood volume</li><li>\u27a4 cell mass.</li><li>\u27a4 Ref: Page no 57-59, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 57-59, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "233de04d",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT a normal physiological change during pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Increased GFR",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increased Cardiac output",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased functional residual capacity",
          "correct": true
        },
        {
          "label": "D",
          "text": "Increased total protein",
          "correct": false
        }
      ],
      "correct_answer": "C. Increased functional residual capacity",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Increased functional residual capacity</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Let\u2019s Discuss all the Options:</li><li>\u2022 Let\u2019s Discuss all the Options:</li><li>\u2022 Option C: Functional residual capacity is decreased in pregnancy (as the diaphragm is pushed up ). Option D: Total protein is increased. Option A : GFR and renal plasma flow are increased. Option B: Cardiac output is increased.</li><li>\u2022 Option C: Functional residual capacity is decreased in pregnancy (as the diaphragm is pushed up ).</li><li>\u2022 Option C:</li><li>\u2022 Functional residual</li><li>\u2022 capacity</li><li>\u2022 decreased</li><li>\u2022 pregnancy</li><li>\u2022 diaphragm is pushed up</li><li>\u2022 Option D: Total protein is increased.</li><li>\u2022 Option D:</li><li>\u2022 Total protein</li><li>\u2022 increased.</li><li>\u2022 Option A : GFR and renal plasma flow are increased.</li><li>\u2022 Option A :</li><li>\u2022 :</li><li>\u2022 GFR and renal plasma flow</li><li>\u2022 increased.</li><li>\u2022 Option B: Cardiac output is increased.</li><li>\u2022 Option B: Cardiac output</li><li>\u2022 increased.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Functional residual capacity is decreased in pregnancy (as the diaphragm is pushed up ).</li><li>\u27a4 Functional residual capacity is decreased in pregnancy (as the diaphragm is pushed up ).</li><li>\u27a4 Functional residual capacity</li><li>\u27a4 decreased</li><li>\u27a4 pregnancy</li><li>\u27a4 diaphragm is pushed up</li><li>\u27a4 Ref: Page no 58-62 Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 58-62 Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "032aa7d0",
      "audio": ""
    },
    {
      "text": "Mean pH of vagina during pregnancy is?",
      "options": [
        {
          "label": "A",
          "text": "4",
          "correct": true
        },
        {
          "label": "B",
          "text": "5",
          "correct": false
        },
        {
          "label": "C",
          "text": "6",
          "correct": false
        },
        {
          "label": "D",
          "text": "7",
          "correct": false
        }
      ],
      "correct_answer": "A. 4",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/screenshot-2024-01-15-181345.jpg"
      ],
      "explanation": "<p><strong>Ans. A. 4</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Vagina</li><li>\u2022 Vagina</li><li>\u2022 Acidic pH (3.5 \u2013 6): due to conversion of glycogen into lactic acid by the Lactobacillus acidophilus (due to high estrogen level )</li><li>\u2022 Acidic pH (3.5 \u2013 6): due to conversion of glycogen into lactic acid by the Lactobacillus acidophilus (due to high estrogen level )</li><li>\u2022 Acidic pH (3.5 \u2013 6):</li><li>\u2022 glycogen into lactic acid</li><li>\u2022 Lactobacillus acidophilus</li><li>\u2022 high estrogen level</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page no 52, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 52, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "70dd3ff5",
      "audio": ""
    },
    {
      "text": "A 23y presents at 6 weeks pregnancy with mild spotting. An ultrasound shows a single live fetus corresponding to 6 weeks. You explain that this could be implantation bleed. This is also known as?",
      "options": [
        {
          "label": "A",
          "text": "Hartman's sign",
          "correct": true
        },
        {
          "label": "B",
          "text": "Arias Stella sign",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hoffman's sign",
          "correct": false
        },
        {
          "label": "D",
          "text": "Reinz's sign",
          "correct": false
        }
      ],
      "correct_answer": "A. Hartman's sign",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Hartman's sign</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Hartman\u2019s sign is also known as placental sign It is bleeding on the expected date of the period and is due to implantation of the embryo</li><li>\u2022 Hartman\u2019s sign is also known as placental sign</li><li>\u2022 Hartman\u2019s sign</li><li>\u2022 placental sign</li><li>\u2022 It is bleeding on the expected date of the period and is due to implantation of the embryo</li><li>\u2022 bleeding</li><li>\u2022 expected date</li><li>\u2022 period</li><li>\u2022 implantation of the embryo</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option B: Arias Stella reaction : The Arias-Stella reaction is a histopathological feature in which there is hormone-related atypical endometrial change characterized by hypertrophy and vacuolization of glandular epithelial cells , associated with marked nuclear pleomorphism, enlargement, and hyperchromasia.</li><li>\u2022 Option B:</li><li>\u2022 Arias Stella reaction</li><li>\u2022 histopathological feature</li><li>\u2022 hormone-related atypical</li><li>\u2022 endometrial</li><li>\u2022 hypertrophy and vacuolization of glandular epithelial cells</li><li>\u2022 marked nuclear</li><li>\u2022 pleomorphism, enlargement,</li><li>\u2022 hyperchromasia.</li><li>\u2022 Option C: Hofman sign : The Hoffman sign is an involuntary flexion movement of the thumb and or index finger when the examiner flicks the fingernail of the middle finger down. The reflexive pathway causes the thumb to flex and adduct quickly. A positive Hoffman sign indicates an upper motor neuron lesion and corticospinal pathway dysfunction likely due to cervical cord compression.</li><li>\u2022 Option C:</li><li>\u2022 Hofman sign</li><li>\u2022 involuntary flexion movement</li><li>\u2022 thumb and or index finger</li><li>\u2022 flicks</li><li>\u2022 middle finger down.</li><li>\u2022 thumb to flex</li><li>\u2022 adduct quickly.</li><li>\u2022 positive</li><li>\u2022 Hoffman sign</li><li>\u2022 upper motor neuron lesion</li><li>\u2022 corticospinal pathway dysfunction</li><li>\u2022 cervical cord</li><li>\u2022 compression.</li><li>\u2022 Option D: Reinz sign: There is no such sign</li><li>\u2022 Option D:</li><li>\u2022 Reinz sign:</li><li>\u2022 no</li><li>\u2022 sign</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hartman\u2019s sign is also known as placental sign It is bleeding on the expected date of the period and is due to implantation of the embryo</li><li>\u27a4 Hartman\u2019s sign is also known as placental sign</li><li>\u27a4 Hartman\u2019s sign</li><li>\u27a4 placental sign</li><li>\u27a4 It is bleeding on the expected date of the period and is due to implantation of the embryo</li><li>\u27a4 bleeding</li><li>\u27a4 expected date</li><li>\u27a4 period</li><li>\u27a4 implantation</li><li>\u27a4 embryo</li><li>\u27a4 Ref: Page 61; DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li><li>\u27a4 Ref: Page 61; DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "752eaf40",
      "audio": ""
    },
    {
      "text": "Which amongst the following is NOT seen in normal pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Increase in systolic blood pressure",
          "correct": true
        },
        {
          "label": "B",
          "text": "Increase in heart rate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increase in cardiac output",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increase in blood volume",
          "correct": false
        }
      ],
      "correct_answer": "A. Increase in systolic blood pressure",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Increase in systolic blood pressure</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Systemic vascular resistance decreases - reduction in BP Reduction in diastolic BP more than systolic Overall decrease in diastolic BP and mean arterial pressure by 5-10 mmHg Maximum fall in the 2 nd trimester No change in central venous pressure and pulmonary capillary wedge pressure</li><li>\u27a4 Systemic vascular resistance decreases - reduction in BP</li><li>\u27a4 Systemic vascular resistance decreases</li><li>\u27a4 reduction</li><li>\u27a4 BP</li><li>\u27a4 Reduction in diastolic BP more than systolic</li><li>\u27a4 Reduction</li><li>\u27a4 diastolic BP</li><li>\u27a4 more</li><li>\u27a4 systolic</li><li>\u27a4 Overall decrease in diastolic BP and mean arterial pressure by 5-10 mmHg</li><li>\u27a4 decrease in diastolic BP</li><li>\u27a4 mean arterial pressure</li><li>\u27a4 5-10 mmHg</li><li>\u27a4 Maximum fall in the 2 nd trimester</li><li>\u27a4 Maximum</li><li>\u27a4 2 nd trimester</li><li>\u27a4 No change in central venous pressure and pulmonary capillary wedge pressure</li><li>\u27a4 No</li><li>\u27a4 central venous pressure</li><li>\u27a4 pulmonary capillary wedge pressure</li><li>\u27a4 Ref: Page no 60, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 60, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8f665b4f",
      "audio": ""
    },
    {
      "text": "Softening of lower uterine segment on bimanual examination is known as?",
      "options": [
        {
          "label": "A",
          "text": "Hegar's Sign",
          "correct": true
        },
        {
          "label": "B",
          "text": "Chadwick Sign",
          "correct": false
        },
        {
          "label": "C",
          "text": "Osiander's Sign",
          "correct": false
        },
        {
          "label": "D",
          "text": "Goodell's Sign",
          "correct": false
        }
      ],
      "correct_answer": "A. Hegar's Sign",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/screenshot-2024-01-15-183408.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Hegar's Sign</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Softening of lower uterine segment on bimanual examination is known as Hegar\u2019s sign</li><li>\u2022 Softening</li><li>\u2022 lower uterine segment</li><li>\u2022 bimanual</li><li>\u2022 Hegar\u2019s sign</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Named Pelvic signs</li><li>\u27a4 Named Pelvic signs</li><li>\u27a4 Ref: Page 61; DDC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li><li>\u27a4 Ref: Page 61; DDC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1035f005",
      "audio": ""
    },
    {
      "text": "Crying of fetus in utero is called as?",
      "options": [
        {
          "label": "A",
          "text": "Vagitus uterinus",
          "correct": true
        },
        {
          "label": "B",
          "text": "Vagitus vaginalis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Utero vaginalis",
          "correct": false
        },
        {
          "label": "D",
          "text": "None of the above",
          "correct": false
        }
      ],
      "correct_answer": "A. Vagitus uterinus",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Vagitus uterinus</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The cry of a fetus in utero is known as vagitus uterinus</li><li>\u2022 cry of a fetus</li><li>\u2022 vagitus uterinus</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The cry of a fetus in utero is known as vagitus uterinus</li><li>\u27a4 cry of a fetus</li><li>\u27a4 utero</li><li>\u27a4 vagitus uterinus</li><li>\u27a4 Ref: Gingras JL, Mitchell EA, Grattan KE; Fetal homologue of infant crying. Archives of Disease in Childhood - Fetal and Neonatal Edition 2005; 90:F415-F418.</li><li>\u27a4 Ref: Gingras JL, Mitchell EA, Grattan KE; Fetal homologue of infant crying. Archives of Disease in Childhood - Fetal and Neonatal Edition 2005; 90:F415-F418.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cafa937b",
      "audio": ""
    },
    {
      "text": "A pregnant woman at 36-week of gestation is admitted in your ward. During the morning rounds, she is lying supine as shown in the figure. What syndrome has been depicted below?",
      "options": [
        {
          "label": "A",
          "text": "Superior vena cava syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Supine vena cava syndrome",
          "correct": true
        },
        {
          "label": "C",
          "text": "Abdominal aorta syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Postural Hypotension syndrome",
          "correct": false
        }
      ],
      "correct_answer": "B. Supine vena cava syndrome",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/08/obg-29.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/1.jpg"
      ],
      "explanation": "<p><strong>Ans. B. Supine vena cava syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Supine hypotension syndrome/ Supine vena cava syndrome</li><li>\u2022 Supine hypotension syndrome/ Supine vena cava syndrome</li><li>\u2022 Seen in 3 rd trimester Pressure of gravid uterus on the IVC in supine position Hypotension, tachycardia and syncope Especially dangerous during cesarean where spinal anesthesia causes hypotension. Hence a left lateral position needs to be given to prevent hypotension (wedge under right hip )</li><li>\u2022 Seen in 3 rd trimester</li><li>\u2022 3 rd trimester</li><li>\u2022 Pressure of gravid uterus on the IVC in supine position</li><li>\u2022 Pressure</li><li>\u2022 IVC</li><li>\u2022 Hypotension, tachycardia and syncope</li><li>\u2022 Hypotension, tachycardia</li><li>\u2022 syncope</li><li>\u2022 Especially dangerous during cesarean where spinal anesthesia causes hypotension. Hence a left lateral position needs to be given to prevent hypotension (wedge under right hip )</li><li>\u2022 dangerous</li><li>\u2022 cesarean</li><li>\u2022 spinal anesthesia</li><li>\u2022 hypotension.</li><li>\u2022 left lateral position</li><li>\u2022 prevent hypotension</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Supine hypotension syndrome/ Supine vena cava syndrome</li><li>\u27a4 Supine hypotension syndrome/ Supine vena cava syndrome</li><li>\u27a4 Seen in 3 rd trimester Pressure of gravid uterus on the IVC in supine position Hypotension, tachycardia and syncope Especially dangerous during cesarean where spinal anesthesia causes hypotension . Hence a left lateral position needs to be given to prevent hypotension ( wedge under right hip )</li><li>\u27a4 Seen in 3 rd trimester</li><li>\u27a4 3 rd trimester</li><li>\u27a4 Pressure of gravid uterus on the IVC in supine position</li><li>\u27a4 Pressure</li><li>\u27a4 IVC</li><li>\u27a4 Hypotension, tachycardia and syncope</li><li>\u27a4 Hypotension, tachycardia</li><li>\u27a4 syncope</li><li>\u27a4 Especially dangerous during cesarean where spinal anesthesia causes hypotension . Hence a left lateral position needs to be given to prevent hypotension ( wedge under right hip )</li><li>\u27a4 dangerous</li><li>\u27a4 cesarean</li><li>\u27a4 spinal anesthesia</li><li>\u27a4 hypotension</li><li>\u27a4 left lateral position</li><li>\u27a4 prevent hypotension</li><li>\u27a4 wedge under right hip</li><li>\u27a4 Ref: Page no 62 - 63, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 62 - 63, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a9f95b54",
      "audio": ""
    },
    {
      "text": "ESR increases in pregnancy because of increase in?",
      "options": [
        {
          "label": "A",
          "text": "Fibrinogen",
          "correct": true
        },
        {
          "label": "B",
          "text": "Albumin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anti-thrombin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Platelets",
          "correct": false
        }
      ],
      "correct_answer": "A. Fibrinogen",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Fibrinogen</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 ESR in pregnancy is increased 4 \u2013 fold . This is due to increased fibrinogen levels</li><li>\u2022 ESR in pregnancy is increased 4 \u2013 fold . This is due to increased fibrinogen levels</li><li>\u2022 ESR</li><li>\u2022 increased 4 \u2013 fold</li><li>\u2022 increased fibrinogen levels</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 ESR in pregnancy is increased 4 \u2013 fold . This is due to increased fibrinogen levels</li><li>\u27a4 ESR in pregnancy is increased 4 \u2013 fold . This is due to increased fibrinogen levels</li><li>\u27a4 ESR</li><li>\u27a4 pregnancy</li><li>\u27a4 increased 4 \u2013 fold</li><li>\u27a4 increased fibrinogen levels</li><li>\u27a4 Ref: Page no 59, Williams Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no 59, Williams Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "aebd92e9",
      "audio": ""
    },
    {
      "text": "Assertion : To define anemia in pregnancy, high cutoff of Hb is taken than the non-pregnant scenarios. Reason : Physiological hemodilution is seen in pregnancy",
      "options": [
        {
          "label": "A",
          "text": "Both assertion and reason are true and the reason is the correct explanation for the assertion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Both assertion and reason are true, but the reason is not the correct explanation for the assertion",
          "correct": false
        },
        {
          "label": "C",
          "text": "Assertion is true, but the reason is false",
          "correct": false
        },
        {
          "label": "D",
          "text": "The assertion is false but reason is true",
          "correct": true
        }
      ],
      "correct_answer": "D. The assertion is false but reason is true",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. The assertion is false but reason is true</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 In pregnancy, there is a disproportionate increase in plasma (50%) compared to the RBC volume (20%) This produces a state of hemodilution during pregnancy This reflects as a fall in Hb by about 2g% leading to physiological anemia</li><li>\u2022 In pregnancy, there is a disproportionate increase in plasma (50%) compared to the RBC volume (20%)</li><li>\u2022 disproportionate increase</li><li>\u2022 plasma (50%)</li><li>\u2022 RBC volume (20%)</li><li>\u2022 This produces a state of hemodilution during pregnancy</li><li>\u2022 hemodilution</li><li>\u2022 pregnancy</li><li>\u2022 This reflects as a fall in Hb by about 2g% leading to physiological anemia</li><li>\u2022 fall in Hb</li><li>\u2022 2g%</li><li>\u2022 physiological anemia</li><li>\u2022 Hence the assertion that to define anemia in pregnancy, high cutoff of Hb is taken than the non-pregnant scenarios is false as we take a lower cut off in pregnancy</li><li>\u2022 assertion</li><li>\u2022 define anemia</li><li>\u2022 pregnancy, high cutoff</li><li>\u2022 Hb</li><li>\u2022 non-pregnant</li><li>\u2022 false</li><li>\u2022 we</li><li>\u2022 lower cut off</li><li>\u2022 pregnancy</li><li>\u2022 The reason is true i.e. physiological hemodilution is seen in pregnancy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In pregnancy , there is a disproportionate increase in plasma (50%) compared to the RBC volume (20%). This produces a state of hemodilution during pregnancy. This reflects as a fall in Hb by about 2g% leading to physiological anemia.</li><li>\u27a4 In pregnancy , there is a disproportionate increase in plasma (50%) compared to the RBC volume (20%).</li><li>\u27a4 pregnancy</li><li>\u27a4 disproportionate increase in plasma (50%)</li><li>\u27a4 RBC volume (20%).</li><li>\u27a4 This produces a state of hemodilution during pregnancy.</li><li>\u27a4 state of hemodilution</li><li>\u27a4 This reflects as a fall in Hb by about 2g% leading to physiological anemia.</li><li>\u27a4 fall in Hb</li><li>\u27a4 2g%</li><li>\u27a4 physiological anemia.</li><li>\u27a4 Ref: Page no 58, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 58, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "65f4b172",
      "audio": ""
    },
    {
      "text": "Which of the following is correct regarding physiological changes in respiratory system in pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Minute ventilation decreases by 50%",
          "correct": false
        },
        {
          "label": "B",
          "text": "Reserve volume is increased",
          "correct": false
        },
        {
          "label": "C",
          "text": "FRC decreases",
          "correct": true
        },
        {
          "label": "D",
          "text": "Total lung capacity increases by approximately 5 % by term",
          "correct": false
        }
      ],
      "correct_answer": "C. FRC decreases",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/screenshot-2024-01-15-185414.jpg"
      ],
      "explanation": "<p><strong>Ans. C. FRC decreases</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page no 65, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 65, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b01efc7f",
      "audio": ""
    },
    {
      "text": "A pregnant female presents with prolonged labor in emergency. She is taken for cesarean section what is the correct position in which the nurse should keep the patient on OT table?",
      "options": [
        {
          "label": "A",
          "text": "Supine with wedge under right hip",
          "correct": true
        },
        {
          "label": "B",
          "text": "Semi fowlers",
          "correct": false
        },
        {
          "label": "C",
          "text": "Trendelenburg with legs in stirrup",
          "correct": false
        },
        {
          "label": "D",
          "text": "Prone position",
          "correct": false
        }
      ],
      "correct_answer": "A. Supine with wedge under right hip",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Supine with wedge under right hip</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Supine hypotension syndrome/ Supine vena cava syndrome</li><li>\u2022 Supine hypotension syndrome/ Supine vena cava syndrome</li><li>\u2022 Seen in 3 rd trimester Pressure of gravid uterus on the IVC in supine position Hypotension, tachycardia and syncope</li><li>\u2022 Seen in 3 rd trimester</li><li>\u2022 Pressure of gravid uterus on the IVC in supine position</li><li>\u2022 Hypotension, tachycardia and syncope</li><li>\u2022 This is especially dangerous during cesarean where spinal anesthesia causes hypotension. Hence a left tilt needs to be given to prevent hypotension.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Supine hypotension syndrome/ Supine vena cava syndrome</li><li>\u27a4 Supine hypotension syndrome/ Supine vena cava syndrome</li><li>\u27a4 Seen in 3 rd trimester Pressure of gravid uterus on the IVC in supine position Hypotension, tachycardia and syncope</li><li>\u27a4 Seen in 3 rd trimester</li><li>\u27a4 Pressure of gravid uterus on the IVC in supine position</li><li>\u27a4 Hypotension, tachycardia and syncope</li><li>\u27a4 This is especially dangerous during cesarean where spinal anesthesia causes hypotension. Hence a left tilt needs to be given to prevent hypotension</li><li>\u27a4 Ref: Page no 62-63, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 62-63, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cfb1d1fa",
      "audio": ""
    },
    {
      "text": "During pregnancy pulmonary volumes and capacities change from the non-pregnant state. Which of these remains unchanged?",
      "options": [
        {
          "label": "A",
          "text": "Vital capacity",
          "correct": true
        },
        {
          "label": "B",
          "text": "FRC (functional residual capacity)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Residual Volume",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tidal volume",
          "correct": false
        }
      ],
      "correct_answer": "A. Vital capacity",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/screenshot-2024-01-15-185414_EcMNghw.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Vital capacity</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Respiratory function in pregnancy:</li><li>\u27a4 Respiratory function in pregnancy:</li><li>\u27a4 Ref: Page no 64, Williams Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no 64, Williams Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "836f3c43",
      "audio": ""
    },
    {
      "text": "Which of the following indices of respiration decreases in pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Respiratory rate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Residual volume",
          "correct": true
        },
        {
          "label": "C",
          "text": "Tidal volume",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vital capacity",
          "correct": false
        }
      ],
      "correct_answer": "B. Residual volume",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/screenshot-2024-01-15-185414_7gkLPzf.jpg"
      ],
      "explanation": "<p><strong>Ans. B. Residual volume</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 The residual volume decreases in pregnancy</li><li>\u2022 residual volume decreases</li><li>\u2022 pregnancy</li><li>\u2022 Other options:</li><li>\u2022 Other options:</li><li>\u2022 The respiratory rate does not change in pregnancy. The tidal volume increases in pregnancy. The vital capacity remains unchanged in pregnancy.</li><li>\u2022 The respiratory rate does not change in pregnancy.</li><li>\u2022 respiratory rate</li><li>\u2022 not</li><li>\u2022 pregnancy.</li><li>\u2022 The tidal volume increases in pregnancy.</li><li>\u2022 tidal volume increases</li><li>\u2022 pregnancy.</li><li>\u2022 The vital capacity remains unchanged in pregnancy.</li><li>\u2022 vital capacity</li><li>\u2022 unchanged</li><li>\u2022 pregnancy.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Respiratory function in pregnancy</li><li>\u27a4 Respiratory function in pregnancy</li><li>\u27a4 Ref: Page no 64-65, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 64-65, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f459c2a9",
      "audio": ""
    },
    {
      "text": "All are true about hemodynamic changes in pregnancy except?",
      "options": [
        {
          "label": "A",
          "text": "Increase in ventricular stroke volume",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increase in systemic vascular resistance",
          "correct": true
        },
        {
          "label": "C",
          "text": "Cardiac output is higher in lateral recumbent than supine position",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increase in heart rate",
          "correct": false
        }
      ],
      "correct_answer": "B. Increase in systemic vascular resistance",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Increase in systemic vascular resistance</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Systemic vascular resistance is reduced in pregnancy thereby causing a fall in BP</li><li>\u2022 Systemic vascular resistance is reduced in pregnancy thereby causing a fall in BP</li><li>\u2022 Systemic vascular resistance</li><li>\u2022 reduced</li><li>\u2022 fall in BP</li><li>\u2022 Other options:</li><li>\u2022 Other options:</li><li>\u2022 Option A: Increase in ventricular stroke volume: The stroke volume is increased in pregnancy Option C: Cardiac output is higher in lateral recumbent than supine position: This is because in supine position there is c ompression of the aorta and the IVC Option D: Increase in heart rate : The heart rate increases in pregnancy</li><li>\u2022 Option A: Increase in ventricular stroke volume: The stroke volume is increased in pregnancy</li><li>\u2022 Option A:</li><li>\u2022 Increase in ventricular stroke volume:</li><li>\u2022 increased</li><li>\u2022 pregnancy</li><li>\u2022 Option C: Cardiac output is higher in lateral recumbent than supine position: This is because in supine position there is c ompression of the aorta and the IVC</li><li>\u2022 Option C:</li><li>\u2022 Cardiac output</li><li>\u2022 higher</li><li>\u2022 lateral recumbent</li><li>\u2022 supine position</li><li>\u2022 ompression of the aorta</li><li>\u2022 IVC</li><li>\u2022 Option D: Increase in heart rate : The heart rate increases in pregnancy</li><li>\u2022 Option D:</li><li>\u2022 Increase</li><li>\u2022 heart rate</li><li>\u2022 increases</li><li>\u2022 pregnancy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Systemic vascular resistance is reduced in pregnancy thereby causing a fall in BP</li><li>\u27a4 Systemic vascular resistance is reduced in pregnancy thereby causing a fall in BP</li><li>\u27a4 Systemic vascular resistance</li><li>\u27a4 reduced</li><li>\u27a4 pregnancy</li><li>\u27a4 fall in BP</li><li>\u27a4 Ref: Page 58, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 58, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2b802ac6",
      "audio": ""
    },
    {
      "text": "In pregnancy, the diaphragm is pushed up at term by an average of?",
      "options": [
        {
          "label": "A",
          "text": "2 cm",
          "correct": false
        },
        {
          "label": "B",
          "text": "3 cm",
          "correct": false
        },
        {
          "label": "C",
          "text": "4 cm",
          "correct": true
        },
        {
          "label": "D",
          "text": "5 cm",
          "correct": false
        }
      ],
      "correct_answer": "C. 4 cm",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. 4 cm</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Anatomical changes in Respiratory System in Pregnancy</li><li>\u27a4 Anatomical changes in Respiratory System in Pregnancy</li><li>\u27a4 Lower ribs flare out Widening of subcostal angle (68\u00b0 to 102\u00b0) Thoracic cage transverse diamete r: increases by 2cm Thoracic cage circumference : increases by 6 cm: Diaphragm: rises by 4 cm</li><li>\u27a4 Lower ribs flare out</li><li>\u27a4 Lower ribs flare out</li><li>\u27a4 Widening of subcostal angle (68\u00b0 to 102\u00b0)</li><li>\u27a4 Widening of subcostal angle</li><li>\u27a4 Thoracic cage transverse diamete r: increases by 2cm</li><li>\u27a4 Thoracic cage transverse diamete</li><li>\u27a4 increases</li><li>\u27a4 2cm</li><li>\u27a4 Thoracic cage circumference : increases by 6 cm:</li><li>\u27a4 Thoracic cage circumference</li><li>\u27a4 increases</li><li>\u27a4 6 cm:</li><li>\u27a4 Diaphragm: rises by 4 cm</li><li>\u27a4 Diaphragm:</li><li>\u27a4 4 cm</li><li>\u27a4 Ref: Page no 64, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 64, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4075b0e6",
      "audio": ""
    },
    {
      "text": "All are anatomical changes seen in pregnancy except?",
      "options": [
        {
          "label": "A",
          "text": "Lower ribs flare out",
          "correct": false
        },
        {
          "label": "B",
          "text": "Narrowing of subcostal angle",
          "correct": true
        },
        {
          "label": "C",
          "text": "Thoracic cage diameter increases by 2cm",
          "correct": false
        },
        {
          "label": "D",
          "text": "Diaphragm rises by 4 cm",
          "correct": false
        }
      ],
      "correct_answer": "B. Narrowing of subcostal angle",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Narrowing of subcostal angle</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 In pregnancy, there is widening of the sub-costal angle (68\u00b0 to 102\u00b0 )</li><li>\u2022 In pregnancy, there is widening of the sub-costal angle</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Anatomical changes in Respiratory System in Pregnancy</li><li>\u27a4 Anatomical changes in Respiratory System in Pregnancy</li><li>\u27a4 Lower ribs flare out Widening of subcostal angle (68\u00b0 to 102\u00b0 ) Thoracic cage transverse diameter : increases by 2cm Thoracic cage circumference: increases by 6 cm: Diaphragm: rises by 4 cm</li><li>\u27a4 Lower ribs flare out</li><li>\u27a4 Lower ribs flare out</li><li>\u27a4 Widening of subcostal angle (68\u00b0 to 102\u00b0 )</li><li>\u27a4 Widening</li><li>\u27a4 subcostal angle (68\u00b0 to 102\u00b0</li><li>\u27a4 )</li><li>\u27a4 Thoracic cage transverse diameter : increases by 2cm</li><li>\u27a4 Thoracic cage transverse diameter</li><li>\u27a4 increases by 2cm</li><li>\u27a4 Thoracic cage circumference: increases by 6 cm:</li><li>\u27a4 Thoracic cage circumference: increases by 6 cm:</li><li>\u27a4 Diaphragm: rises by 4 cm</li><li>\u27a4 Diaphragm: rises by 4 cm</li><li>\u27a4 Ref: Page no 64, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 64, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "426958d1",
      "audio": ""
    },
    {
      "text": "All the below are physiological changes in pregnancy except:",
      "options": [
        {
          "label": "A",
          "text": "Renal pelvis enlargement",
          "correct": false
        },
        {
          "label": "B",
          "text": "Left ureteric dilatation more than right ureteric dilatation",
          "correct": true
        },
        {
          "label": "C",
          "text": "Decreased renal re-absorption of amnio acids",
          "correct": false
        },
        {
          "label": "D",
          "text": "Decreased renal re-absorption of glucose",
          "correct": false
        }
      ],
      "correct_answer": "B. Left ureteric dilatation more than right ureteric dilatation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Left ureteric dilatation more than right ureteric dilatation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 In pregnancy, there is right ureteric dilatation is more than left (due to dextro-rotation of the uterus and the right ovarian vein crossing over the right ureter )</li><li>\u2022 right ureteric dilatation</li><li>\u2022 more</li><li>\u2022 left</li><li>\u2022 dextro-rotation</li><li>\u2022 uterus</li><li>\u2022 right ovarian vein</li><li>\u2022 crossing</li><li>\u2022 right ureter</li><li>\u2022 Other options:</li><li>\u2022 Other options:</li><li>\u2022 Option A: Renal pelvis enlargement : mild pelvicalyceal enlargement of the kidneys is normally seen in pregnancy due to pressure of the gravid uterus Option C and D: In pregnancy , there is decreased renal reabsorption of: Glucose Amino acids Uric acid Water soluble vitamins</li><li>\u2022 Option A: Renal pelvis enlargement : mild pelvicalyceal enlargement of the kidneys is normally seen in pregnancy due to pressure of the gravid uterus</li><li>\u2022 Option A:</li><li>\u2022 Renal pelvis enlargement</li><li>\u2022 pelvicalyceal enlargement</li><li>\u2022 kidneys</li><li>\u2022 pregnancy</li><li>\u2022 pressure</li><li>\u2022 gravid uterus</li><li>\u2022 Option C and D: In pregnancy , there is decreased renal reabsorption of: Glucose Amino acids Uric acid Water soluble vitamins</li><li>\u2022 Option C and D:</li><li>\u2022 pregnancy</li><li>\u2022 decreased renal reabsorption</li><li>\u2022 Glucose Amino acids Uric acid Water soluble vitamins</li><li>\u2022 Glucose</li><li>\u2022 Glucose</li><li>\u2022 Amino acids</li><li>\u2022 Amino acids</li><li>\u2022 Uric acid</li><li>\u2022 Uric acid</li><li>\u2022 Water soluble vitamins</li><li>\u2022 Water soluble vitamins</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In pregnancy , there i s right ureteric dilatation is more than left (due to dextro-rotation of the uterus and the right ovarian vein crossing over the right ureter )</li><li>\u27a4 In pregnancy , there i s right ureteric dilatation is more than left (due to dextro-rotation of the uterus and the right ovarian vein crossing over the right ureter )</li><li>\u27a4 pregnancy</li><li>\u27a4 s right ureteric dilatation</li><li>\u27a4 more</li><li>\u27a4 left</li><li>\u27a4 dextro-rotation of the uterus</li><li>\u27a4 right</li><li>\u27a4 ovarian vein crossing</li><li>\u27a4 right ureter</li><li>\u27a4 Ref: Page no 65-66, Willliams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 65-66, Willliams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "936892e6",
      "audio": ""
    },
    {
      "text": "A 25 y primigravid woman presents to the OPD at 8 weeks pregnancy. Her BMI is 27. She asks you what is the average weight gain she needs to gain in pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "5 \u2013 9 kg",
          "correct": false
        },
        {
          "label": "B",
          "text": "7 \u2013 11 kg",
          "correct": true
        },
        {
          "label": "C",
          "text": "11 \u2013 15 kg",
          "correct": false
        },
        {
          "label": "D",
          "text": "12 \u2013 18 kg",
          "correct": false
        }
      ],
      "correct_answer": "B. 7 \u2013 11 kg",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/screenshot-2024-01-15-193434.jpg"
      ],
      "explanation": "<p><strong>Ans. B. 7-11 kg</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 As this patient is overweight (BMI is 27), her average weight gain should be lesser than normal i.e. 7-11kg</li><li>\u2022 overweight (BMI is 27),</li><li>\u2022 average weight gain</li><li>\u2022 lesser</li><li>\u2022 normal i.e. 7-11kg</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The table below shows the ideal weight gain on pregnancy based on a patient\u2019s pre-pregnancy BMI</li><li>\u27a4 ideal weight gain</li><li>\u27a4 pregnancy</li><li>\u27a4 pre-pregnancy BMI</li><li>\u27a4 Ideal Weight Gain in Pregnancy</li><li>\u27a4 Ref: Page no 170, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 170, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "66b52eb8",
      "audio": ""
    },
    {
      "text": "All the following clotting factors are increased in pregnancy except?",
      "options": [
        {
          "label": "A",
          "text": "Factor VII",
          "correct": false
        },
        {
          "label": "B",
          "text": "Factor VIII",
          "correct": false
        },
        {
          "label": "C",
          "text": "Factor XII",
          "correct": false
        },
        {
          "label": "D",
          "text": "Factor XIII",
          "correct": true
        }
      ],
      "correct_answer": "D. Factor XIII",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Factor XIII</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Pregnancy is a hypercoagulable state Fibrinogen level : raised by 50% (200-400 mg/ dl to 300-600 mg/dl) ESR increased 4-fold Platelet count: there may be a slight fall Gestational thrombocytopenia due to hemodilution and increased platelet consumption No adverse effect on pregnancy Usually seen in the 3 rd trimester Increase in plasma levels of Factors : 1, 2, 7, 8, 9, 10 Plasma levels of 2, 5 12 \u2013 unchanged/ mildly increased Factors 11, 13 \u2013 slightly decreased Clotting time: unaffected</li><li>\u2022 Pregnancy is a hypercoagulable state</li><li>\u2022 Pregnancy</li><li>\u2022 hypercoagulable state</li><li>\u2022 Fibrinogen level : raised by 50% (200-400 mg/ dl to 300-600 mg/dl)</li><li>\u2022 Fibrinogen level</li><li>\u2022 raised</li><li>\u2022 50%</li><li>\u2022 ESR increased 4-fold</li><li>\u2022 ESR increased 4-fold</li><li>\u2022 Platelet count: there may be a slight fall Gestational thrombocytopenia due to hemodilution and increased platelet consumption No adverse effect on pregnancy Usually seen in the 3 rd trimester</li><li>\u2022 Platelet count:</li><li>\u2022 slight fall</li><li>\u2022 Gestational thrombocytopenia due to hemodilution and increased platelet consumption No adverse effect on pregnancy Usually seen in the 3 rd trimester</li><li>\u2022 Gestational thrombocytopenia due to hemodilution and increased platelet consumption</li><li>\u2022 Gestational thrombocytopenia</li><li>\u2022 hemodilution</li><li>\u2022 increased platelet consumption</li><li>\u2022 No adverse effect on pregnancy</li><li>\u2022 No</li><li>\u2022 pregnancy</li><li>\u2022 Usually seen in the 3 rd trimester</li><li>\u2022 3 rd trimester</li><li>\u2022 Increase in plasma levels of Factors : 1, 2, 7, 8, 9, 10</li><li>\u2022 Increase</li><li>\u2022 Factors</li><li>\u2022 1, 2, 7, 8, 9, 10</li><li>\u2022 Plasma levels of 2, 5 12 \u2013 unchanged/ mildly increased</li><li>\u2022 Plasma levels</li><li>\u2022 2, 5 12</li><li>\u2022 unchanged/ mildly increased</li><li>\u2022 Factors 11, 13 \u2013 slightly decreased</li><li>\u2022 Factors 11, 13</li><li>\u2022 decreased</li><li>\u2022 Clotting time: unaffected</li><li>\u2022 Clotting time:</li><li>\u2022 unaffected</li><li>\u2022 Ref: Page no 59 -60, Williams Obstetrics 25 th edition</li><li>\u2022 Ref: Page no 59 -60, Williams Obstetrics 25 th edition</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3dc7b798",
      "audio": ""
    },
    {
      "text": "Estrogen and progesterone is first two months of pregnancy are produced by?",
      "options": [
        {
          "label": "A",
          "text": "Fetal ovaries",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fetal adrenal",
          "correct": false
        },
        {
          "label": "C",
          "text": "Placenta",
          "correct": false
        },
        {
          "label": "D",
          "text": "Corpus luteum",
          "correct": true
        }
      ],
      "correct_answer": "D. Corpus luteum",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Corpus luteum</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In the initial few weeks \u2014the main source of estrogen and progesterone during pregnancy is corpus luteum . This function is gradually taken over by the placenta by 10-12 weeks</li><li>\u27a4 In the initial few weeks \u2014the main source of estrogen and progesterone during pregnancy is corpus luteum .</li><li>\u27a4 few weeks</li><li>\u27a4 main source</li><li>\u27a4 estrogen and progesterone</li><li>\u27a4 pregnancy</li><li>\u27a4 corpus luteum</li><li>\u27a4 This function is gradually taken over by the placenta by 10-12 weeks</li><li>\u27a4 function</li><li>\u27a4 gradually</li><li>\u27a4 placenta by 10-12 weeks</li><li>\u27a4 Ref: Page no 230, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page no 230, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1270a1fc",
      "audio": ""
    },
    {
      "text": "All of the following occur in pregnancy EXCEPT?",
      "options": [
        {
          "label": "A",
          "text": "Increase in Cardiac output",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increase in stroke volume",
          "correct": false
        },
        {
          "label": "C",
          "text": "Decrease in fibrinogen levels",
          "correct": true
        },
        {
          "label": "D",
          "text": "Rise in the venous pressure in the lower limb in supine position",
          "correct": false
        }
      ],
      "correct_answer": "C. Decrease in fibrinogen levels",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Decrease in fibrinogen levels</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Physiological changes associated with pregnancy: Blood volume increases progressively from 6-8 weeks gestation (pregnancy) and reaches a maximum at approximately 32-34 weeks with little change thereafter. Renal plasma flow and glomerular filtration rate begin to increase progressively during the first trimester . Increases in blood volume and cardiac output . Elevations in plasma flow and glomerular filtration result in an elevation in creatinine clearance. Blood urea and serum creatinine are reduced by 40%. Here is also an increase in filtered sodium, but tubular absorption is increased by an increase in aldosterone secretion, via the renin-angiotensin mechanism. There is also a decrease in plasma osmolarity . RBC & Haemoglobin: RBC volume is increased to the extent of 20-30%. Total increase in volume is about 350ml ; the amount to be regulated by the increased demand of oxygen transport during pregnancy . Disproportionate increase in plasma and RBC volume produces a state of haemodilution during pregnancy. Thus, even though the total haemoglobin mass increases during pregnancy to the extent of 18-20 percent, there is apparent fall in haemoglobin concentration. At term the fall is about 2 gms from the non-pregnant value . There is simultaneous fall in number of red cells by 15-20% and the hematocrit level.</li><li>\u27a4 Physiological changes associated with pregnancy: Blood volume increases progressively from 6-8 weeks gestation (pregnancy) and reaches a maximum at approximately 32-34 weeks with little change thereafter. Renal plasma flow and glomerular filtration rate begin to increase progressively during the first trimester . Increases in blood volume and cardiac output . Elevations in plasma flow and glomerular filtration result in an elevation in creatinine clearance. Blood urea and serum creatinine are reduced by 40%. Here is also an increase in filtered sodium, but tubular absorption is increased by an increase in aldosterone secretion, via the renin-angiotensin mechanism. There is also a decrease in plasma osmolarity .</li><li>\u27a4 Blood volume increases progressively from 6-8 weeks gestation (pregnancy) and reaches a maximum at approximately 32-34 weeks with little change thereafter. Renal plasma flow and glomerular filtration rate begin to increase progressively during the first trimester . Increases in blood volume and cardiac output . Elevations in plasma flow and glomerular filtration result in an elevation in creatinine clearance. Blood urea and serum creatinine are reduced by 40%. Here is also an increase in filtered sodium, but tubular absorption is increased by an increase in aldosterone secretion, via the renin-angiotensin mechanism. There is also a decrease in plasma osmolarity .</li><li>\u27a4 Blood volume increases progressively from 6-8 weeks gestation (pregnancy) and reaches a maximum at approximately 32-34 weeks with little change thereafter.</li><li>\u27a4 Blood volume increases</li><li>\u27a4 6-8 weeks gestation</li><li>\u27a4 maximum</li><li>\u27a4 32-34 weeks</li><li>\u27a4 Renal plasma flow and glomerular filtration rate begin to increase progressively during the first trimester .</li><li>\u27a4 Renal plasma flow and glomerular filtration rate</li><li>\u27a4 increase</li><li>\u27a4 first trimester</li><li>\u27a4 Increases in blood volume and cardiac output .</li><li>\u27a4 Increases</li><li>\u27a4 blood volume and cardiac output</li><li>\u27a4 Elevations in plasma flow and glomerular filtration result in an elevation in creatinine clearance.</li><li>\u27a4 Elevations</li><li>\u27a4 plasma flow</li><li>\u27a4 glomerular filtration</li><li>\u27a4 elevation in creatinine clearance.</li><li>\u27a4 Blood urea and serum creatinine are reduced by 40%.</li><li>\u27a4 Blood urea</li><li>\u27a4 serum creatinine</li><li>\u27a4 reduced by 40%.</li><li>\u27a4 Here is also an increase in filtered sodium, but tubular absorption is increased by an increase in aldosterone secretion, via the renin-angiotensin mechanism.</li><li>\u27a4 increase in filtered sodium,</li><li>\u27a4 tubular absorption</li><li>\u27a4 increased</li><li>\u27a4 increase</li><li>\u27a4 aldosterone</li><li>\u27a4 renin-angiotensin mechanism.</li><li>\u27a4 There is also a decrease in plasma osmolarity .</li><li>\u27a4 decrease</li><li>\u27a4 plasma osmolarity</li><li>\u27a4 RBC & Haemoglobin: RBC volume is increased to the extent of 20-30%. Total increase in volume is about 350ml ; the amount to be regulated by the increased demand of oxygen transport during pregnancy . Disproportionate increase in plasma and RBC volume produces a state of haemodilution during pregnancy. Thus, even though the total haemoglobin mass increases during pregnancy to the extent of 18-20 percent, there is apparent fall in haemoglobin concentration. At term the fall is about 2 gms from the non-pregnant value . There is simultaneous fall in number of red cells by 15-20% and the hematocrit level.</li><li>\u27a4 RBC volume is increased to the extent of 20-30%. Total increase in volume is about 350ml ; the amount to be regulated by the increased demand of oxygen transport during pregnancy . Disproportionate increase in plasma and RBC volume produces a state of haemodilution during pregnancy. Thus, even though the total haemoglobin mass increases during pregnancy to the extent of 18-20 percent, there is apparent fall in haemoglobin concentration. At term the fall is about 2 gms from the non-pregnant value . There is simultaneous fall in number of red cells by 15-20% and the hematocrit level.</li><li>\u27a4 RBC volume is increased to the extent of 20-30%.</li><li>\u27a4 RBC volume</li><li>\u27a4 increased</li><li>\u27a4 20-30%.</li><li>\u27a4 Total increase in volume is about 350ml ; the amount to be regulated by the increased demand of oxygen transport during pregnancy .</li><li>\u27a4 Total increase</li><li>\u27a4 350ml</li><li>\u27a4 increased demand of oxygen transport</li><li>\u27a4 pregnancy</li><li>\u27a4 Disproportionate increase in plasma and RBC volume produces a state of haemodilution during pregnancy.</li><li>\u27a4 Disproportionate increase</li><li>\u27a4 plasma and RBC volume</li><li>\u27a4 haemodilution</li><li>\u27a4 pregnancy.</li><li>\u27a4 Thus, even though the total haemoglobin mass increases during pregnancy to the extent of 18-20 percent, there is apparent fall in haemoglobin concentration.</li><li>\u27a4 total haemoglobin</li><li>\u27a4 increases</li><li>\u27a4 18-20 percent,</li><li>\u27a4 fall in haemoglobin concentration.</li><li>\u27a4 At term the fall is about 2 gms from the non-pregnant value .</li><li>\u27a4 At term</li><li>\u27a4 2 gms</li><li>\u27a4 non-pregnant value</li><li>\u27a4 There is simultaneous fall in number of red cells by 15-20% and the hematocrit level.</li><li>\u27a4 fall in number of red cells</li><li>\u27a4 15-20%</li><li>\u27a4 hematocrit level.</li><li>\u27a4 Ref: Page no 60, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 60, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dc876661",
      "audio": ""
    },
    {
      "text": "You are called in to evaluate the heart of a 19-year-old primigravida at term. Listening carefully to the heart, you determine that there is a split S1, normal S2, S3 easily audible with a 2/6 systolic ejection murmur greater during inspiration, and a soft diastolic murmur. You immediately recognize which of the following?",
      "options": [
        {
          "label": "A",
          "text": "The presence of the S3 is abnormal",
          "correct": false
        },
        {
          "label": "B",
          "text": "The systolic ejection murmur is unusual in a pregnant woman at term",
          "correct": false
        },
        {
          "label": "C",
          "text": "The combination of a prominent S3 and soft diastolic murmur is a significant abnormality",
          "correct": false
        },
        {
          "label": "D",
          "text": "All findings recorded are normal changes in pregnancy",
          "correct": true
        }
      ],
      "correct_answer": "D. All findings recorded are normal changes in pregnancy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. All findings recorded are normal changes in pregnancy</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Normal cardiovascular findings in pregnancy are:</li><li>\u27a4 Normal cardiovascular findings in pregnancy are:</li><li>\u27a4 On Examination:</li><li>\u27a4 On Examination:</li><li>\u27a4 Apex beat is shifted to the 4 th intercostal space; 2.5 cm outside the mid-clavicular line. PR increases Mildly elevated JVP Ejection Systolic murmur at apical/pulmonary area (grade 1/2) Rarely (20%): A soft diastolic murmur may be heard Mammary murmur \u2013 left 2 nd and 3 rd intercostal space \u2013 due to increased flow in the internal mammary vessels. S3 \u2013 due to rapid diastolic filling S4 \u2013 rare ECG \u2013 normal pattern; sometimes left axis deviation.</li><li>\u27a4 Apex beat is shifted to the 4 th intercostal space; 2.5 cm outside the mid-clavicular line.</li><li>\u27a4 Apex beat is shifted to the 4 th intercostal space; 2.5 cm outside the mid-clavicular line.</li><li>\u27a4 PR increases</li><li>\u27a4 PR increases</li><li>\u27a4 Mildly elevated JVP</li><li>\u27a4 Mildly elevated JVP</li><li>\u27a4 Ejection Systolic murmur at apical/pulmonary area (grade 1/2)</li><li>\u27a4 Ejection Systolic murmur at apical/pulmonary area (grade 1/2)</li><li>\u27a4 Rarely (20%): A soft diastolic murmur may be heard</li><li>\u27a4 Rarely (20%): A soft diastolic murmur may be heard</li><li>\u27a4 Mammary murmur \u2013 left 2 nd and 3 rd intercostal space \u2013 due to increased flow in the internal mammary vessels.</li><li>\u27a4 Mammary murmur \u2013 left 2 nd and 3 rd intercostal space \u2013 due to increased flow in the internal mammary vessels.</li><li>\u27a4 S3 \u2013 due to rapid diastolic filling</li><li>\u27a4 S3 \u2013 due to rapid diastolic filling</li><li>\u27a4 S4 \u2013 rare</li><li>\u27a4 S4 \u2013 rare</li><li>\u27a4 ECG \u2013 normal pattern; sometimes left axis deviation.</li><li>\u27a4 ECG \u2013 normal pattern; sometimes left axis deviation.</li><li>\u27a4 Ref: Page no 61, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 61, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3f5e1e88",
      "audio": ""
    },
    {
      "text": "Which of the following hormones is primarily secreted by fetal adrenal cortex?",
      "options": [
        {
          "label": "A",
          "text": "Cortisol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Corticosterone",
          "correct": false
        },
        {
          "label": "C",
          "text": "DHEAS",
          "correct": true
        },
        {
          "label": "D",
          "text": "Progesterone",
          "correct": false
        }
      ],
      "correct_answer": "C. DHEAS",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/16/2.jpg"
      ],
      "explanation": "<p><strong>Ans. C. DHEAS</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Fetoplacental Unit</li><li>\u27a4 Fetoplacental Unit</li><li>\u27a4 The fetus and the placenta interact in the formation of steroid hormones . The placenta synthesizes pregnenolone and progesterone from cholesterol. Some of the progesterone enters the fetal circulation and provides the substrate for the formation of cortisol and corticosterone in the fetal adrenal glands. Some of the pregnenolone enters the fetus and, along with pregnenolone synthesized in the fetal liver , is the substrate for the formation of dehydroepiandrosterone sulfate (DHEAS) and 16-hydroxydehydroepiandrosterone sulfate (16-OHDHEAS) in the fetal adrenal. Some 16-hydroxylation also occurs in the fetal liver . DHEAS and 16-OHDHEAS are transported back to the placenta, where DHEAS forms estradiol and 16-OHDHEAS forms estriol. The principal estrogen formed is estriol, and since fetal 16-OHDHEAS is the principal substrate for the estrogens, the urinary estriol excretion of the mother can be monitored as an index of the state of the fetus.</li><li>\u27a4 The fetus and the placenta interact in the formation of steroid hormones .</li><li>\u27a4 fetus</li><li>\u27a4 placenta interact</li><li>\u27a4 steroid hormones</li><li>\u27a4 The placenta synthesizes pregnenolone and progesterone from cholesterol.</li><li>\u27a4 placenta synthesizes pregnenolone and progesterone</li><li>\u27a4 Some of the progesterone enters the fetal circulation and provides the substrate for the formation of cortisol and corticosterone in the fetal adrenal glands.</li><li>\u27a4 progesterone</li><li>\u27a4 fetal circulation</li><li>\u27a4 substrate</li><li>\u27a4 cortisol and corticosterone</li><li>\u27a4 fetal adrenal glands.</li><li>\u27a4 Some of the pregnenolone enters the fetus and, along with pregnenolone synthesized in the fetal liver , is the substrate for the formation of dehydroepiandrosterone sulfate (DHEAS) and 16-hydroxydehydroepiandrosterone sulfate (16-OHDHEAS) in the fetal adrenal.</li><li>\u27a4 pregnenolone</li><li>\u27a4 fetus</li><li>\u27a4 pregnenolone synthesized</li><li>\u27a4 fetal liver</li><li>\u27a4 substrate</li><li>\u27a4 dehydroepiandrosterone sulfate (DHEAS)</li><li>\u27a4 16-hydroxydehydroepiandrosterone sulfate</li><li>\u27a4 fetal adrenal.</li><li>\u27a4 Some 16-hydroxylation also occurs in the fetal liver . DHEAS and 16-OHDHEAS are transported back to the placenta, where DHEAS forms estradiol and 16-OHDHEAS forms estriol.</li><li>\u27a4 16-hydroxylation</li><li>\u27a4 fetal liver</li><li>\u27a4 DHEAS and 16-OHDHEAS</li><li>\u27a4 transported back</li><li>\u27a4 placenta,</li><li>\u27a4 estradiol and 16-OHDHEAS</li><li>\u27a4 estriol.</li><li>\u27a4 The principal estrogen formed is estriol, and since fetal 16-OHDHEAS is the principal substrate for the estrogens, the urinary estriol excretion of the mother can be monitored as an index of the state of the fetus.</li><li>\u27a4 estrogen</li><li>\u27a4 estriol,</li><li>\u27a4 fetal 16-OHDHEAS</li><li>\u27a4 principal substrate</li><li>\u27a4 estrogens,</li><li>\u27a4 urinary estriol</li><li>\u27a4 mother</li><li>\u27a4 monitored</li><li>\u27a4 state of the fetus.</li><li>\u27a4 Ref: Page 281, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page 281, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0ce0a62b",
      "audio": ""
    },
    {
      "text": "A 29-year-old G2P1 woman at 28 weeks\u2019 gestation, who had normal haemoglobin level 4 weeks ago at her first prenatal visit, complains of 1 week of fatigue and now has a haemoglobin level of 7.0 g/ dL. She noted dark-coloured urine after taking an antibiotic for a urinary tract infection. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Iron deficiency anemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thalassemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "G6PD deficiency anemia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Vitamin B12 deficiency",
          "correct": false
        }
      ],
      "correct_answer": "C. G6PD deficiency anemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. G6PD deficiency anemia</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 G6PD deficiency results in increased sensitivity to drug induced haemolysis on intake of oxidant drugs . This can be seen in pregnancy also.</li><li>\u27a4 G6PD deficiency results in increased sensitivity to drug induced haemolysis on intake of oxidant drugs . This can be seen in pregnancy also.</li><li>\u27a4 G6PD deficiency</li><li>\u27a4 increased sensitivity</li><li>\u27a4 drug induced haemolysis</li><li>\u27a4 oxidant drugs</li><li>\u27a4 seen</li><li>\u27a4 pregnancy</li><li>\u27a4 Ref: Page 2739, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page 2739, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b2b3495d",
      "audio": ""
    },
    {
      "text": "Which of the following best describes the function of pregnancy associated plasma protein A (PAPP-A)?",
      "options": [
        {
          "label": "A",
          "text": "Carrier protein for estrogen and progesterone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Helps in maintenance of placenta",
          "correct": false
        },
        {
          "label": "C",
          "text": "Immunosuppression against fetal antigens",
          "correct": true
        },
        {
          "label": "D",
          "text": "Maintains colloid osmotic pressure in maternal blood",
          "correct": false
        }
      ],
      "correct_answer": "C. Immunosuppression against fetal antigens",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Immunosuppression against fetal antigens</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Pregnancy-associated plasma protein-A (PAPP-A) largest of the pregnancy associated proteins is produced by both the embryo and the placenta (syncytio-cytotrophoblasts) during pregnancy. This protein is thought to have several different functions, including preventing recognition of the fetus by the maternal immune system, matrix mineralization and angiogenesis. Levels of PAPP-A rise from first detection in the first trimester until term. Maternal serum concentrations are related to subsequent fetal growth and this relationship has suggested that it can be used as a diagnostic test for adverse pregnancy outcomes ( intrauterine growth restriction, premature birth, preeclampsia, and stillbirth ).</li><li>\u27a4 Pregnancy-associated plasma protein-A (PAPP-A) largest of the pregnancy associated proteins is produced by both the embryo and the placenta (syncytio-cytotrophoblasts) during pregnancy.</li><li>\u27a4 Pregnancy-associated plasma protein-A (PAPP-A)</li><li>\u27a4 pregnancy</li><li>\u27a4 proteins</li><li>\u27a4 both</li><li>\u27a4 embryo and the placenta (syncytio-cytotrophoblasts)</li><li>\u27a4 This protein is thought to have several different functions, including preventing recognition of the fetus by the maternal immune system, matrix mineralization and angiogenesis.</li><li>\u27a4 preventing recognition of the fetus</li><li>\u27a4 maternal</li><li>\u27a4 immune system, matrix mineralization and angiogenesis.</li><li>\u27a4 Levels of PAPP-A rise from first detection in the first trimester until term.</li><li>\u27a4 PAPP-A rise</li><li>\u27a4 first</li><li>\u27a4 first trimester until term.</li><li>\u27a4 Maternal serum concentrations are related to subsequent fetal growth and this relationship has suggested that it can be used as a diagnostic test for adverse pregnancy outcomes ( intrauterine growth restriction, premature birth, preeclampsia, and stillbirth ).</li><li>\u27a4 Maternal serum concentrations</li><li>\u27a4 fetal growth</li><li>\u27a4 diagnostic test</li><li>\u27a4 pregnancy outcomes</li><li>\u27a4 intrauterine growth restriction, premature birth,</li><li>\u27a4 preeclampsia, and stillbirth</li><li>\u27a4 Ref: Page no 863, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page no 863, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cccdcaf7",
      "audio": ""
    },
    {
      "text": "W hich of the following hormones is primarily responsible for the physiological increase in maternal insulin resistance during pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Progesterone",
          "correct": true
        },
        {
          "label": "B",
          "text": "Prolactin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Human chorionic gonadotropin (hCG)",
          "correct": false
        },
        {
          "label": "D",
          "text": "ACTH",
          "correct": false
        }
      ],
      "correct_answer": "A. Progesterone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Progesterone is the hormone primarily responsible for the physiological increase in maternal insulin resistance during pregnancy . This resistance helps divert glucose to the developing fetus , ensuring an adequate energy supply . The combination of elevated progesterone and other hormones like human placental lactogen contributes to this insulin resistance .</li><li>\u2022 Progesterone is the hormone primarily responsible for the physiological increase in maternal insulin resistance during pregnancy . This resistance helps divert glucose to the developing fetus , ensuring an adequate energy supply . The combination of elevated progesterone and other hormones like human placental lactogen contributes to this insulin resistance .</li><li>\u2022 Progesterone</li><li>\u2022 physiological increase</li><li>\u2022 maternal insulin resistance</li><li>\u2022 pregnancy</li><li>\u2022 divert glucose</li><li>\u2022 developing fetus</li><li>\u2022 adequate energy supply</li><li>\u2022 elevated progesterone</li><li>\u2022 human placental lactogen</li><li>\u2022 insulin resistance</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective: Pregnancy is a diabetogenic state</li><li>\u27a4 There is hyperinsulinemia due to hypertrophy/ hyperplasia of beta cells of pancreas. However, despite this, there is postprandial hyperglycemia due to peripheral insulin resistance mediated primarily by progesterone and also by estrogen, cortisol and hPL. There is also mild fasting hypoglycemia. There is no change in plasma glucagon levels.</li><li>\u27a4 There is hyperinsulinemia due to hypertrophy/ hyperplasia of beta cells of pancreas.</li><li>\u27a4 hyperinsulinemia</li><li>\u27a4 hypertrophy/ hyperplasia</li><li>\u27a4 beta cells of pancreas.</li><li>\u27a4 However, despite this, there is postprandial hyperglycemia due to peripheral insulin resistance mediated primarily by progesterone and also by estrogen, cortisol and hPL.</li><li>\u27a4 postprandial hyperglycemia</li><li>\u27a4 peripheral insulin resistance</li><li>\u27a4 progesterone</li><li>\u27a4 There is also mild fasting hypoglycemia.</li><li>\u27a4 mild fasting hypoglycemia.</li><li>\u27a4 There is no change in plasma glucagon levels.</li><li>\u27a4 no</li><li>\u27a4 plasma glucagon levels.</li><li>\u27a4 Ref: Page No 56, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page No 56, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "36b00f65",
      "audio": ""
    },
    {
      "text": "A 28-year-old pregnant woman at 32 weeks of gestation presents with lower extremity edema. She is concerned about the swelling and asks the physician about the reason for this condition. Which of the following physiological changes in pregnancy primarily contributes to peripheral edema?",
      "options": [
        {
          "label": "A",
          "text": "Increased aldosterone levels",
          "correct": false
        },
        {
          "label": "B",
          "text": "Decreased venous pressure",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased plasma oncotic pressure",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increased capillary permeability",
          "correct": true
        }
      ],
      "correct_answer": "D. Increased capillary permeability",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The primary physiological change in pregnancy contributing to peripheral edema is increased capillary permeability. Hormones like progesterone and estrogen cause the dilation of small blood vessels and increased capillary permeability . This allows for the escape of fluid and proteins into the extracellular space , leading to edema , particularly in the lower extremities.</li><li>\u27a4 primary physiological change</li><li>\u27a4 peripheral edema</li><li>\u27a4 increased capillary permeability.</li><li>\u27a4 progesterone and estrogen</li><li>\u27a4 dilation of small blood vessels</li><li>\u27a4 increased capillary permeability</li><li>\u27a4 fluid and proteins</li><li>\u27a4 extracellular space</li><li>\u27a4 edema</li><li>\u27a4 lower extremities.</li><li>\u27a4 Ref: Page No 55, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page No 55, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3f20a2f5",
      "audio": ""
    },
    {
      "text": "A 24-year-old woman, who is 12 weeks pregnant, complains of frequent urination and a sensation of urinary urgency. Which of the following physiological changes in pregnancy is primarily responsible for her symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Uterine compression of the bladder",
          "correct": true
        },
        {
          "label": "B",
          "text": "Elevated glomerular filtration rate (GFR)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Decreased blood flow to the kidneys",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increased antidiuretic hormone (ADH) secretion",
          "correct": false
        }
      ],
      "correct_answer": "A. Uterine compression of the bladder",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The frequent urination and urinary urgency experienced by the pregnant woman are primarily due to uterine compression of the bladder. As the uterus enlarges and presses against the bladder, it reduces the bladder's capacity , leading to increased urinary frequency.</li><li>\u27a4 frequent urination and urinary urgency</li><li>\u27a4 pregnant woman</li><li>\u27a4 uterine compression</li><li>\u27a4 bladder.</li><li>\u27a4 uterus enlarges and presses</li><li>\u27a4 bladder,</li><li>\u27a4 reduces the bladder's capacity</li><li>\u27a4 increased urinary</li><li>\u27a4 frequency.</li><li>\u27a4 Ref: Page No 68 , William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page No 68 , William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "308afc89",
      "audio": ""
    },
    {
      "text": "During pregnancy, the maternal cardiovascular system undergoes significant changes to support the growing fetus. Which of the following adaptations is a physiological change unique to pregnancy that contributes to maintaining systemic blood pressure and uteroplacental perfusion?",
      "options": [
        {
          "label": "A",
          "text": "Increased systemic vascular resistance",
          "correct": false
        },
        {
          "label": "B",
          "text": "Elevated maternal hemoglobin concentration",
          "correct": false
        },
        {
          "label": "C",
          "text": "Decreased cardiac output",
          "correct": false
        },
        {
          "label": "D",
          "text": "Activation of the renin-angiotensin-aldosterone system",
          "correct": true
        }
      ],
      "correct_answer": "D. Activation of the renin-angiotensin-aldosterone system",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Increase</li><li>\u27a4 Increase</li><li>\u27a4 Heart rate</li><li>\u27a4 Stroke volume</li><li>\u27a4 Cardiac output</li><li>\u27a4 Blood, red blood cell, and plasma volume</li><li>\u27a4 Decrease</li><li>\u27a4 Decrease</li><li>\u27a4 Systemic vascular resistance</li><li>\u27a4 Systolic, diastolic, and mean arterial pressure</li><li>\u27a4 Unchanged</li><li>\u27a4 Unchanged</li><li>\u27a4 Central venous pressure</li><li>\u27a4 Pulmonary capillary wedge pressure</li><li>\u27a4 Left ventricular ejection fraction</li><li>\u27a4 Left ventricular diastolic function</li><li>\u27a4 Troponin I</li><li>\u27a4 Brain natriuretic peptide</li><li>\u27a4 Ref: Page No 63, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page No 63, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c4e711ea",
      "audio": ""
    },
    {
      "text": "A 23-year woman presents to the OPD. She is recently married and has missed her period and is overdue by 2 weeks. She wants to know if she is pregnant or not. If she is pregnant which will NOT be seen on clinical examination?",
      "options": [
        {
          "label": "A",
          "text": "Jaquemier\u2019s sign",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hegar\u2019s sign",
          "correct": false
        },
        {
          "label": "C",
          "text": "Osiander\u2019s sign",
          "correct": false
        },
        {
          "label": "D",
          "text": "Robert\u2019s sign",
          "correct": true
        }
      ],
      "correct_answer": "D. Robert\u2019s sign",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/01.jpg"
      ],
      "explanation": "<p><strong>Ans. D. Robert\u2019s sign</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Let\u2019s Discuss all Options:</li><li>\u2022 Let\u2019s Discuss all Options:</li><li>\u2022 Option D. Robert sign is the presence of a gas shadow in the aorta and other large vessels following intra-uterine fetal demise. Option A, B, C. Jaquemier, Hegar and Osiander signs are all seen in pregnancy.</li><li>\u2022 Option D. Robert sign is the presence of a gas shadow in the aorta and other large vessels following intra-uterine fetal demise.</li><li>\u2022 Option D.</li><li>\u2022 Option A, B, C. Jaquemier, Hegar and Osiander signs are all seen in pregnancy.</li><li>\u2022 Option A, B, C.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Named Pelvic signs</li><li>\u27a4 Named Pelvic signs</li><li>\u27a4 Finding it Difficult to remember? These may help!</li><li>\u27a4 \u201cJack & Chad had a blue van. Ossy\u2019s pulse increased.\u201d \u201cA soft cervix is good\u201d</li><li>\u27a4 \u201cJack & Chad had a blue van. Ossy\u2019s pulse increased.\u201d</li><li>\u27a4 \u201cA soft cervix is good\u201d</li><li>\u27a4 Ref:  Page 61; DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li><li>\u27a4 Ref:  Page 61; DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a7597a85",
      "audio": ""
    },
    {
      "text": "A 23-year primigravida presents at 6 weeks with spotting. She is very anxious. On ultrasound, there is a single live intrauterine fetus corresponding to 6 weeks and cardiac activity is seen. She is reassured that this spotting could be normal and due to fusion of the decidua. What is this sign known as?",
      "options": [
        {
          "label": "A",
          "text": "Palmer sign",
          "correct": false
        },
        {
          "label": "B",
          "text": "Piscacek\u2019s sign",
          "correct": false
        },
        {
          "label": "C",
          "text": "Placental sign",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hegar\u2019s sign",
          "correct": false
        }
      ],
      "correct_answer": "C. Placental sign",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/02.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Placental sign</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Placental sign is mild bleeding/ spotting which may be seen before complete fusion of the decidua vera with the decidua capsularis and is also called implantation bleed ; It may be cyclical and may last till 12 weeks.</li><li>\u2022 Placental sign</li><li>\u2022 also called implantation bleed</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Palmer sign, Piscacek\u2019s sign and Hegar sign are all clinical signs of pregnancy in the 1 st trimester</li><li>\u2022 Palmer sign, Piscacek\u2019s sign and Hegar sign are all clinical signs of pregnancy in the 1 st trimester</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The named signs in pregnancy are:</li><li>\u27a4 Ref: Page 61; DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li><li>\u27a4 Ref: Page 61; DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "224f2a86",
      "audio": ""
    },
    {
      "text": "A 25-year woman has missed her period. She does a urine pregnancy test at home to see if she is pregnant. Which is correct regarding the urine pregnancy test?",
      "options": [
        {
          "label": "A",
          "text": "It can detect \u03b2hCG in the urine and appears before \u03b2hCG can be detected in the blood.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Most pregnancy test detect the \u03b1 subunit of beta hCG",
          "correct": false
        },
        {
          "label": "C",
          "text": "Maximum level of hCG is reached at about 50 days of a missed period",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tests based on ELISA are positive on the 1 st day of a missed period.",
          "correct": true
        }
      ],
      "correct_answer": "D. Tests based on ELISA are positive on the 1 st day of a missed period.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/screenshot-2024-01-11-130150.jpg"
      ],
      "explanation": "<p><strong>Ans. D. Tests based on ELISA are positive on the 1stday of a missed period.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Let\u2019s Discuss all options:</li><li>\u2022 Let\u2019s Discuss all options:</li><li>\u2022 Option A. It can detect \u03b2hCG in the urine and appears before \u03b2hCG can be detected in the blood. This is incorrect. First beta hCG appears in the blood and then in the urine Option B. Most pregnancy tests detect the \u03b1 subunit of beta hCG: This is also incorrect. Most tests detect the beta subunit of hCG</li><li>\u2022 Option A. It can detect \u03b2hCG in the urine and appears before \u03b2hCG can be detected in the blood. This is incorrect. First beta hCG appears in the blood and then in the urine</li><li>\u2022 Option A.</li><li>\u2022 Option B. Most pregnancy tests detect the \u03b1 subunit of beta hCG: This is also incorrect. Most tests detect the beta subunit of hCG</li><li>\u2022 Option B.</li><li>\u2022 Option C. Maximum level of hCG is reached at about 50 days of a missed period. This is also incorrect. Maximum levels of beta hCG are at 10 weeks (70-80 days)</li><li>\u2022 Option C. Maximum level of hCG is reached at about 50 days of a missed period. This is also incorrect. Maximum levels of beta hCG are at 10 weeks (70-80 days)</li><li>\u2022 Option C.</li><li>\u2022 Option D. Tests based on ELISA are positive on the 1 st day of a missed period. This is a correct statement.</li><li>\u2022 Option D. Tests based on ELISA are positive on the 1 st day of a missed period. This is a correct statement.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Pregnancy tests depend on detection of the antigen (hCG); usually the beta unit, present in the maternal urine or serum with antibody either polyclonal or monoclonal available commercially Maximum levels of beta hCG are at 10 weeks (70-80 days) Serum detection of hCG is earlier than detection of hCG in the urine ELISA based tests are positive as early as on the 1 st day of a missed period (urine) and 4-5 days before a missed period (serum)</li><li>\u27a4 Pregnancy tests depend on detection of the antigen (hCG); usually the beta unit, present in the maternal urine or serum with antibody either polyclonal or monoclonal available commercially</li><li>\u27a4 Maximum levels of beta hCG are at 10 weeks (70-80 days)</li><li>\u27a4 Serum detection of hCG is earlier than detection of hCG in the urine</li><li>\u27a4 ELISA based tests are positive as early as on the 1 st day of a missed period (urine) and 4-5 days before a missed period (serum)</li><li>\u27a4 Ref: Page 62, DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li><li>\u27a4 Ref: Page 62, DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4c052419",
      "audio": ""
    },
    {
      "text": "A 28-year G2 presents at 5 weeks pregnancy with mild abdominal pain. On examination, there is no pallor, and her vital signs are stable. An ultrasound reveals the following. Which is correct regarding this?",
      "options": [
        {
          "label": "A",
          "text": "A follow up ultrasound after 2 weeks is advised",
          "correct": true
        },
        {
          "label": "B",
          "text": "Beta hCG to be done with serial monitoring",
          "correct": false
        },
        {
          "label": "C",
          "text": "Laparoscopy and salpingotomy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Inj Methotrexate 50mg/m 2",
          "correct": false
        }
      ],
      "correct_answer": "A. A follow up ultrasound after 2 weeks is advised",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/picture1.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. A follow up ultrasound after 2 weeks is advised</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 This image shows an intra-uterine gestational sac which is seen at 5 weeks of pregnancy As a gestational sac is seen, the next best step would be to follow up with a repeat ultrasound after 10 \u2013 14 days to look for the fetal pole and cardiac activity.</li><li>\u2022 This image shows an intra-uterine gestational sac which is seen at 5 weeks of pregnancy</li><li>\u2022 As a gestational sac is seen, the next best step would be to follow up with a repeat ultrasound after 10 \u2013 14 days to look for the fetal pole and cardiac activity.</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option B. Beta hCG to be done with serial monitoring: This is indicated when the ultrasound does not show anything, i.e. a pregnancy of unknown location. Option C. Laparoscopy and salpingotomy: This is indicated in an unruptured ectopic pregnancy. In this case the gestational sac is seen in the uterus. Option D. Inj Methotrexate 50mg/m 2 : This is indicated in a patient with unruptured ectopic pregnancy but in this case, the gestational sac is seen in the uterus</li><li>\u2022 Option B. Beta hCG to be done with serial monitoring: This is indicated when the ultrasound does not show anything, i.e. a pregnancy of unknown location.</li><li>\u2022 Option B.</li><li>\u2022 Beta hCG to be done with serial monitoring:</li><li>\u2022 Option C. Laparoscopy and salpingotomy: This is indicated in an unruptured ectopic pregnancy. In this case the gestational sac is seen in the uterus.</li><li>\u2022 Option C.</li><li>\u2022 Laparoscopy and salpingotomy:</li><li>\u2022 Option D. Inj Methotrexate 50mg/m 2 : This is indicated in a patient with unruptured ectopic pregnancy but in this case, the gestational sac is seen in the uterus</li><li>\u2022 Option D.</li><li>\u2022 Inj Methotrexate 50mg/m 2 :</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Features of an intra-uterine gestational sac: Eccentric Regular and round Double decidual sac sign seen Intra-decidual sac sign seen Yolk sac seen (at 5.5 weeks) Associated peripheral vascularity seen Order of appearance of structures on a Trans-vaginal Scan in an intra-uterine pregnancy (These appear 1 week later on a Trans-abdominal scan) 5 weeks: Gestational sac 5.5 weeks: Yolk sac (1 st anatomic structure to be seen in the gestational sac) 6 weeks: Fetal pole with cardiac activity</li><li>\u27a4 Features of an intra-uterine gestational sac: Eccentric Regular and round Double decidual sac sign seen Intra-decidual sac sign seen Yolk sac seen (at 5.5 weeks) Associated peripheral vascularity seen</li><li>\u27a4 Eccentric Regular and round Double decidual sac sign seen Intra-decidual sac sign seen Yolk sac seen (at 5.5 weeks) Associated peripheral vascularity seen</li><li>\u27a4 Eccentric</li><li>\u27a4 Regular and round</li><li>\u27a4 Double decidual sac sign seen</li><li>\u27a4 Intra-decidual sac sign seen</li><li>\u27a4 Yolk sac seen (at 5.5 weeks)</li><li>\u27a4 Associated peripheral vascularity seen</li><li>\u27a4 Order of appearance of structures on a Trans-vaginal Scan in an intra-uterine pregnancy (These appear 1 week later on a Trans-abdominal scan) 5 weeks: Gestational sac 5.5 weeks: Yolk sac (1 st anatomic structure to be seen in the gestational sac) 6 weeks: Fetal pole with cardiac activity</li><li>\u27a4 5 weeks: Gestational sac 5.5 weeks: Yolk sac (1 st anatomic structure to be seen in the gestational sac) 6 weeks: Fetal pole with cardiac activity</li><li>\u27a4 5 weeks: Gestational sac</li><li>\u27a4 5.5 weeks: Yolk sac (1 st anatomic structure to be seen in the gestational sac)</li><li>\u27a4 6 weeks: Fetal pole with cardiac activity</li><li>\u27a4 Ref:  Page 158, William\u2019s Obstetrics; 25 th edition</li><li>\u27a4 Ref:  Page 158, William\u2019s Obstetrics; 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0a3da027",
      "audio": ""
    },
    {
      "text": "A woman presents to the antenatal OPD. She is not sure of her dates. On abdominal examination, external ballottement is elicited. When is the earliest, this sign can be seen?",
      "options": [
        {
          "label": "A",
          "text": "6 \u2013 8 weeks",
          "correct": false
        },
        {
          "label": "B",
          "text": "10 \u2013 12 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "14 \u2013 16 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "18 \u2013 20 weeks",
          "correct": true
        }
      ],
      "correct_answer": "D. 18 \u2013 20 weeks",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/picture2.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/picture3.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/picture4.jpg"
      ],
      "explanation": "<p><strong>Ans. D. 18-20 weeks</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 External Ballotment is as shown below. It appears at 18-20 weeks</li><li>\u2022 External Ballotment is as shown below. It appears at 18-20 weeks</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 This is External Ballotment. External Ballottement can be elicited after 18-20 weeks by a push to the fetal parts with one hand abdominally and the other hand receiving the impulse</li><li>\u27a4 This is internal Ballottement. It can be elicited at 16 weeks by a push to the fetal parts with the two fingers through the anterior fornix.</li><li>\u27a4 This is internal Ballottement. It can be elicited at 16 weeks by a push to the fetal parts with the two fingers through the anterior fornix.</li><li>\u27a4 Ref: Page 62, DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li><li>\u27a4 Ref: Page 62, DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "573cadfe",
      "audio": ""
    },
    {
      "text": "A 27-year primigravida visits the antenatal OPD at 24 weeks. An intern examines the patient. Which is NOT an expected finding in this patient?",
      "options": [
        {
          "label": "A",
          "text": "External Ballotment",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fetal Heart auscultated",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hegar\u2019s Sign",
          "correct": true
        },
        {
          "label": "D",
          "text": "The uterine fundus is palpated at the upper border of the umbilicus",
          "correct": false
        }
      ],
      "correct_answer": "C. Hegar\u2019s Sign",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Hegar\u2019s sign</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In the 2 nd trimester, the following are seen:</li><li>\u27a4 On Inspection: Striae gravidarum and linea nigra are seen On Palpation: Uterus palpable at 12 \u2013 14 weeks, lower border of umbilicus at 20 weeks and upper border at 24 weeks External ballotment at 18-20 weeks Internal ballotment after 16 weeks Fetal Heart rate can be auscultated as early as 20 weeks</li><li>\u27a4 On Inspection: Striae gravidarum and linea nigra are seen</li><li>\u27a4 Striae gravidarum and linea nigra are seen</li><li>\u27a4 Striae gravidarum and linea nigra are seen</li><li>\u27a4 On Palpation: Uterus palpable at 12 \u2013 14 weeks, lower border of umbilicus at 20 weeks and upper border at 24 weeks External ballotment at 18-20 weeks Internal ballotment after 16 weeks Fetal Heart rate can be auscultated as early as 20 weeks</li><li>\u27a4 Uterus palpable at 12 \u2013 14 weeks, lower border of umbilicus at 20 weeks and upper border at 24 weeks External ballotment at 18-20 weeks Internal ballotment after 16 weeks Fetal Heart rate can be auscultated as early as 20 weeks</li><li>\u27a4 Uterus palpable at 12 \u2013 14 weeks, lower border of umbilicus at 20 weeks and upper border at 24 weeks</li><li>\u27a4 External ballotment at 18-20 weeks</li><li>\u27a4 Internal ballotment after 16 weeks</li><li>\u27a4 Fetal Heart rate can be auscultated as early as 20 weeks</li><li>\u27a4 Ref: Page 64, DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li><li>\u27a4 Ref: Page 64, DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b6a1f945",
      "audio": ""
    },
    {
      "text": "An intra-decidual sign is seen in:",
      "options": [
        {
          "label": "A",
          "text": "A blighted ovum",
          "correct": false
        },
        {
          "label": "B",
          "text": "A missed abortion",
          "correct": false
        },
        {
          "label": "C",
          "text": "An ectopic pregnancy",
          "correct": false
        },
        {
          "label": "D",
          "text": "An intrauterine pregnancy",
          "correct": true
        }
      ],
      "correct_answer": "D. An intrauterine pregnancy",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/screenshot-2024-01-11-131357.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/picture5.jpg"
      ],
      "explanation": "<p><strong>Ans. D. An intrauterine pregnancy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 2 important signs on USG in early intrauterine pregnancy:</li><li>\u2022 Intra-decidual sign \u2013 An anechoic center surrounded by a single echogenic rim Double decidual sign \u2013 2 concentric echogenic rings surrounding the gestational sac</li><li>\u2022 Intra-decidual sign \u2013 An anechoic center surrounded by a single echogenic rim</li><li>\u2022 Double decidual sign \u2013 2 concentric echogenic rings surrounding the gestational sac</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A. A blighted ovum : In a blighted ovum, on ultrasound, no fetal pole is seen even at a mean sac diameter of 25mm Option B. A missed abortion: This is defined as either the absence of cardiac activity even when the fetal pole is 7mm or the disappearance of an earlier present cardiac activity Option C. An ectopic pregnancy: An unruptured ectopic will have several ultrasound signs including A pseudo sac A gestational sac in the adnexal region Bagel sign Blob sign Ring of fire sign</li><li>\u2022 Option A. A blighted ovum : In a blighted ovum, on ultrasound, no fetal pole is seen even at a mean sac diameter of 25mm</li><li>\u2022 Option A.</li><li>\u2022 A blighted ovum</li><li>\u2022 Option B. A missed abortion: This is defined as either the absence of cardiac activity even when the fetal pole is 7mm or the disappearance of an earlier present cardiac activity</li><li>\u2022 Option B.</li><li>\u2022 A missed abortion:</li><li>\u2022 Option C. An ectopic pregnancy: An unruptured ectopic will have several ultrasound signs including</li><li>\u2022 Option C.</li><li>\u2022 An ectopic pregnancy:</li><li>\u2022 A pseudo sac</li><li>\u2022 A gestational sac in the adnexal region</li><li>\u2022 Bagel sign</li><li>\u2022 Blob sign</li><li>\u2022 Ring of fire sign</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 2 important signs on USG in early intrauterine pregnancy:</li><li>\u27a4 Intra-decidual sign \u2013 An anechoic center surrounded by a single echogenic rim Double decidual sign \u2013 2 concentric echogenic rings surrounding the gestational sac</li><li>\u27a4 Intra-decidual sign \u2013 An anechoic center surrounded by a single echogenic rim</li><li>\u27a4 Double decidual sign \u2013 2 concentric echogenic rings surrounding the gestational sac</li><li>\u27a4 Double decidual sac sign:</li><li>\u27a4 is a useful feature on early pregnancy ultrasound to confirm an early intrauterine pregnancy (IUP) Especially useful when the yolk sac or embryo is still not visualized It consists of the decidua parietalis (decidua lining the uterine cavity) and decidua capsularis (decidua lining the gestational sac) It is seen as two concentric rings surrounding an anechoic gestational sac.</li><li>\u27a4 is a useful feature on early pregnancy ultrasound to confirm an early intrauterine pregnancy (IUP)</li><li>\u27a4 Especially useful when the yolk sac or embryo is still not visualized</li><li>\u27a4 It consists of the decidua parietalis (decidua lining the uterine cavity) and decidua capsularis (decidua lining the gestational sac)</li><li>\u27a4 It is seen as two concentric rings surrounding an anechoic gestational sac.</li><li>\u27a4 Where the two adhere is the decidua basalis, and is the site of future placental formation</li><li>\u27a4 Intra-decidual sac sign</li><li>\u27a4 Earliest sign of an intrauterine pregnancy on ultrasound Gestational sac seen eccentric to central endometrial cavity line Rapidly progresses to double decidual sac sign if the pregnancy is normal</li><li>\u27a4 Earliest sign of an intrauterine pregnancy on ultrasound</li><li>\u27a4 Gestational sac seen eccentric to central endometrial cavity line</li><li>\u27a4 Rapidly progresses to double decidual sac sign if the pregnancy is normal</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6d04a079",
      "audio": ""
    },
    {
      "text": "A 23-year primigravida presents at 8 weeks. She complains of nausea and occasional vomiting. Which is true regarding nausea and vomiting in pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Majority of women complain of increased vomiting in the morning",
          "correct": false
        },
        {
          "label": "B",
          "text": "Excessive vomiting is seen more in women with single than multiple fetuses",
          "correct": false
        },
        {
          "label": "C",
          "text": "80% are relieved by 14 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "It more commonly occurs in women with a h/o migraine",
          "correct": true
        }
      ],
      "correct_answer": "D. It more commonly occurs in women with a h/o migraine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. It more commonly occurs in women with a h/o migraine</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 About Hyperemesis Gravidarum</li><li>\u27a4 About Hyperemesis Gravidarum</li><li>\u27a4 Nausea and vomiting in pregnancy is a common symptom; It is seen in about 70 % of all pregnant women. Erroneously called morning sickness as it can occur at any time and is not specific to the morning Starts in the 1 st trimester 50% are relieved by 14 weeks and 90% by 22 weeks. More common in Multiple pregnancy Molar pregnancy (Increased \u03b2hCG) h/o nausea and vomiting in an earlier pregnancy h/o nausea and vomiting with OCPs Mother or sister with morning sickness during pregnancy h/o migraine</li><li>\u27a4 Nausea and vomiting in pregnancy is a common symptom;</li><li>\u27a4 It is seen in about 70 % of all pregnant women.</li><li>\u27a4 Erroneously called morning sickness as it can occur at any time and is not specific to the morning</li><li>\u27a4 Starts in the 1 st trimester</li><li>\u27a4 50% are relieved by 14 weeks and 90% by 22 weeks.</li><li>\u27a4 More common in Multiple pregnancy Molar pregnancy (Increased \u03b2hCG) h/o nausea and vomiting in an earlier pregnancy h/o nausea and vomiting with OCPs Mother or sister with morning sickness during pregnancy h/o migraine</li><li>\u27a4 Multiple pregnancy Molar pregnancy (Increased \u03b2hCG) h/o nausea and vomiting in an earlier pregnancy h/o nausea and vomiting with OCPs Mother or sister with morning sickness during pregnancy h/o migraine</li><li>\u27a4 Multiple pregnancy</li><li>\u27a4 Molar pregnancy (Increased \u03b2hCG)</li><li>\u27a4 h/o nausea and vomiting in an earlier pregnancy</li><li>\u27a4 h/o nausea and vomiting with OCPs</li><li>\u27a4 Mother or sister with morning sickness during pregnancy</li><li>\u27a4 h/o migraine</li><li>\u27a4 Ref: Page 158, William\u2019s Obstetrics; 25 th edition; Page no 117, Gabbe Obstetrics 8 th edition</li><li>\u27a4 Ref: Page 158, William\u2019s Obstetrics; 25 th edition; Page no 117, Gabbe Obstetrics 8 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "15c65f43",
      "audio": ""
    },
    {
      "text": "A 21-year primigravida presents at 21 weeks. She is anxious as she has still not perceived \u201cQuickening\u201d. All are possible reasons except?",
      "options": [
        {
          "label": "A",
          "text": "Maternal obesity",
          "correct": false
        },
        {
          "label": "B",
          "text": "Multiple pregnancy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Anterior placenta",
          "correct": false
        },
        {
          "label": "D",
          "text": "Fetal demise",
          "correct": false
        }
      ],
      "correct_answer": "B. Multiple pregnancy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Multiple pregnancy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Multiple pregnancy will result in earlier quickening and not in delayed quickening Delayed quickening is seen in Anterior placenta Maternal obesity Polyhydramnios or oligohydramnios Fetal demise</li><li>\u2022 Multiple pregnancy will result in earlier quickening and not in delayed quickening</li><li>\u2022 Delayed quickening is seen in Anterior placenta Maternal obesity Polyhydramnios or oligohydramnios Fetal demise</li><li>\u2022 Anterior placenta Maternal obesity Polyhydramnios or oligohydramnios Fetal demise</li><li>\u2022 Anterior placenta</li><li>\u2022 Maternal obesity</li><li>\u2022 Polyhydramnios or oligohydramnios</li><li>\u2022 Fetal demise</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 \u201cQuickening\u201d is \u201cfeeling of life\u201d It is usually felt at about the 18 th week in primis and 2 weeks earlier in multis. Its appearance is a useful guide to see how accurate the dating is especially in women who are unsure of their LMP and do not have an early trimester ultrasound. Delayed quickening is seen in Anterior placenta Maternal obesity Polyhydramnios or oligohydramnios Fetal demise</li><li>\u27a4 \u201cQuickening\u201d is \u201cfeeling of life\u201d</li><li>\u27a4 It is usually felt at about the 18 th week in primis and 2 weeks earlier in multis.</li><li>\u27a4 Its appearance is a useful guide to see how accurate the dating is especially in women who are unsure of their LMP and do not have an early trimester ultrasound.</li><li>\u27a4 Delayed quickening is seen in Anterior placenta Maternal obesity Polyhydramnios or oligohydramnios Fetal demise</li><li>\u27a4 Anterior placenta Maternal obesity Polyhydramnios or oligohydramnios Fetal demise</li><li>\u27a4 Anterior placenta</li><li>\u27a4 Maternal obesity</li><li>\u27a4 Polyhydramnios or oligohydramnios</li><li>\u27a4 Fetal demise</li><li>\u27a4 Ref: Page no 63, DC Dutta\u2019s Textbook of Obstetrics, 9 th edition</li><li>\u27a4 Ref: Page no 63, DC Dutta\u2019s Textbook of Obstetrics, 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "44514b76",
      "audio": ""
    },
    {
      "text": "A 28-year primigravida presents with amenorrhoea. Her UPT is positive. She is not sure of her LMP. An ultrasound is done which shows the following. Which is NOT a possible diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Early pregnancy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ectopic pregnancy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Missed abortion",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pregnancy of unknown location",
          "correct": false
        }
      ],
      "correct_answer": "C. Missed abortion",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/picture6.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Missed abortion</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The ultrasound shows uterus with a normal endometrial lining. There is no evidence of an intra-uterine gestational sac seen. The following possibilities thus arise : (Option A, B and D)</li><li>\u2022 The ultrasound shows uterus with a normal endometrial lining. There is no evidence of an intra-uterine gestational sac seen.</li><li>\u2022 The following possibilities thus arise : (Option A, B and D)</li><li>\u2022 : (Option A, B and D)</li><li>\u2022 A very early pregnancy. An intrauterine gestational sac is visible on ultrasound only when the serum beta hCG crosses a certain value. This is called the discriminatory zone and is 6000IU/ml for transabdominal scans and 1500 IU/ml for transvaginal scans. If the beta hCG is below 1500, a gestational sac will not be seen An ectopic pregnancy: The image seen is only of the uterus. An ectopic pregnancy which is very early also may not be apparent on ultrasound A pregnancy of unknown location: This is when there is no evidence of pregnancy on the ultrasound despite the urine pregnancy test being positive. Serial beta hCG tests are done in such scenarios</li><li>\u2022 A very early pregnancy. An intrauterine gestational sac is visible on ultrasound only when the serum beta hCG crosses a certain value. This is called the discriminatory zone and is 6000IU/ml for transabdominal scans and 1500 IU/ml for transvaginal scans. If the beta hCG is below 1500, a gestational sac will not be seen</li><li>\u2022 An ectopic pregnancy: The image seen is only of the uterus. An ectopic pregnancy which is very early also may not be apparent on ultrasound</li><li>\u2022 A pregnancy of unknown location: This is when there is no evidence of pregnancy on the ultrasound despite the urine pregnancy test being positive. Serial beta hCG tests are done in such scenarios</li><li>\u2022 Option C. In a missed abortion, on ultrasound, there will be an intrauterine gestational sac seen on ultrasound. A missed abortion is diagnosed when an earlier cardiac activity is not seen or when the CRL is 7 mm but no cardiac activity is seen.</li><li>\u2022 Option C. In a missed abortion, on ultrasound, there will be an intrauterine gestational sac seen on ultrasound. A missed abortion is diagnosed when an earlier cardiac activity is not seen or when the CRL is 7 mm but no cardiac activity is seen.</li><li>\u2022 Option C.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In a missed abortion, there will be an intrauterine gestational sac seen on ultrasound. A missed abortion is diagnosed when an earlier cardiac activity is not seen or when the CRL is 7 mm but no cardiac activity is seen.</li><li>\u27a4 Ref: Page 158, William\u2019s Obstetrics; 25 th edition</li><li>\u27a4 Ref: Page 158, William\u2019s Obstetrics; 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a5b564d7",
      "audio": ""
    },
    {
      "text": "Match the following change with the period of gestation seen in?",
      "options": [
        {
          "label": "A",
          "text": "a4 b3 c2 d1",
          "correct": false
        },
        {
          "label": "B",
          "text": "a1 b3 c2 d4",
          "correct": false
        },
        {
          "label": "C",
          "text": "a2 b4 c3 d1",
          "correct": false
        },
        {
          "label": "D",
          "text": "a2 b3 c4 d1",
          "correct": true
        }
      ],
      "correct_answer": "D. a2 b3 c4 d1",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/033.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. a2 b3 c4 d1</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Internal Ballotment (can be elicited at 16 weeks by a push to the fetal parts with the two fingers through the anterior fornix):  seen between 16 \u2013 28 weeks FHR is 1 st auscultated by stethoscope at 18-20 weeks Hegar\u2019s sign (On bimanual exam, the abdominal and vaginal fingers approximate below the body of the uterus) is seen between 8 \u2013 12 weeks Lightening occurs (Feeling of dropping down of the baby in the pelvis) at 38 weeks</li><li>\u2022 Internal Ballotment (can be elicited at 16 weeks by a push to the fetal parts with the two fingers through the anterior fornix):  seen between 16 \u2013 28 weeks</li><li>\u2022 FHR is 1 st auscultated by stethoscope at 18-20 weeks</li><li>\u2022 Hegar\u2019s sign (On bimanual exam, the abdominal and vaginal fingers approximate below the body of the uterus) is seen between 8 \u2013 12 weeks</li><li>\u2022 Lightening occurs (Feeling of dropping down of the baby in the pelvis) at 38 weeks</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Internal Ballotment (can be elicited at 16 weeks by a push to the fetal parts with the two fingers through the anterior fornix):  seen between 16 \u2013 28 weeks FHR is 1 st auscultated by stethoscope at 18-20 weeks Hegar\u2019s sign (On bimanual exam, the abdominal and vaginal fingers approximate below the body of the uterus) is seen between 8 \u2013 12 weeks Lightening occurs (Feeling of dropping down of the baby in the pelvis) at 38 weeks</li><li>\u27a4 Internal Ballotment (can be elicited at 16 weeks by a push to the fetal parts with the two fingers through the anterior fornix):  seen between 16 \u2013 28 weeks</li><li>\u27a4 FHR is 1 st auscultated by stethoscope at 18-20 weeks</li><li>\u27a4 Hegar\u2019s sign (On bimanual exam, the abdominal and vaginal fingers approximate below the body of the uterus) is seen between 8 \u2013 12 weeks</li><li>\u27a4 Lightening occurs (Feeling of dropping down of the baby in the pelvis) at 38 weeks</li><li>\u27a4 Ref:  Page 61; DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li><li>\u27a4 Ref:  Page 61; DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0a611251",
      "audio": ""
    },
    {
      "text": "A 23-year woman presents with 6 weeks amenorrhoea. She is not unsure if she is pregnant or not. Which is the next best step?",
      "options": [
        {
          "label": "A",
          "text": "Clinical examination",
          "correct": true
        },
        {
          "label": "B",
          "text": "Serum beta hCG",
          "correct": false
        },
        {
          "label": "C",
          "text": "Urine beta hCG",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ultrasound",
          "correct": false
        }
      ],
      "correct_answer": "A. Clinical examination",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Clinical examination</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 In the question, the next best step is asked A clinical examination always precedes any investigation</li><li>\u2022 In the question, the next best step is asked</li><li>\u2022 A clinical examination always precedes any investigation</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option B. Serum HCG: This is indicated only in situations with a positive urine pregnancy test, but nothing seen on the ultrasound (pregnancy of unknown location)</li><li>\u2022 Option B. Serum HCG: This is indicated only in situations with a positive urine pregnancy test, but nothing seen on the ultrasound (pregnancy of unknown location)</li><li>\u2022 Option B.</li><li>\u2022 Serum HCG:</li><li>\u2022 Option C. Urine HCG: This would be the most practical step especially and is usually done in a patient with suspected pregnancy. However, in the ideal setting, and for answering in an exam, a clinical exam always precedes tests.</li><li>\u2022 Option C. Urine HCG: This would be the most practical step especially and is usually done in a patient with suspected pregnancy. However, in the ideal setting, and for answering in an exam, a clinical exam always precedes tests.</li><li>\u2022 Option C.</li><li>\u2022 Urine HCG:</li><li>\u2022 Option D. Once pregnancy is suspected on clinical exam or the urine pregnancy test is positive, a TVS is done.</li><li>\u2022 Option D. Once pregnancy is suspected on clinical exam or the urine pregnancy test is positive, a TVS is done.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In a patient with suspected pregnancy, examination is always the next immediate step</li><li>\u27a4 In a patient with suspected pregnancy, examination is always the next immediate step</li><li>\u27a4 Ref:  Page 60; DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li><li>\u27a4 Ref:  Page 60; DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5807db8d",
      "audio": ""
    },
    {
      "text": "A 28-year G2 presents to the antenatal OPD. She is 14 weeks gestation and this is her 1 st visit. She has 1 child who is 3 years old delivered vaginally. Which will be seen on examination in this patient?",
      "options": [
        {
          "label": "A",
          "text": "FHR will be auscultated",
          "correct": false
        },
        {
          "label": "B",
          "text": "Linea nigra will be seen",
          "correct": false
        },
        {
          "label": "C",
          "text": "Internal ballotment will be present",
          "correct": false
        },
        {
          "label": "D",
          "text": "Uterus will be palpable just above the pubic symphysis",
          "correct": true
        }
      ],
      "correct_answer": "D. Uterus will be palpable just above the pubic symphysis",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/picture7_1ioL8MD.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/picture8.jpg"
      ],
      "explanation": "<p><strong>Ans. D. Uterus will be palpable just above the pubic symphysis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 At 14 weeks, the uterus will be palpable (just above the pubic symphysis)</li><li>\u2022 At 14 weeks, the uterus will be palpable (just above the pubic symphysis)</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A. FHR will be auscultated for the first time 18-20 weeks Option B. Linea nigra appears at 18-20 weeks Option C. Internal ballotment is seen between 16-28 weeks</li><li>\u2022 Option A. FHR will be auscultated for the first time 18-20 weeks</li><li>\u2022 Option A.</li><li>\u2022 Option B. Linea nigra appears at 18-20 weeks</li><li>\u2022 Option B.</li><li>\u2022 Option C. Internal ballotment is seen between 16-28 weeks</li><li>\u2022 Option C.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Linea nigra appears at 18-20 weeks FHR is auscultated first between 18-20 weeks Internal ballotment is seen between 16-28 weeks External ballotment is seen at 20 weeks</li><li>\u27a4 Linea nigra appears at 18-20 weeks</li><li>\u27a4 FHR is auscultated first between 18-20 weeks</li><li>\u27a4 Internal ballotment is seen between 16-28 weeks</li><li>\u27a4 External ballotment is seen at 20 weeks</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "da3501fa",
      "audio": ""
    },
    {
      "text": "The most accurate determination of gestational age in a pregnancy is by:",
      "options": [
        {
          "label": "A",
          "text": "Accurate LMP",
          "correct": false
        },
        {
          "label": "B",
          "text": "CRL on ultrasound",
          "correct": true
        },
        {
          "label": "C",
          "text": "Date of coitus",
          "correct": false
        },
        {
          "label": "D",
          "text": "Date of quickening",
          "correct": false
        }
      ],
      "correct_answer": "B. CRL on ultrasound",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. CRL on ultrasound</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Crown-Rump Length (CRL) is the most accurate measurement of gestational age with a variation of \u00b1 5 days.</li><li>\u2022 Crown-Rump Length (CRL) is the most accurate measurement of gestational age with a variation of \u00b1 5 days.</li><li>\u2022 Other options : LMP, date of coitus or date of quickening are not as accurate as CRL for determination of gestational age.</li><li>\u2022 Other options</li><li>\u2022 :</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page No 186, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page No 186, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "33d39d3d",
      "audio": ""
    },
    {
      "text": "Which of these graphs accurately represents \u03b2HCG variation in normal pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "",
          "correct": false
        },
        {
          "label": "B",
          "text": "",
          "correct": true
        },
        {
          "label": "C",
          "text": "",
          "correct": false
        },
        {
          "label": "D",
          "text": "",
          "correct": false
        }
      ],
      "correct_answer": "B. ",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/picture9.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/picture10.jpg"
      ],
      "explanation": "<p><strong>Ans. B. B</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 \u03b2hCG is produced by syncytiotrophoblasts \u03b2hCG increases in the 1 st trimester and reaches a peak at 10 weeks. Doubling time in early pregnancy is 1.4-2 days It then declines slowly to reach a plateau at 14-16 weeks This is how \u03b2hCG values appears on a graphical representation</li><li>\u2022 \u03b2hCG is produced by syncytiotrophoblasts</li><li>\u2022 \u03b2hCG increases in the 1 st trimester and reaches a peak at 10 weeks.</li><li>\u2022 Doubling time in early pregnancy is 1.4-2 days</li><li>\u2022 It then declines slowly to reach a plateau at 14-16 weeks</li><li>\u2022 This is how \u03b2hCG values appears on a graphical representation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 \u03b2hCG increases in the 1 st trimester and reaches a peak at 10 weeks. Doubling time in early pregnancy is 1.4-2 days It then declines slowly to reach a plateau at 14-16 weeks This is how \u03b2hCG values appears on a graphical representation</li><li>\u27a4 \u03b2hCG increases in the 1 st trimester and reaches a peak at 10 weeks.</li><li>\u27a4 Doubling time in early pregnancy is 1.4-2 days</li><li>\u27a4 It then declines slowly to reach a plateau at 14-16 weeks</li><li>\u27a4 This is how \u03b2hCG values appears on a graphical representation</li><li>\u27a4 Ref: Page No:158, William\u2019s Obstetrics 25 th</li><li>\u27a4 Ref: Page No:158, William\u2019s Obstetrics 25 th</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "539f7afe",
      "audio": ""
    },
    {
      "text": "A 28-year-old woman presents to the clinic with concerns about a possible pregnancy. She has missed her last two menstrual periods. Which of the following is the most appropriate initial diagnostic test after a clinical examination at this stage in the OPD?",
      "options": [
        {
          "label": "A",
          "text": "Serum hCG measurement",
          "correct": false
        },
        {
          "label": "B",
          "text": "Urine hCG pregnancy test",
          "correct": true
        },
        {
          "label": "C",
          "text": "Transvaginal ultrasound",
          "correct": false
        },
        {
          "label": "D",
          "text": "Serum progesterone measurement",
          "correct": false
        }
      ],
      "correct_answer": "B. Urine hCG pregnancy test",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Urine hCG pregnancy test</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Ref:  Page 60; DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li><li>\u2022 Ref:  Page 60; DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "44942fd5",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman with irregular menstrual cycles presents with nausea and breast tenderness. She suspects pregnancy and wants to know the earliest test that can provide accurate results. Which diagnostic test is the most sensitive for early pregnancy detection?",
      "options": [
        {
          "label": "A",
          "text": "Serum hCG measurement",
          "correct": true
        },
        {
          "label": "B",
          "text": "Urine hCG pregnancy test",
          "correct": false
        },
        {
          "label": "C",
          "text": "Transvaginal ultrasound",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pelvic exam",
          "correct": false
        }
      ],
      "correct_answer": "A. Serum hCG measurement",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Serum hCG measurement</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Option B. Urine hCG : This is positive 2-3 days after a missed period Option C. TVS : This shows a gestational sac at 5 weeks Option D. Pelvic exam : Earliest signs on pelvic exam appear at 6-8 weeks</li><li>\u2022 Option B. Urine hCG : This is positive 2-3 days after a missed period</li><li>\u2022 Option B. Urine hCG</li><li>\u2022 Option C. TVS : This shows a gestational sac at 5 weeks</li><li>\u2022 Option C. TVS</li><li>\u2022 Option D. Pelvic exam : Earliest signs on pelvic exam appear at 6-8 weeks</li><li>\u2022 Option D. Pelvic exam</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective: The earliest test of pregnancy is a serum bhCG. This is positive 7-10 days post conception</li><li>\u27a4 Ref: William\u2019s textbook of obstetrics 25 th edition pg 158</li><li>\u27a4 Ref: William\u2019s textbook of obstetrics 25 th edition pg 158</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b5af10d5",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman in her first trimester presents for a prenatal visit. Her last menstrual period (LMP) was 8 weeks ago. On physical examination, the uterus is not palpable abdominally. What is the next best step in confirming the gestational age of the pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Transvaginal ultrasound",
          "correct": true
        },
        {
          "label": "B",
          "text": "Pelvic exam",
          "correct": false
        },
        {
          "label": "C",
          "text": "Urine hCG pregnancy test",
          "correct": false
        },
        {
          "label": "D",
          "text": "Serum progesterone measurement",
          "correct": false
        }
      ],
      "correct_answer": "A. Transvaginal ultrasound",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Transvaginal ultrasound</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Other Options</li><li>\u2022 Other Options</li><li>\u2022 Option B. Pelvic exam: This is not accurate to determine gestational age Option C. Urine hCG: will confirm the presence of hCG but will not tell us the date Option D. Serum progesterone rises in pregnancy but this does not corelate with the dating of pregnancy</li><li>\u2022 Option B. Pelvic exam: This is not accurate to determine gestational age</li><li>\u2022 Option B.</li><li>\u2022 Option C. Urine hCG: will confirm the presence of hCG but will not tell us the date</li><li>\u2022 Option C.</li><li>\u2022 Option D. Serum progesterone rises in pregnancy but this does not corelate with the dating of pregnancy</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Ref: William\u2019s textbook of obstetrics 25 th edition pg 159</li><li>\u27a4 Ref: William\u2019s textbook of obstetrics 25 th edition pg 159</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ca2758c5",
      "audio": ""
    },
    {
      "text": "A 26-year-old woman with a history of ectopic pregnancy presents with abdominal pain and vaginal bleeding. She suspects she might be pregnant. Which diagnostic test is essential in this situation to rule out an ectopic pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Serum hCG measurement",
          "correct": false
        },
        {
          "label": "B",
          "text": "Urine hCG pregnancy test",
          "correct": false
        },
        {
          "label": "C",
          "text": "Transvaginal ultrasound",
          "correct": true
        },
        {
          "label": "D",
          "text": "Serum progesterone measurement",
          "correct": false
        }
      ],
      "correct_answer": "C. Transvaginal ultrasound",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Transvaginal ultrasound</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 In a woman with a history of ectopic pregnancy and symptoms of abdominal pain and vaginal bleeding, it is crucial to rule out another ectopic pregnancy. Transvaginal ultrasound is the preferred diagnostic test as it can visualize the uterus and adnexa and determine the location of the pregnancy, which is essential in cases of suspected ectopic pregnancy. If the TVS is inconclusive, then the next best step would be to do a serum bhCG doubling (0h and 48h)</li><li>\u2022 In a woman with a history of ectopic pregnancy and symptoms of abdominal pain and vaginal bleeding, it is crucial to rule out another ectopic pregnancy. Transvaginal ultrasound is the preferred diagnostic test as it can visualize the uterus and adnexa and determine the location of the pregnancy, which is essential in cases of suspected ectopic pregnancy.</li><li>\u2022 If the TVS is inconclusive, then the next best step would be to do a serum bhCG doubling (0h and 48h)</li><li>\u2022 Other Options</li><li>\u2022 Other Options</li><li>\u2022 Option A: Serum hCG will not be the initial test do diagnose an ectopic. Only if the ultrasound is inconclusive, do we check the serum bhCG at 0h and 48h Option B: Urine bhCG just confirm pregnancy. It does not tell us the site of pregnancy Option D: Serum progesterone levels increase in pregnancy</li><li>\u2022 Option A: Serum hCG will not be the initial test do diagnose an ectopic. Only if the ultrasound is inconclusive, do we check the serum bhCG at 0h and 48h</li><li>\u2022 Option A:</li><li>\u2022 Option B: Urine bhCG just confirm pregnancy. It does not tell us the site of pregnancy</li><li>\u2022 Option B:</li><li>\u2022 Option D: Serum progesterone levels increase in pregnancy</li><li>\u2022 Option D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A patient with amenorrhoea (early pregnancy) and bleeding or pain, the first test done is always a Transvaginal scan (TVS)</li><li>\u27a4 Ref: William\u2019s textbook of obstetrics 25 th edition pg 159</li><li>\u27a4 Ref: William\u2019s textbook of obstetrics 25 th edition pg 159</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0637b5ea",
      "audio": ""
    },
    {
      "text": "A middle-aged woman came to OPD with a twin pregnancy. She already had 2 first trimester abortions and she has a 3-year-old female child who was born at the end of the 9 th month of gestation. Which of the following is her accurate representation?",
      "options": [
        {
          "label": "A",
          "text": "G4 P1 L1 A2",
          "correct": true
        },
        {
          "label": "B",
          "text": "G4 P3 L1 A2",
          "correct": false
        },
        {
          "label": "C",
          "text": "G3 P1 L1 A2",
          "correct": false
        },
        {
          "label": "D",
          "text": "G3 P3 L1 A2",
          "correct": false
        }
      ],
      "correct_answer": "A. G4 P1 L1 A2",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Determining the Parity Index/ Obstetric Formula</li><li>\u2022 2 formulas</li><li>\u2022 2 formulas</li><li>\u2022 1. G __ P __ L __ A ___</li><li>\u2022 1. G __ P __ L __ A ___</li><li>\u2022 Gravida (G): The number of times a woman has conceived including the present pregnancy irrespective of the gestational age or the outcome. Para (P): The number of times a pregnancy has crossed the period of viability (taken as 28 weeks for all practical purposes) EXCLUDING the present pregnancy. Living (L): The total number of living children the woman has. Abortion (A): The total number of times the pregnancy has resulted in an abortion/ pregnancy has not crossed the period of viability.</li><li>\u2022 Gravida (G): The number of times a woman has conceived including the present pregnancy irrespective of the gestational age or the outcome.</li><li>\u2022 Para (P): The number of times a pregnancy has crossed the period of viability (taken as 28 weeks for all practical purposes) EXCLUDING the present pregnancy.</li><li>\u2022 Living (L): The total number of living children the woman has.</li><li>\u2022 Abortion (A): The total number of times the pregnancy has resulted in an abortion/ pregnancy has not crossed the period of viability.</li><li>\u2022 In this patient, this is her 4 th pregnancy, so she is G4; she has 1 pregnancy who was born at term, so she is P1; she has 2 abortions so she is A2 and she has 1 living child so she is L1.</li><li>\u2022 In this patient, this is her 4 th pregnancy, so she is G4; she has 1 pregnancy who was born at term, so she is P1; she has 2 abortions so she is A2 and she has 1 living child so she is L1.</li><li>\u2022 Hence she is G4P11A2</li><li>\u2022 Hence she is G4P11A2</li><li>\u2022 *** IMPORTANT: A Twin pregnancy which has crossed the period of viability is considered as Para 1 NOT Para 2. But if it results in 2 living children it will be Live 2. ***</li><li>\u2022 *** IMPORTANT: A Twin pregnancy which has crossed the period of viability is considered as Para 1 NOT Para 2. But if it results in 2 living children it will be Live 2. ***</li><li>\u2022 2. P A-B-C-D (A: term; B: preterm; C: abortions; D: Living)</li><li>\u2022 2. P A-B-C-D (A: term; B: preterm; C: abortions; D: Living)</li><li>\u2022 This is another way to write the formula.</li><li>\u2022 This is another way to write the formula.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Gravida (G): The number of times a woman has conceived including the present pregnancy irrespective of the gestational age or the outcome. Para (P): The number of times a pregnancy has crossed the period of viability (taken as 28 weeks for all practical purposes) EXCLUDING the present pregnancy. Living (L): The total number of living children the woman has. Abortion (A): The total number of times the pregnancy has resulted in an abortion/ pregnancy has not crossed the period of viability.</li><li>\u27a4 Gravida (G): The number of times a woman has conceived including the present pregnancy irrespective of the gestational age or the outcome.</li><li>\u27a4 Para (P): The number of times a pregnancy has crossed the period of viability (taken as 28 weeks for all practical purposes) EXCLUDING the present pregnancy.</li><li>\u27a4 Living (L): The total number of living children the woman has.</li><li>\u27a4 Abortion (A): The total number of times the pregnancy has resulted in an abortion/ pregnancy has not crossed the period of viability.</li><li>\u27a4 Ref: Page 160, William\u2019s Obstetrics; 25 th edition</li><li>\u27a4 Ref: Page 160, William\u2019s Obstetrics; 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d86b1ef2",
      "audio": ""
    },
    {
      "text": "All are true regarding the definition of para except:",
      "options": [
        {
          "label": "A",
          "text": "It excludes the present pregnancy.",
          "correct": false
        },
        {
          "label": "B",
          "text": "It includes all pregnancies that have crossed the period of viability.",
          "correct": false
        },
        {
          "label": "C",
          "text": "It is taken as 2 in case of a previous twin pregnancy.",
          "correct": true
        },
        {
          "label": "D",
          "text": "It does not include spontaneous abortions.",
          "correct": false
        }
      ],
      "correct_answer": "C. It is taken as 2 in case of a previous twin pregnancy.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. It is taken as 2 in case of a previous twin pregnancy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Let\u2019s Discuss all Options</li><li>\u2022 Let\u2019s Discuss all Options</li><li>\u2022 Option A: It excludes the present pregnancy: Para (P) is the number of times a pregnancy has crossed the period of viability (taken as 28 weeks for all practical purposes) EXCLUDING the present pregnancy Option B: It includes all pregnancies that have crossed the period of viability: Para (P) is the number of times a pregnancy has crossed the period of viability (taken as 28 weeks for all practical purposes) EXCLUDING the present pregnancy Option C: It is taken as 2 in case of a previous twin pregnancy. This is wrong. In a previous twin pregnancy, P is 1 as it is the number of pregnancies that are counted and not the number of fetuses. Option D: It does not include spontaneous abortions: Spontaneous or induced abortions are denoted by A.</li><li>\u2022 Option A: It excludes the present pregnancy: Para (P) is the number of times a pregnancy has crossed the period of viability (taken as 28 weeks for all practical purposes) EXCLUDING the present pregnancy</li><li>\u2022 Option A:</li><li>\u2022 Option B: It includes all pregnancies that have crossed the period of viability: Para (P) is the number of times a pregnancy has crossed the period of viability (taken as 28 weeks for all practical purposes) EXCLUDING the present pregnancy</li><li>\u2022 Option B:</li><li>\u2022 Option C: It is taken as 2 in case of a previous twin pregnancy. This is wrong. In a previous twin pregnancy, P is 1 as it is the number of pregnancies that are counted and not the number of fetuses.</li><li>\u2022 Option C:</li><li>\u2022 Option D: It does not include spontaneous abortions: Spontaneous or induced abortions are denoted by A.</li><li>\u2022 Option D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The obstetric formula is written as:</li><li>\u27a4 The obstetric formula is written as:</li><li>\u27a4 2 formulas</li><li>\u27a4 2 formulas</li><li>\u27a4 1. G __ P __ L __ A ___</li><li>\u27a4 1. G __ P __ L __ A ___</li><li>\u27a4 Gravida (G): The number of times a woman has conceived including the present pregnancy irrespective of the gestational age or the outcome. Para (P): The number of times a pregnancy has crossed the period of viability (taken as 28 weeks for all practical purposes) EXCLUDING the present pregnancy. Living (L): The total number of living children the woman has. Abortion (A): The total number of times the pregnancy has resulted in an abortion/ pregnancy has not crossed the period of viability.</li><li>\u27a4 Gravida (G): The number of times a woman has conceived including the present pregnancy irrespective of the gestational age or the outcome.</li><li>\u27a4 Para (P): The number of times a pregnancy has crossed the period of viability (taken as 28 weeks for all practical purposes) EXCLUDING the present pregnancy.</li><li>\u27a4 Living (L): The total number of living children the woman has.</li><li>\u27a4 Abortion (A): The total number of times the pregnancy has resulted in an abortion/ pregnancy has not crossed the period of viability.</li><li>\u27a4 *** IMPORTANT: A Twin pregnancy which has crossed the period of viability is considered as Para 1 NOT Para 2. But if it results in 2 living children it will be Live 2. ***</li><li>\u27a4 *** IMPORTANT: A Twin pregnancy which has crossed the period of viability is considered as Para 1 NOT Para 2. But if it results in 2 living children it will be Live 2. ***</li><li>\u27a4 2. P A-B-C-D (A: term; B: preterm; C: abortions; D: Living)</li><li>\u27a4 2. P A-B-C-D (A: term; B: preterm; C: abortions; D: Living)</li><li>\u27a4 This is another way to write the formula.</li><li>\u27a4 This is another way to write the formula.</li><li>\u27a4 Ref: Page 160, William\u2019s Obstetrics; 25 th edition</li><li>\u27a4 Ref: Page 160, William\u2019s Obstetrics; 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1e7199d8",
      "audio": ""
    },
    {
      "text": "Identify the examination being done in the image below:",
      "options": [
        {
          "label": "A",
          "text": "Fundal grip",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lateral grip",
          "correct": true
        },
        {
          "label": "C",
          "text": "1 st pelvic grip",
          "correct": false
        },
        {
          "label": "D",
          "text": "2 nd pelvic grip",
          "correct": false
        }
      ],
      "correct_answer": "B. Lateral grip",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/09/obg-26-copy.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/09/obg-26.jpg"
      ],
      "explanation": "<p><strong>Ans. B. Lateral grip</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The maneuver shown in the image is the Lateral Grip or Leopold\u2019s 2 nd maneuver</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Leopold Maneuvers:</li><li>\u27a4 Leopold Maneuvers:</li><li>\u27a4 Leopold in 1894 described 4 abdominal maneuvers to diagnose fetal presentation. These maneuvers may be difficult in</li><li>\u27a4 Obesity Oligohydramnios and polyhydramnios Anterior placenta Fundal grip (A): to assess which fetal pole (cephalic or podalic) occupies the fundus. The breech gives the sensation of a large nodular mass; the head feel hard, round and mobile The Lateral grip (B): determines the side of the back (hard, resistant) and the limbs (numerous, small irregular mobile parts) The 1 st pelvic grip (3 rd maneuver aka Pawlik grip - C): determining fetal presentation. The 2 nd pelvic grip (4 th maneuver - D): determines the degree of descent. This maneuver is done facing the feet of the patient and trying to approximate the hands of the examiner. IF the hands approximate; the head has not descended into the pelvis. If the hands diverge, the head has descended into the pelvis.</li><li>\u27a4 Obesity</li><li>\u27a4 Oligohydramnios and polyhydramnios</li><li>\u27a4 Anterior placenta Fundal grip (A): to assess which fetal pole (cephalic or podalic) occupies the fundus. The breech gives the sensation of a large nodular mass; the head feel hard, round and mobile The Lateral grip (B): determines the side of the back (hard, resistant) and the limbs (numerous, small irregular mobile parts) The 1 st pelvic grip (3 rd maneuver aka Pawlik grip - C): determining fetal presentation. The 2 nd pelvic grip (4 th maneuver - D): determines the degree of descent. This maneuver is done facing the feet of the patient and trying to approximate the hands of the examiner. IF the hands approximate; the head has not descended into the pelvis. If the hands diverge, the head has descended into the pelvis.</li><li>\u27a4 Fundal grip (A): to assess which fetal pole (cephalic or podalic) occupies the fundus. The breech gives the sensation of a large nodular mass; the head feel hard, round and mobile The Lateral grip (B): determines the side of the back (hard, resistant) and the limbs (numerous, small irregular mobile parts) The 1 st pelvic grip (3 rd maneuver aka Pawlik grip - C): determining fetal presentation. The 2 nd pelvic grip (4 th maneuver - D): determines the degree of descent. This maneuver is done facing the feet of the patient and trying to approximate the hands of the examiner. IF the hands approximate; the head has not descended into the pelvis. If the hands diverge, the head has descended into the pelvis.</li><li>\u27a4 Fundal grip (A): to assess which fetal pole (cephalic or podalic) occupies the fundus. The breech gives the sensation of a large nodular mass; the head feel hard, round and mobile</li><li>\u27a4 Fundal grip (A):</li><li>\u27a4 The Lateral grip (B): determines the side of the back (hard, resistant) and the limbs (numerous, small irregular mobile parts)</li><li>\u27a4 The Lateral grip (B):</li><li>\u27a4 The 1 st pelvic grip (3 rd maneuver aka Pawlik grip - C): determining fetal presentation.</li><li>\u27a4 The 1 st pelvic grip (3 rd maneuver aka Pawlik grip - C):</li><li>\u27a4 The 2 nd pelvic grip (4 th maneuver - D): determines the degree of descent. This maneuver is done facing the feet of the patient and trying to approximate the hands of the examiner. IF the hands approximate; the head has not descended into the pelvis. If the hands diverge, the head has descended into the pelvis.</li><li>\u27a4 The 2 nd pelvic grip (4 th maneuver - D):</li><li>\u27a4 Ref: Page 424, William\u2019s Obstetrics; 25 th edition</li><li>\u27a4 Ref: Page 424, William\u2019s Obstetrics; 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "74d2f21b",
      "audio": ""
    },
    {
      "text": "All the following methods can be used to calculate the EDD except:",
      "options": [
        {
          "label": "A",
          "text": "Adding 9 months and 7 days to the LMP",
          "correct": false
        },
        {
          "label": "B",
          "text": "Adding 38 weeks to the LMP",
          "correct": true
        },
        {
          "label": "C",
          "text": "Adding 280 days to the LMP",
          "correct": false
        },
        {
          "label": "D",
          "text": "Subtracting 3 months and adding 7 days to the LMP",
          "correct": false
        }
      ],
      "correct_answer": "B. Adding 38 weeks to the LMP",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Calculating the EDD:</li><li>\u2022 Calculating the EDD:</li><li>\u2022 Normal duration of pregnancy: 280 days (40 weeks); hence Option B is incorrect. To arrive at the EDD, we add 280 days or 40 weeks to the LMP.</li><li>\u2022 Normal duration of pregnancy: 280 days (40 weeks); hence Option B is incorrect. To arrive at the EDD, we add 280 days or 40 weeks to the LMP.</li><li>\u2022 Other Options:</li><li>\u2022 Calculating the EDD: Naegele\u2019s formula . To the LMP (1 st day of the last menstrual day Add 9 months + 7 days Subtract 3 months and add 7 days For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</li><li>\u2022 Calculating the EDD: Naegele\u2019s formula . To the LMP (1 st day of the last menstrual day Add 9 months + 7 days Subtract 3 months and add 7 days For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</li><li>\u2022 Naegele\u2019s formula</li><li>\u2022 Add 9 months + 7 days Subtract 3 months and add 7 days For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</li><li>\u2022 Add 9 months + 7 days</li><li>\u2022 Subtract 3 months and add 7 days</li><li>\u2022 For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Calculating the EDD: Naegele\u2019s formula . To the LMP (1 st day of the last menstrual day) Add 9 months + 7 days Subtract 3 months and add 7 days For IVF Pregnancies: add 38 weeks to the date of the embryo transfer Remember the EDD falls at 40 weeks (280 days) from the LMP Dating the pregnancy: If discrepancy in dates/ unsure of LMP; the best way to determine the dating is by ULTRASOUND 1st trimester CRL: most accurate (till 14 weeks) BPD in the 2nd trimester</li><li>\u27a4 Calculating the EDD: Naegele\u2019s formula . To the LMP (1 st day of the last menstrual day) Add 9 months + 7 days Subtract 3 months and add 7 days For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</li><li>\u27a4 Naegele\u2019s formula</li><li>\u27a4 Add 9 months + 7 days Subtract 3 months and add 7 days For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</li><li>\u27a4 Add 9 months + 7 days</li><li>\u27a4 Subtract 3 months and add 7 days</li><li>\u27a4 For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</li><li>\u27a4 Remember the EDD falls at 40 weeks (280 days) from the LMP</li><li>\u27a4 Dating the pregnancy: If discrepancy in dates/ unsure of LMP; the best way to determine the dating is by ULTRASOUND 1st trimester CRL: most accurate (till 14 weeks) BPD in the 2nd trimester</li><li>\u27a4 Dating the pregnancy:</li><li>\u27a4 1st trimester CRL: most accurate (till 14 weeks) BPD in the 2nd trimester</li><li>\u27a4 1st trimester CRL: most accurate (till 14 weeks)</li><li>\u27a4 BPD in the 2nd trimester</li><li>\u27a4 Ref: Page no 168, William\u2019s Obstetrics; 25 th edition</li><li>\u27a4 Ref: Page no 168, William\u2019s Obstetrics; 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b5212064",
      "audio": ""
    },
    {
      "text": "A primigravida was given dietary advice in the 2nd trimester. What should be the extra calorie intake?",
      "options": [
        {
          "label": "A",
          "text": "200 Kcal",
          "correct": false
        },
        {
          "label": "B",
          "text": "300 Kcal",
          "correct": true
        },
        {
          "label": "C",
          "text": "500 Kcal",
          "correct": false
        },
        {
          "label": "D",
          "text": "No extra calories",
          "correct": false
        }
      ],
      "correct_answer": "B. 300 Kcal",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Pregnancy requires a total additional of 80,000 Kcal; mostly in the latter half An average caloric increase of 300 Kcal/ day recommended If we divide this trimester wise, 0Kcal/ day in 1 st trimester 340Kcal/ day in 2 nd trimester 452Kcal/ day in 3rd trimesters</li><li>\u2022 Pregnancy requires a total additional of 80,000 Kcal; mostly in the latter half</li><li>\u2022 An average caloric increase of 300 Kcal/ day recommended</li><li>\u2022 If we divide this trimester wise, 0Kcal/ day in 1 st trimester 340Kcal/ day in 2 nd trimester 452Kcal/ day in 3rd trimesters</li><li>\u2022 0Kcal/ day in 1 st trimester 340Kcal/ day in 2 nd trimester 452Kcal/ day in 3rd trimesters</li><li>\u2022 0Kcal/ day in 1 st trimester</li><li>\u2022 340Kcal/ day in 2 nd trimester</li><li>\u2022 452Kcal/ day in 3rd trimesters</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Pregnancy requires a total additional of 80,000 Kcal; mostly in the latter half An average caloric increase of 300 Kcal/ day recommended If we divide this trimester wise, 0Kcal/ day in 1 st trimester 340Kcal/ day in 2 nd trimester 452Kcal/ day in 3rd trimesters If a question is asked regarding extra calorie in the 1 st trimester, the answer will be NO Additional Requirement. Women who breastfeed require approximately 500 additional kcal/day; beyond what is usually recommended for non-pregnant women RDA of proteins in pregnancy: 60 \u2013 65g/ day (increase by 15g/ day)</li><li>\u27a4 Pregnancy requires a total additional of 80,000 Kcal; mostly in the latter half</li><li>\u27a4 An average caloric increase of 300 Kcal/ day recommended</li><li>\u27a4 If we divide this trimester wise, 0Kcal/ day in 1 st trimester 340Kcal/ day in 2 nd trimester 452Kcal/ day in 3rd trimesters</li><li>\u27a4 0Kcal/ day in 1 st trimester 340Kcal/ day in 2 nd trimester 452Kcal/ day in 3rd trimesters</li><li>\u27a4 0Kcal/ day in 1 st trimester</li><li>\u27a4 340Kcal/ day in 2 nd trimester</li><li>\u27a4 452Kcal/ day in 3rd trimesters</li><li>\u27a4 If a question is asked regarding extra calorie in the 1 st trimester, the answer will be NO Additional Requirement.</li><li>\u27a4 Women who breastfeed require approximately 500 additional kcal/day; beyond what is usually recommended for non-pregnant women</li><li>\u27a4 RDA of proteins in pregnancy: 60 \u2013 65g/ day (increase by 15g/ day)</li><li>\u27a4 Ref: Page no 168, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no 168, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "49ea1c1c",
      "audio": ""
    },
    {
      "text": "A 25-year Primi gravida is at 24 weeks pregnancy. Her pre-pregnancy BMI was 22. She is concerned she hasn\u2019t been gaining enough weight during pregnancy. What should her ideal weight gain (kg)/ week be?",
      "options": [
        {
          "label": "A",
          "text": "0.5 kg / week",
          "correct": false
        },
        {
          "label": "B",
          "text": "0.4 kg / week",
          "correct": true
        },
        {
          "label": "C",
          "text": "0.3 kg / week",
          "correct": false
        },
        {
          "label": "D",
          "text": "0.2 kg / week",
          "correct": false
        }
      ],
      "correct_answer": "B. 0.4 kg / week",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/10/screenshot-2024-01-10-114427.jpg"
      ],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 In a woman with normal BMI, the ideal weight gain is 0.4kg/ week in the 2 nd and 3 rd trimester</li><li>\u2022 In a woman with normal BMI, the ideal weight gain is 0.4kg/ week in the 2 nd and 3 rd trimester</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ideal weight gain in pregnancy</li><li>\u27a4 Ref: Page no 170, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no 170, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2bb40908",
      "audio": ""
    },
    {
      "text": "All are components of pre-conceptional counselling except?",
      "options": [
        {
          "label": "A",
          "text": "Identifying potential high-risk factors like Hypertension, anemia, diabetes etc",
          "correct": false
        },
        {
          "label": "B",
          "text": "Starting women on folic acid preconceptionally",
          "correct": false
        },
        {
          "label": "C",
          "text": "Assessing for genetic diseases and offering counselling",
          "correct": false
        },
        {
          "label": "D",
          "text": "Offering rubella immunization post conception",
          "correct": true
        }
      ],
      "correct_answer": "D. Offering rubella immunization post conception",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Offering rubella immunization post conception</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Let\u2019s Discuss all Options:</li><li>\u2022 Let\u2019s Discuss all Options:</li><li>\u2022 Option A: Identify high risk factors: Diabetes (HBA1C), HTN, Epilepsy, Thyroid disorders (TSH), Anemia (Hb) Option B: Pre-conceptional Folic Acid (0.4 mg/ day (400mcg per day)  to low risk; 4 mg/ day to high risk for neural tube defects - NTD). Women at high risk for NTD are H/o previous baby with NTD Pre-gestational Diabetes Mellitus Folic acid deficiency Obesity Epilepsy/ on Antiepileptic Drugs (AED) Option C: Assess for genetic diseases (h/o sickle cell ds, cystic fibrosis, thalassemia etc.) Option D: Immunization status: Rubella; if unimmunized or status unknown, Rubella vaccination is to be given with advice to avoid conception till 1 month following vaccination as it is a live vaccine with potential teratogenic side effects to the fetus.</li><li>\u2022 Option A: Identify high risk factors: Diabetes (HBA1C), HTN, Epilepsy, Thyroid disorders (TSH), Anemia (Hb)</li><li>\u2022 Option A:</li><li>\u2022 Option B: Pre-conceptional Folic Acid (0.4 mg/ day (400mcg per day)  to low risk; 4 mg/ day to high risk for neural tube defects - NTD). Women at high risk for NTD are H/o previous baby with NTD Pre-gestational Diabetes Mellitus Folic acid deficiency Obesity Epilepsy/ on Antiepileptic Drugs (AED)</li><li>\u2022 Option B:</li><li>\u2022 H/o previous baby with NTD Pre-gestational Diabetes Mellitus Folic acid deficiency Obesity Epilepsy/ on Antiepileptic Drugs (AED)</li><li>\u2022 H/o previous baby with NTD</li><li>\u2022 Pre-gestational Diabetes Mellitus</li><li>\u2022 Folic acid deficiency</li><li>\u2022 Obesity</li><li>\u2022 Epilepsy/ on Antiepileptic Drugs (AED)</li><li>\u2022 Option C: Assess for genetic diseases (h/o sickle cell ds, cystic fibrosis, thalassemia etc.)</li><li>\u2022 Option C:</li><li>\u2022 Option D: Immunization status: Rubella; if unimmunized or status unknown, Rubella vaccination is to be given with advice to avoid conception till 1 month following vaccination as it is a live vaccine with potential teratogenic side effects to the fetus.</li><li>\u2022 Option D:</li><li>\u2022 Rubella; if unimmunized or status unknown, Rubella vaccination is to be given with advice to avoid conception till 1 month following vaccination as it is a live vaccine with potential teratogenic side effects to the fetus.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Components of pre-conceptional counseling:</li><li>\u27a4 Components of pre-conceptional counseling:</li><li>\u27a4 Identify high risk factors: Diabetes (HBA1C), HTN, Epilepsy, Thyroid disorders (TSH), Anemia (Hb) Immunization status: Rubella; if unimmunized or status unknown, Rubella vaccination is to be given with advice to avoid conception till 1 month following vaccination as it is a live vaccine with potential teratogenic side effects to the fetus. Check the BMI and advise optimization prior to planning pregnancy Stop/change any teratogenic drug (antiepileptic, warfarin, ACE inhibitor, ARB) Pre-conceptional Folic Acid (0.4 mg/ day (400mcg per day)  to low risk; 4 mg/ day to high risk for neural tube defects - NTD). Women at high risk for NTD are H/o previous baby with NTD Pre-gestational Diabetes Mellitus Folic acid deficiency Obesity Epilepsy/ on Antiepileptic Drugs (AED) Assess for genetic diseases (h/o sickle cell ds, cystic fibrosis, thalassemia etc.) Smoking, alcohol, drug abuse \u2013 Advise to STOP</li><li>\u27a4 Identify high risk factors: Diabetes (HBA1C), HTN, Epilepsy, Thyroid disorders (TSH), Anemia (Hb)</li><li>\u27a4 Immunization status: Rubella; if unimmunized or status unknown, Rubella vaccination is to be given with advice to avoid conception till 1 month following vaccination as it is a live vaccine with potential teratogenic side effects to the fetus.</li><li>\u27a4 Rubella; if unimmunized or status unknown, Rubella vaccination is to be given with advice to avoid conception till 1 month following vaccination as it is a live vaccine with potential teratogenic side effects to the fetus.</li><li>\u27a4 Check the BMI and advise optimization prior to planning pregnancy</li><li>\u27a4 Stop/change any teratogenic drug (antiepileptic, warfarin, ACE inhibitor, ARB)</li><li>\u27a4 (antiepileptic, warfarin, ACE inhibitor, ARB)</li><li>\u27a4 Pre-conceptional Folic Acid (0.4 mg/ day (400mcg per day)  to low risk; 4 mg/ day to high risk for neural tube defects - NTD). Women at high risk for NTD are H/o previous baby with NTD Pre-gestational Diabetes Mellitus Folic acid deficiency Obesity Epilepsy/ on Antiepileptic Drugs (AED)</li><li>\u27a4 H/o previous baby with NTD Pre-gestational Diabetes Mellitus Folic acid deficiency Obesity Epilepsy/ on Antiepileptic Drugs (AED)</li><li>\u27a4 H/o previous baby with NTD</li><li>\u27a4 Pre-gestational Diabetes Mellitus</li><li>\u27a4 Folic acid deficiency</li><li>\u27a4 Obesity</li><li>\u27a4 Epilepsy/ on Antiepileptic Drugs (AED)</li><li>\u27a4 Assess for genetic diseases (h/o sickle cell ds, cystic fibrosis, thalassemia etc.)</li><li>\u27a4 Smoking, alcohol, drug abuse \u2013 Advise to STOP</li><li>\u27a4 Ref: Page no,172, 147 Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no,172, 147 Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5a97c5e5",
      "audio": ""
    },
    {
      "text": "What is the WHO recommendation for Antenatal Visits?",
      "options": [
        {
          "label": "A",
          "text": "At least 4 visits, including the registration visit",
          "correct": false
        },
        {
          "label": "B",
          "text": "At least 4 visits excluding the registration visit",
          "correct": false
        },
        {
          "label": "C",
          "text": "At least 8 visits with 1 in the 1 st trimester, 2 in the 2 nd trimester and 5 in the 3 rd trimester",
          "correct": true
        },
        {
          "label": "D",
          "text": "At least 8 visits, 2 in the 1 st trimester, 2 in the 2 nd trimester and 4 in the 3 rd trimester",
          "correct": false
        }
      ],
      "correct_answer": "C. At least 8 visits with 1 in the 1 st trimester, 2 in the 2 nd trimester and 5 in the 3 rd trimester",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. At least 8 visits with 1 in the 1sttrimester, 2 in the 2ndtrimester and 5 in the 3rdtrimester</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 As per the WHO, 8 contact visits are recommended in the antenatal period.</li><li>\u2022 As per the WHO, 8 contact visits are recommended in the antenatal period.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Protocol for Antenatal Visits</li><li>\u27a4 Protocol for Antenatal Visits</li><li>\u27a4 MOHFW (Indian guidelines) At least4 visits including the first (Registration visit) \u2013 Minimum requirement Suggested schedule 1st Visit: Within 12 weeks 2nd Visit: 14 \u2013 26 weeks 3rd Visit: 28 \u2013 34 weeks 4th visit: 36 weeks \u2013 term WHO (2016): 8 visits. 1st Trimester: Contact 1: upto 12 weeks 2nd Trimester Contact 2 (20 weeks) & Contact 3 (26 weeks) 3rd Trimester Contact 4 (30 week), Contact 5 (34 weeks), contact 6 (36 weeks), contact 7 (38 weeks) & Contact 8 (40 weeks)</li><li>\u27a4 MOHFW (Indian guidelines) At least4 visits including the first (Registration visit) \u2013 Minimum requirement Suggested schedule 1st Visit: Within 12 weeks 2nd Visit: 14 \u2013 26 weeks 3rd Visit: 28 \u2013 34 weeks 4th visit: 36 weeks \u2013 term</li><li>\u27a4 MOHFW (Indian guidelines)</li><li>\u27a4 At least4 visits including the first (Registration visit) \u2013 Minimum requirement Suggested schedule 1st Visit: Within 12 weeks 2nd Visit: 14 \u2013 26 weeks 3rd Visit: 28 \u2013 34 weeks 4th visit: 36 weeks \u2013 term</li><li>\u27a4 At least4 visits including the first (Registration visit) \u2013 Minimum requirement</li><li>\u27a4 At least4 visits</li><li>\u27a4 Suggested schedule 1st Visit: Within 12 weeks 2nd Visit: 14 \u2013 26 weeks 3rd Visit: 28 \u2013 34 weeks 4th visit: 36 weeks \u2013 term</li><li>\u27a4 1st Visit: Within 12 weeks 2nd Visit: 14 \u2013 26 weeks 3rd Visit: 28 \u2013 34 weeks 4th visit: 36 weeks \u2013 term</li><li>\u27a4 1st Visit: Within 12 weeks</li><li>\u27a4 2nd Visit: 14 \u2013 26 weeks</li><li>\u27a4 3rd Visit: 28 \u2013 34 weeks</li><li>\u27a4 4th visit: 36 weeks \u2013 term</li><li>\u27a4 WHO (2016): 8 visits. 1st Trimester: Contact 1: upto 12 weeks 2nd Trimester Contact 2 (20 weeks) & Contact 3 (26 weeks) 3rd Trimester Contact 4 (30 week), Contact 5 (34 weeks), contact 6 (36 weeks), contact 7 (38 weeks) & Contact 8 (40 weeks)</li><li>\u27a4 WHO (2016): 8 visits.</li><li>\u27a4 1st Trimester: Contact 1: upto 12 weeks 2nd Trimester Contact 2 (20 weeks) & Contact 3 (26 weeks) 3rd Trimester Contact 4 (30 week), Contact 5 (34 weeks), contact 6 (36 weeks), contact 7 (38 weeks) & Contact 8 (40 weeks)</li><li>\u27a4 1st Trimester: Contact 1: upto 12 weeks</li><li>\u27a4 Contact 1: upto 12 weeks</li><li>\u27a4 Contact 1: upto 12 weeks</li><li>\u27a4 2nd Trimester Contact 2 (20 weeks) & Contact 3 (26 weeks)</li><li>\u27a4 Contact 2 (20 weeks) & Contact 3 (26 weeks)</li><li>\u27a4 Contact 2 (20 weeks) & Contact 3 (26 weeks)</li><li>\u27a4 3rd Trimester Contact 4 (30 week), Contact 5 (34 weeks), contact 6 (36 weeks), contact 7 (38 weeks) & Contact 8 (40 weeks)</li><li>\u27a4 Contact 4 (30 week), Contact 5 (34 weeks), contact 6 (36 weeks), contact 7 (38 weeks) & Contact 8 (40 weeks)</li><li>\u27a4 Contact 4 (30 week), Contact 5 (34 weeks), contact 6 (36 weeks), contact 7 (38 weeks) & Contact 8 (40 weeks)</li><li>\u27a4 Ideally (& as per ACOG): once every month till 28 weeks, every 2 weeks till 36 weeks and then weekly till 40 weeks: So total of 12 \u2013 14 visits.</li><li>\u27a4 Ideally</li><li>\u27a4 Ref: WHO Recommendations on Antenatal care for a positive pregnancy experience , MOHFW guidelines and Williams Obstetrics Pg 164 ,  25 th edition</li><li>\u27a4 Ref: WHO Recommendations on Antenatal care for a positive pregnancy experience , MOHFW guidelines and Williams Obstetrics Pg 164 ,  25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "633d39ff",
      "audio": ""
    },
    {
      "text": "A primigravida was given dietary advice in the first trimester. What should be the extra calorie intake in pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "200 KCal",
          "correct": false
        },
        {
          "label": "B",
          "text": "300 KCal",
          "correct": false
        },
        {
          "label": "C",
          "text": "500 KCcal",
          "correct": false
        },
        {
          "label": "D",
          "text": "No extra calories",
          "correct": true
        }
      ],
      "correct_answer": "D. No extra calories",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. No extra calories</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 In the 1 st trimester of pregnancy, no additional calorie requirement is required</li><li>\u2022 In the 1 st trimester of pregnancy, no additional calorie requirement is required</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Pregnancy requires a total additional of 80,000 Kcal; mostly in the latter half An average caloric increase of 300 Kcal/ day recommended If we divide this trimester wise, 0Kcal/ day in 1 st trimester 340Kcal/ day in 2 nd trimester 452Kcal/ day in 3rd trimesters If a question is asked regarding extra calorie in the 1 st trimester, the answer will be NO Additional Requirement. Women who breastfeed require approximately 500 additional kcal/day; beyond what is usually recommended for non-pregnant women RDA of proteins in pregnancy: 60 \u2013 65g/ day (increase by 15g/ day)</li><li>\u27a4 Pregnancy requires a total additional of 80,000 Kcal; mostly in the latter half</li><li>\u27a4 An average caloric increase of 300 Kcal/ day recommended</li><li>\u27a4 If we divide this trimester wise, 0Kcal/ day in 1 st trimester 340Kcal/ day in 2 nd trimester 452Kcal/ day in 3rd trimesters</li><li>\u27a4 0Kcal/ day in 1 st trimester 340Kcal/ day in 2 nd trimester 452Kcal/ day in 3rd trimesters</li><li>\u27a4 0Kcal/ day in 1 st trimester</li><li>\u27a4 340Kcal/ day in 2 nd trimester</li><li>\u27a4 452Kcal/ day in 3rd trimesters</li><li>\u27a4 If a question is asked regarding extra calorie in the 1 st trimester, the answer will be NO Additional Requirement.</li><li>\u27a4 Women who breastfeed require approximately 500 additional kcal/day; beyond what is usually recommended for non-pregnant women</li><li>\u27a4 RDA of proteins in pregnancy: 60 \u2013 65g/ day (increase by 15g/ day)</li><li>\u27a4 Ref: Page no 168, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no 168, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ad41c258",
      "audio": ""
    },
    {
      "text": "Identify the grip in the picture used for checking ballotability of head?",
      "options": [
        {
          "label": "A",
          "text": "Pelvic grip",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pawlick grip",
          "correct": true
        },
        {
          "label": "C",
          "text": "Fundal grip",
          "correct": false
        },
        {
          "label": "D",
          "text": "Umbilical grip",
          "correct": false
        }
      ],
      "correct_answer": "B. Pawlick grip",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/09/fmg-2.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/09/obg-26_WgYopAf.jpg"
      ],
      "explanation": "<p><strong>Ans. B. Pawlick grip</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 The image shows the #rd Leopold maneuver; also called the 1 st pelvic grip; also called the Pawlik grip.</li><li>\u2022 The image shows the #rd Leopold maneuver; also called the 1 st pelvic grip; also called the Pawlik grip.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 There are 4 Leopold Maneuvers:</li><li>\u27a4 Fundal grip (A): to assess which fetal pole (cephalic or podalic) occupies the fundus. The breech gives the sensation of a large nodular mass; the head feel hard, round and mobile The Lateral grip (B): determines the side of the back (hard, resistant) and the limbs (numerous, small irregular mobile parts) The 1 st pelvic grip (3 rd maneuver aka Pawlik grip - C): determining fetal presentation. The 2 nd pelvic grip (4 th maneuver - D): determines the degree of descent. This maneuver is done facing the feet of the patient and trying to approximate the hands of the examiner. IF the hands approximate; the head has not descended into the pelvis. If the hands diverge, the head has descended into the pelvis.</li><li>\u27a4 Fundal grip (A): to assess which fetal pole (cephalic or podalic) occupies the fundus. The breech gives the sensation of a large nodular mass; the head feel hard, round and mobile</li><li>\u27a4 Fundal grip (A):</li><li>\u27a4 The Lateral grip (B): determines the side of the back (hard, resistant) and the limbs (numerous, small irregular mobile parts)</li><li>\u27a4 The Lateral grip (B):</li><li>\u27a4 The 1 st pelvic grip (3 rd maneuver aka Pawlik grip - C): determining fetal presentation.</li><li>\u27a4 The 1 st pelvic grip (3 rd maneuver aka Pawlik grip - C):</li><li>\u27a4 The 2 nd pelvic grip (4 th maneuver - D): determines the degree of descent. This maneuver is done facing the feet of the patient and trying to approximate the hands of the examiner. IF the hands approximate; the head has not descended into the pelvis. If the hands diverge, the head has descended into the pelvis.</li><li>\u27a4 The 2 nd pelvic grip (4 th maneuver - D):</li><li>\u27a4 Ref: Page 424, William\u2019s Obstetrics; 25 th edition</li><li>\u27a4 Ref: Page 424, William\u2019s Obstetrics; 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "abaeb55b",
      "audio": ""
    },
    {
      "text": "A patient presented at 20 weeks of gestation. The patient\u2019s LMP was 9 th January. What will be the estimated date of delivery?",
      "options": [
        {
          "label": "A",
          "text": "9 th January",
          "correct": false
        },
        {
          "label": "B",
          "text": "16 th September",
          "correct": false
        },
        {
          "label": "C",
          "text": "16 th October",
          "correct": true
        },
        {
          "label": "D",
          "text": "9 th October",
          "correct": false
        }
      ],
      "correct_answer": "C. 16 th October",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. 16thOctober</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 If we use Nagele\u2019s rule for this patient, adding 9 months and 7 days ti 9 th Jan will give us 16 th October.</li><li>\u2022 If we use Nagele\u2019s rule for this patient, adding 9 months and 7 days ti 9 th Jan will give us 16 th October.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Calculating the EDD:</li><li>\u27a4 Calculating the EDD:</li><li>\u27a4 Normal duration of pregnancy: 280 days (40 weeks) Calculating the EDD: Naegele\u2019s formula . To the LMP (1 st day of the last menstrual day Add 9 months + 7 days Subtract 3 months and add 7 days For IVF Pregnancies: add 38 weeks to the date of the embryo transfer Dating the pregnancy: If discrepancy in dates/ unsure of LMP; the best way to determine the dating is by ULTRASOUND 1st trimester CRL: most accurate (till 14 weeks) BPD in the 2nd trimester</li><li>\u27a4 Normal duration of pregnancy: 280 days (40 weeks)</li><li>\u27a4 Calculating the EDD: Naegele\u2019s formula . To the LMP (1 st day of the last menstrual day Add 9 months + 7 days Subtract 3 months and add 7 days For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</li><li>\u27a4 Naegele\u2019s formula</li><li>\u27a4 Add 9 months + 7 days Subtract 3 months and add 7 days For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</li><li>\u27a4 Add 9 months + 7 days</li><li>\u27a4 Subtract 3 months and add 7 days</li><li>\u27a4 For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</li><li>\u27a4 Dating the pregnancy: If discrepancy in dates/ unsure of LMP; the best way to determine the dating is by ULTRASOUND 1st trimester CRL: most accurate (till 14 weeks) BPD in the 2nd trimester</li><li>\u27a4 Dating the pregnancy:</li><li>\u27a4 1st trimester CRL: most accurate (till 14 weeks) BPD in the 2nd trimester</li><li>\u27a4 1st trimester CRL: most accurate (till 14 weeks)</li><li>\u27a4 BPD in the 2nd trimester</li><li>\u27a4 Ref: Page no 168, William\u2019s Obstetrics; 25 th edition</li><li>\u27a4 Ref: Page no 168, William\u2019s Obstetrics; 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "afdeca03",
      "audio": ""
    },
    {
      "text": "Use of folic acid to prevent neural tube defects should be best initiated:",
      "options": [
        {
          "label": "A",
          "text": "At 6 weeks of pregnancy",
          "correct": false
        },
        {
          "label": "B",
          "text": "At 8 weeks of pregnancy",
          "correct": false
        },
        {
          "label": "C",
          "text": "At least 3 months prior to conception",
          "correct": true
        },
        {
          "label": "D",
          "text": "At least 6 months prior to conception",
          "correct": false
        }
      ],
      "correct_answer": "C. At least 3 months prior to conception",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. At least 3 months prior to conception</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Folic acid should ideally be started 3 months pre-conceptionally and continued till the 1 st 3 months of pregnancy</li><li>\u2022 Folic acid should ideally be started 3 months pre-conceptionally and continued till the 1 st 3 months of pregnancy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Folic acid supplementation in pregnancy</li><li>\u27a4 Lowers the risk of developing NTDs Daily intake of 400 mcg of folic acid in the periconceptional period can prevent NTDs The neural tube has already closed by 6 weeks hence it should be started much before this time</li><li>\u27a4 Lowers the risk of developing NTDs</li><li>\u27a4 Daily intake of 400 mcg of folic acid in the periconceptional period can prevent NTDs</li><li>\u27a4 The neural tube has already closed by 6 weeks hence it should be started much before this time</li><li>\u27a4 Ref: Page 169, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 169, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9cffba56",
      "audio": ""
    },
    {
      "text": "Iron and Folic acid supplementation dose for pregnant women in Anemia Mukt Bharat?",
      "options": [
        {
          "label": "A",
          "text": "500 mcg folic acid and 60 mg iron weekly",
          "correct": false
        },
        {
          "label": "B",
          "text": "500 mcg folic acid and 60 mg iron daily",
          "correct": true
        },
        {
          "label": "C",
          "text": "400 mcg folic acid and 100 mg iron daily",
          "correct": false
        },
        {
          "label": "D",
          "text": "400 mcg folic acid and 60 mg daily",
          "correct": false
        }
      ],
      "correct_answer": "B. 500 mcg folic acid and 60 mg iron daily",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. 500 mcg folic acid and 60 mg iron daily</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 As per the National Health Program \u201cAnemia Mukt Bharat\u201d started in 2018:</li><li>\u27a4 Pregnant and Lactating women (of 0-6 months child): Should receive:</li><li>\u27a4 Daily, 1 Iron and Folic Acid tablet starting from the fourth month of pregnancy (that is from the second trimester) Continued throughout pregnancy (minimum 180 days during pregnancy) and To be continued for 180 days, post-partum Each tablet containing 60 mg elemental Iron + 500 mcg Folic Acid, sugar-coated and red-colour.</li><li>\u27a4 Daily, 1 Iron and Folic Acid tablet starting from the fourth month of pregnancy (that is from the second trimester)</li><li>\u27a4 Continued throughout pregnancy (minimum 180 days during pregnancy) and</li><li>\u27a4 To be continued for 180 days, post-partum</li><li>\u27a4 Each tablet containing 60 mg elemental Iron + 500 mcg Folic Acid, sugar-coated and red-colour.</li><li>\u27a4 Ref: https://anemiamuktbharat.info/</li><li>\u27a4 Ref:</li><li>\u27a4 https://anemiamuktbharat.info/</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "350c49a6",
      "audio": ""
    },
    {
      "text": "A 28-year-old pregnant woman presents for her first prenatal visit. What is the primary goal of the initial prenatal visit?",
      "options": [
        {
          "label": "A",
          "text": "Diagnosis of fetal anomalies",
          "correct": false
        },
        {
          "label": "B",
          "text": "Establishment of a due date",
          "correct": false
        },
        {
          "label": "C",
          "text": "Assessment of maternal health",
          "correct": true
        },
        {
          "label": "D",
          "text": "Determination of fetal sex",
          "correct": false
        }
      ],
      "correct_answer": "C. Assessment of maternal health",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Assessment of maternal health</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Other options:</li><li>\u2022 Other options:</li><li>\u2022 Option A: Diagnosis of fetal anomalies is done initially at 11-14 weeks and then again at 18-22 weeks (Level 2/ anomaly scan) Option B: Establishment of a due date: This is done in the initial visit but is not the primary goal Option D: Determination of fetal sex is not important and is not legal in India</li><li>\u2022 Option A: Diagnosis of fetal anomalies is done initially at 11-14 weeks and then again at 18-22 weeks (Level 2/ anomaly scan)</li><li>\u2022 Option A:</li><li>\u2022 Option B: Establishment of a due date: This is done in the initial visit but is not the primary goal</li><li>\u2022 Option B:</li><li>\u2022 Option D: Determination of fetal sex is not important and is not legal in India</li><li>\u2022 Option D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page no 161, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no 161, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0deb51f9",
      "audio": ""
    },
    {
      "text": "A 32-year-old pregnant woman is scheduled for her first prenatal visit. Which of the following laboratory tests is typically performed at the initial prenatal visit to screen for underlying health conditions and to provide a baseline for comparison throughout pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Glucose tolerance test",
          "correct": false
        },
        {
          "label": "B",
          "text": "Urinalysis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Rubella titer",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pap smear",
          "correct": false
        }
      ],
      "correct_answer": "B. Urinalysis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Urinalysis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Other options:</li><li>\u2022 Other options:</li><li>\u2022 Option A: Glucose tolerance test is generally performed between 24-28 weeks Option C: Rubella antibody titers are checked prior to conception; if IgG is negative vaccine should be given before planning pregnancy Option D: Pap smear is generally not performed in pregnancy and has no bearing on the overall maternal health.</li><li>\u2022 Option A: Glucose tolerance test is generally performed between 24-28 weeks</li><li>\u2022 Option A:</li><li>\u2022 Option C: Rubella antibody titers are checked prior to conception; if IgG is negative vaccine should be given before planning pregnancy</li><li>\u2022 Option C:</li><li>\u2022 Option D: Pap smear is generally not performed in pregnancy and has no bearing on the overall maternal health.</li><li>\u2022 Option D:</li><li>\u2022 Ref: Page no 163 , William\u2019s Obstetrics, 25 th edition</li><li>\u2022 Ref: Page no 163 , William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5c365bed",
      "audio": ""
    },
    {
      "text": "A pregnant woman had a previous baby with history of neural tube defect. Which routine antenatal screening test should be offered?",
      "options": [
        {
          "label": "A",
          "text": "Non-stress test (NST)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Amniocentesis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Alpha-fetoprotein (AFP) screening",
          "correct": true
        },
        {
          "label": "D",
          "text": "Fetal kick counts",
          "correct": false
        }
      ],
      "correct_answer": "C. Alpha-fetoprotein (AFP) screening",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Alpha-fetoprotein (AFP) screening</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Alpha-fetoprotein (AFP) screening is a routine antenatal test typically offered around 15-20 weeks of gestation to assess the risk of neural tube defects and other fetal anomalies. Abnormal AFP levels may indicate the need for further diagnostic tests, such as amniocentesis.</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A. NST : This is a test of antepartum fetal assessment and is usually done after 32 weeks Option B. Amniocentesis : Diagnostic amniocentesis is usually done for detecting fetal chromosomal anomalies Option D. Fetal kick count : This is a test of antepartum fetal assessment and is advised after 28 weeks</li><li>\u2022 Option A. NST : This is a test of antepartum fetal assessment and is usually done after 32 weeks</li><li>\u2022 Option A. NST</li><li>\u2022 Option B. Amniocentesis : Diagnostic amniocentesis is usually done for detecting fetal chromosomal anomalies</li><li>\u2022 Option B. Amniocentesis</li><li>\u2022 Option D. Fetal kick count : This is a test of antepartum fetal assessment and is advised after 28 weeks</li><li>\u2022 Option D. Fetal kick count</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page no 192, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no 192, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "392f46cd",
      "audio": ""
    },
    {
      "text": "A pregnant woman presents for her second trimester prenatal visit. She asks about the recommended weight gain during pregnancy. What advice should be given to her?",
      "options": [
        {
          "label": "A",
          "text": "She should aim to gain as little weight as possible to prevent complications.",
          "correct": false
        },
        {
          "label": "B",
          "text": "She should aim to gain at least 12 kg; regardless of her pre-pregnancy weight.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Weight gain recommendations depend on her pre-pregnancy BMI.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Weight gain is not a concern during pregnancy.",
          "correct": false
        }
      ],
      "correct_answer": "C. Weight gain recommendations depend on her pre-pregnancy BMI.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/11/screenshot-2023-12-11-180817.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Weight gain recommendations depend on her pre-pregnancy BMI.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page no 166, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no 166, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "834ca934",
      "audio": ""
    },
    {
      "text": "A 35-year-old pregnant woman presents for her third trimester prenatal visit. She has no known medical conditions and is experiencing a healthy pregnancy. What should be the focus of antenatal care during the third trimester?",
      "options": [
        {
          "label": "A",
          "text": "Ultrasound for fetal organ assessment",
          "correct": false
        },
        {
          "label": "B",
          "text": "Routine prenatal testing for genetic disorders",
          "correct": false
        },
        {
          "label": "C",
          "text": "Monitoring fetal growth and well-being",
          "correct": true
        },
        {
          "label": "D",
          "text": "Assessment of maternal blood pressure and urine protein",
          "correct": false
        }
      ],
      "correct_answer": "C. Monitoring fetal growth and well-being",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Monitoring fetal growth and well-being</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Option A: Ultrasound for fetal organ assessment is done between 18-20 weeks (level 2/ anomaly scan) Option B: Routine prenatal testing for genetic disorders is done between 11-14 weeks Option D: Assessment of maternal BP is done at every visit and if high, a urine protein is checked.</li><li>\u2022 Option A: Ultrasound for fetal organ assessment is done between 18-20 weeks (level 2/ anomaly scan)</li><li>\u2022 Option A:</li><li>\u2022 Option B: Routine prenatal testing for genetic disorders is done between 11-14 weeks</li><li>\u2022 Option B:</li><li>\u2022 Option D: Assessment of maternal BP is done at every visit and if high, a urine protein is checked.</li><li>\u2022 Option D:</li><li>\u2022 Ref: Page no 163, William\u2019s Obstetrics, 25 th edition</li><li>\u2022 Ref: Page no 163, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dceca281",
      "audio": ""
    },
    {
      "text": "Which of the following vaccines is NOT contraindicated in Pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Measles",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rabies",
          "correct": true
        },
        {
          "label": "C",
          "text": "Rubella",
          "correct": false
        },
        {
          "label": "D",
          "text": "Varicella",
          "correct": false
        }
      ],
      "correct_answer": "B. Rabies",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Rabies</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Rabies vaccine is not contra-indicated in pregnancy and should be given when indicated</li><li>\u2022 Rabies vaccine is not contra-indicated in pregnancy and should be given when indicated</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Most live vaccines (Rabies, rubella, varicella) are contra-indicated in pregnancy. However, yellow fever which is a live vaccine is an exception and can be given to pregnant women when travelling to an endemic area.</li><li>\u2022 Most live vaccines (Rabies, rubella, varicella) are contra-indicated in pregnancy. However, yellow fever which is a live vaccine is an exception and can be given to pregnant women when travelling to an endemic area.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Rabies vaccine is safe in pregnancy and can be given when indicated</li><li>\u27a4 Rabies vaccine is safe in pregnancy and can be given when indicated</li><li>\u27a4 Ref: Page no 172, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no 172, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "72a9011e",
      "audio": ""
    },
    {
      "text": "A 24-year woman in her 1 st antenatal checkup reveals to her Doctor that she had taken the 1 st dose of Hepatitis B immunization prior to conception. She now asks if she should continue with the immunization schedule or not. What is the correct response?",
      "options": [
        {
          "label": "A",
          "text": "Continue with the scheduled immunization schedule.",
          "correct": true
        },
        {
          "label": "B",
          "text": "Delay the completion of immunization till after delivery",
          "correct": false
        },
        {
          "label": "C",
          "text": "Terminate the pregnancy and continue the immunization",
          "correct": false
        },
        {
          "label": "D",
          "text": "Delay the immunization till after 20 weeks as organogenesis will be complete by then.",
          "correct": false
        }
      ],
      "correct_answer": "A. Continue with the scheduled immunization schedule.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Continue with the scheduled immunization schedule</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Hepatitis B vaccination is safe in pregnancy and the immunization schedule can be continued if the patient becomes pregnant.</li><li>\u2022 Hepatitis B vaccination is safe in pregnancy and the immunization schedule can be continued if the patient becomes pregnant.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hepatitis B immunization in pregnancy: Indicated in:</li><li>\u27a4 Those women completing their immunization schedule which was started pre conception High risk groups \u2013 Household contacts, partners are positive, multiple sexual partners, chronic liver disease, HIV +ve Dose: 0.5 ml IM at 0, 1, 6 months</li><li>\u27a4 Those women completing their immunization schedule which was started pre conception</li><li>\u27a4 High risk groups \u2013 Household contacts, partners are positive, multiple sexual partners, chronic liver disease, HIV +ve</li><li>\u27a4 Dose: 0.5 ml IM at 0, 1, 6 months</li><li>\u27a4 Ref: Page No 172 William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page No 172 William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0acae699",
      "audio": ""
    },
    {
      "text": "Which is the only vaccine known to cause fetal harm?",
      "options": [
        {
          "label": "A",
          "text": "Chicken pox",
          "correct": false
        },
        {
          "label": "B",
          "text": "HSV",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mumps",
          "correct": false
        },
        {
          "label": "D",
          "text": "Small pox",
          "correct": true
        }
      ],
      "correct_answer": "D. Small pox",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Small pox</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 All live vaccines have a theoretical risk of causing fetal harm But the only vaccine that is known to cause fetal harm is small pox</li><li>\u2022 All live vaccines have a theoretical risk of causing fetal harm</li><li>\u2022 But the only vaccine that is known to cause fetal harm is small pox</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 All live vaccines have a theoretical risk of causing fetal harm But the only vaccine that is known to cause fetal harm is small pox</li><li>\u27a4 All live vaccines have a theoretical risk of causing fetal harm</li><li>\u27a4 But the only vaccine that is known to cause fetal harm is small pox</li><li>\u27a4 Ref: Page no 499, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page no 499, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3cdbad0b",
      "audio": ""
    },
    {
      "text": "What is the preferred schedule of immunization in pregnancy regarding tetanus as per the ministry of health and family welfare?",
      "options": [
        {
          "label": "A",
          "text": "Inj Td: 1 st dose: early in pregnancy, 2 nd dose: After 4 weeks; booster: if received 2 Td doses in a pregnancy within the last 3 years",
          "correct": true
        },
        {
          "label": "B",
          "text": "Inj TT 1 st dose early in pregnancy, 2 nd dose after 4 weeks and booster if received 2 TT doses in a pregnancy within the last 3 years",
          "correct": false
        },
        {
          "label": "C",
          "text": "Inj Tdap 1 st dose in the 2 nd trimester and 2 nd dose in the 3 rd trimester",
          "correct": false
        },
        {
          "label": "D",
          "text": "Inj TT or Td 1 st dose in early pregnancy and 2 nd dose after 4 weeks.",
          "correct": false
        }
      ],
      "correct_answer": "A. Inj Td: 1 st dose: early in pregnancy, 2 nd dose: After 4 weeks; booster: if received 2 Td doses in a pregnancy within the last 3 years",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Inj Td: 1stdose: early in pregnancy, 2nddose: After 4 weeks; booster:\u00a0 if received 2 Td doses in a pregnancy within the last 3 years</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Vaccines given in pregnancy as per Ministry of Health and Family Welfare</li><li>\u2022 Vaccines given in pregnancy as per Ministry of Health and Family Welfare</li><li>\u2022 TT, Td or Tdap Td has replaced TT (as per MOHFW) 1 st dose: early in pregnancy 2 nd dose: After 4 weeks Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u2022 TT, Td or Tdap Td has replaced TT (as per MOHFW) 1 st dose: early in pregnancy 2 nd dose: After 4 weeks Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u2022 TT, Td or Tdap</li><li>\u2022 Td has replaced TT (as per MOHFW) 1 st dose: early in pregnancy 2 nd dose: After 4 weeks Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u2022 Td has replaced TT (as per MOHFW)</li><li>\u2022 1 st dose: early in pregnancy</li><li>\u2022 2 nd dose: After 4 weeks</li><li>\u2022 Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u2022 **As per ACOG Committee Guidelines 2017, Tdap: One dose of Td replaced with Tdap preferably given between 27-36 weeks of gestation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vaccines given in pregnancy as per Ministry of Health and Family Welfare</li><li>\u27a4 Vaccines given in pregnancy as per Ministry of Health and Family Welfare</li><li>\u27a4 TT, Td or Tdap Td has replaced TT (as per MOHFW) 1 st dose: early in pregnancy 2 nd dose: After 4 weeks Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u27a4 TT, Td or Tdap Td has replaced TT (as per MOHFW) 1 st dose: early in pregnancy 2 nd dose: After 4 weeks Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u27a4 TT, Td or Tdap</li><li>\u27a4 Td has replaced TT (as per MOHFW) 1 st dose: early in pregnancy 2 nd dose: After 4 weeks Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u27a4 Td has replaced TT (as per MOHFW)</li><li>\u27a4 1 st dose: early in pregnancy</li><li>\u27a4 2 nd dose: After 4 weeks</li><li>\u27a4 Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u27a4 **As per ACOG Committee Guidelines 2017, Tdap: One dose of Td replaced with Tdap preferably given between 27-36 weeks of gestation</li><li>\u27a4 **As per ACOG Committee Guidelines 2017, Tdap: One dose of Td replaced with Tdap preferably given between 27-36 weeks of gestation</li><li>\u27a4 Ref : https://www.fogsi.org/wp-content/uploads/2015/11/vaccination_women.pdf</li><li>\u27a4 Ref :</li><li>\u27a4 https://www.fogsi.org/wp-content/uploads/2015/11/vaccination_women.pdf</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f02d6de6",
      "audio": ""
    },
    {
      "text": "A 25-year woman has received the 1 st dose of Gardasil vaccine. Before she receives the 2 nd dose, she conceives. What is the next best step?",
      "options": [
        {
          "label": "A",
          "text": "Continue the vaccine schedule during pregnancy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Continue the vaccine schedule post-delivery",
          "correct": true
        },
        {
          "label": "C",
          "text": "Restart the entire vaccine schedule post-delivery",
          "correct": false
        },
        {
          "label": "D",
          "text": "Terminate the pregnancy",
          "correct": false
        }
      ],
      "correct_answer": "B. Continue the vaccine schedule post-delivery",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Continue the vaccine schedule post-delivery</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 If HPV vaccine has been interrupted because of pregnancy, continue the schedule after delivery HPV vaccine is not given during pregnancy.</li><li>\u27a4 If HPV vaccine has been interrupted because of pregnancy, continue the schedule after delivery</li><li>\u27a4 HPV vaccine is not given during pregnancy.</li><li>\u27a4 Ref: Page no 499, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page no 499, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fb54650d",
      "audio": ""
    },
    {
      "text": "A 32-year woman who is planning to conceive visits her doctor for a pre conceptional visit. The Doctor asks her if she has been immunized against Rubella. She is not sure so she is advised to get a IgG rubella done which is positive. What is the next best step?",
      "options": [
        {
          "label": "A",
          "text": "Give the Rubella vaccine.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Advise her not to conceive for the next 3 months.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Advise her not to conceive for the next 1 month.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tell her she can safely conceive.",
          "correct": true
        }
      ],
      "correct_answer": "D. Tell her she can safely conceive.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Tell her she can safely conceive</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 A positive IgG rubella means that she is immunized against rubella She does not require any vaccination and can safely plan conception If she was IgG rubella negative, then she is susceptible to rubella in pregnancy and should be advised rubella vaccination As it is a live vaccine, she should not conceive for at least 1 month following vaccination</li><li>\u2022 A positive IgG rubella means that she is immunized against rubella</li><li>\u2022 She does not require any vaccination and can safely plan conception</li><li>\u2022 If she was IgG rubella negative, then she is susceptible to rubella in pregnancy and should be advised rubella vaccination</li><li>\u2022 As it is a live vaccine, she should not conceive for at least 1 month following vaccination</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A positive IgG rubella indicates the patient is immune and does not require pre-conceptional rubella vaccination</li><li>\u27a4 A positive IgG rubella indicates the patient is immune and does not require pre-conceptional rubella vaccination</li><li>\u27a4 Ref: Page no 499, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page no 499, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "950936d7",
      "audio": ""
    },
    {
      "text": "A 28-year-old pregnant woman is scheduled for her prenatal visit. She inquires about vaccines recommended during pregnancy. Which vaccine is generally considered safe and recommended for pregnant women to protect both the mother and the newborn?",
      "options": [
        {
          "label": "A",
          "text": "Mumps, Measles, and Rubella (MMR) vaccine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tetanus, diphtheria, and acellular pertussis (Tdap) vaccine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Human papillomavirus (HPV) vaccine",
          "correct": false
        },
        {
          "label": "D",
          "text": "All the above",
          "correct": false
        }
      ],
      "correct_answer": "B. Tetanus, diphtheria, and acellular pertussis (Tdap) vaccine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Tetanus, diphtheria, and acellular pertussis (Tdap) vaccine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The Tdap vaccine is generally considered safe and recommended for pregnant women, typically between 27-36 weeks of gestation. This vaccine helps protect the mother from tetanus, diphtheria, and pertussis (whooping cough), and it also provides passive immunity to the newborn, as pertussis can be severe in infants.</li><li>\u2022 The Tdap vaccine is generally considered safe and recommended for pregnant women, typically between 27-36 weeks of gestation. This vaccine helps protect the mother from tetanus, diphtheria, and pertussis (whooping cough), and it also provides passive immunity to the newborn, as pertussis can be severe in infants.</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option C: The HPV vaccine is not typically given during pregnancy. It is usually recommended for females before becoming pregnant to prevent HPV infection, which can lead to cervical cancer. If a woman becomes pregnant during the HPV vaccination series, it is generally recommended to complete the series after pregnancy, as there is limited data on its use during pregnancy. Option A: The MMR vaccine is not typically recommended during pregnancy because it is a live attenuated vaccine, meaning it contains weakened forms of the viruses. Live vaccines are generally contraindicated during pregnancy due to potential risks to the developing fetus.</li><li>\u2022 Option C: The HPV vaccine is not typically given during pregnancy. It is usually recommended for females before becoming pregnant to prevent HPV infection, which can lead to cervical cancer. If a woman becomes pregnant during the HPV vaccination series, it is generally recommended to complete the series after pregnancy, as there is limited data on its use during pregnancy.</li><li>\u2022 Option C:</li><li>\u2022 Option A: The MMR vaccine is not typically recommended during pregnancy because it is a live attenuated vaccine, meaning it contains weakened forms of the viruses. Live vaccines are generally contraindicated during pregnancy due to potential risks to the developing fetus.</li><li>\u2022 Option A:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Tdap is safe in pregnancy; given between 27-36 weeks; can replace the 2 nd dose of Td; provides immunity to mother and newborn against tetanus, diphtheria, and pertussis.</li><li>\u27a4 Tdap is safe in pregnancy; given between 27-36 weeks; can replace the 2 nd dose of Td; provides immunity to mother and newborn against tetanus, diphtheria, and pertussis.</li><li>\u27a4 Ref: Page no 172, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no 172, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "922814da",
      "audio": ""
    },
    {
      "text": "A 25-year-old pregnant woman, who is a healthcare worker, asks about receiving the hepatitis B vaccine during pregnancy. What is the most appropriate recommendation regarding hepatitis B vaccination for pregnant healthcare workers?",
      "options": [
        {
          "label": "A",
          "text": "Administer the hepatitis B vaccine during pregnancy.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Delay hepatitis B vaccination until after delivery.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hepatitis B vaccination is not necessary for pregnant healthcare workers.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Recommend hepatitis B vaccination after assessing the patient's risk factors.",
          "correct": true
        }
      ],
      "correct_answer": "D. Recommend hepatitis B vaccination after assessing the patient's risk factors.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Recommend hepatitis B vaccination after assessing the patient's risk factors.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Hepatitis B vaccination is recommended for pregnant healthcare workers, but the timing should be individualized. Pregnant healthcare workers should be assessed for their risk of exposure to hepatitis B and, if indicated, should receive the vaccine after careful consideration of the potential benefits and risks.</li><li>\u2022 Hepatitis B vaccination is recommended for pregnant healthcare workers, but the timing should be individualized. Pregnant healthcare workers should be assessed for their risk of exposure to hepatitis B and, if indicated, should receive the vaccine after careful consideration of the potential benefits and risks.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hepatitis B vaccine is safe in pregnancy and is recommended to high risk groups</li><li>\u27a4 Hepatitis B vaccine is safe in pregnancy and is recommended to high risk groups</li><li>\u27a4 Ref: Page no 172, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no 172, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "45e703e3",
      "audio": ""
    },
    {
      "text": "A 30-year-old pregnant woman is planning to travel to a region with a high risk of malaria. She inquires about receiving the yellow fever vaccine during pregnancy. What is the most appropriate recommendation regarding yellow fever vaccination for pregnant travelers?",
      "options": [
        {
          "label": "A",
          "text": "Administer the yellow fever vaccine in the puerperium",
          "correct": false
        },
        {
          "label": "B",
          "text": "Administer yellow fever immunoglobulin (YF-IG) only.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Yellow fever vaccination is not necessary for pregnant travelers.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Advise against travel to yellow fever-endemic areas during pregnancy.",
          "correct": true
        }
      ],
      "correct_answer": "D. Advise against travel to yellow fever-endemic areas during pregnancy.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Advise against travel to yellow fever-endemic areas during pregnancy.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 All live vaccines are contra-indicated in pregnancy However, an exception to this rule is the yellow fever vaccine as the benefits outweigh the risks. Pregnant women planning travel to yellow fever endemic areas should be advised to postpone travel until after pregnancy or avoid travel to those regions if possible; but if the travel cannot be avoided, then the yellow fever vaccine can be administered.</li><li>\u2022 All live vaccines are contra-indicated in pregnancy</li><li>\u2022 However, an exception to this rule is the yellow fever vaccine as the benefits outweigh the risks.</li><li>\u2022 Pregnant women planning travel to yellow fever endemic areas should be advised to postpone travel until after pregnancy or avoid travel to those regions if possible; but if the travel cannot be avoided, then the yellow fever vaccine can be administered.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Yellow fever vaccine, even though a live vaccine can be administered to women traveling to an endemic area</li><li>\u27a4 Yellow fever vaccine, even though a live vaccine can be administered to women traveling to an endemic area</li><li>\u27a4 Ref: Page no 172, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no 172, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "87d9bc86",
      "audio": ""
    },
    {
      "text": "A 34-year-old pregnant woman is in her second trimester and has not received the influenza vaccine this season. She asks if it is safe to get the vaccine during pregnancy. What should be recommended regarding the influenza vaccine for pregnant women?",
      "options": [
        {
          "label": "A",
          "text": "Administer the influenza vaccine during pregnancy, regardless of the trimester.",
          "correct": true
        },
        {
          "label": "B",
          "text": "Delay influenza vaccination until after delivery.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Administer the influenza vaccine only if there is an ongoing flu outbreak in the community. Influenza vaccination is not necessary for pregnant women.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Influenza vaccine cannot be administered during pregnancy or during lactation",
          "correct": false
        }
      ],
      "correct_answer": "A. Administer the influenza vaccine during pregnancy, regardless of the trimester.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Administer the influenza vaccine during pregnancy, regardless of the trimester.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The ACOG recommends influenza vaccine (inactivated) to all pregnant women irrespective of the trimester during the influenza season</li><li>\u27a4 The ACOG recommends influenza vaccine (inactivated) to all pregnant women irrespective of the trimester during the influenza season</li><li>\u27a4 The ACOG recommends influenza vaccine (inactivated) to all pregnant women irrespective of the trimester during the influenza season</li><li>\u27a4 Ref: Page no 172, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no 172, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "08ab4b32",
      "audio": ""
    },
    {
      "text": "Which of the following is not included in quadruple test for antenatal detection of Down syndrome?",
      "options": [
        {
          "label": "A",
          "text": "AFP",
          "correct": false
        },
        {
          "label": "B",
          "text": "\u03b2- hCG",
          "correct": false
        },
        {
          "label": "C",
          "text": "Estriol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Inhibin-B",
          "correct": true
        }
      ],
      "correct_answer": "D. Inhibin-B",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/screenshot-2024-01-09-185442.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Inhibin -B</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The triple and Quadruple test are done between 15 \u2013 21 weeks.</li><li>\u2022 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein. Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A. Inhibin A is a component of quadruple. Not Inhibin B</li><li>\u2022 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein.</li><li>\u2022 Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u2022 Inhibin A is a component of quadruple. Not Inhibin B</li><li>\u2022 *Easy to remember: B for B ig; so in Down\u2019s syndrome; B eta hCG and Inhi B in A: B ig/ Increased</li><li>\u2022 B</li><li>\u2022 B</li><li>\u2022 B</li><li>\u2022 B</li><li>\u2022 B</li><li>\u2022 Other Options</li><li>\u2022 Other Options</li><li>\u2022 Option A (AFP), Option B (beta hCG) and Option C (Estriol) are all components of the Quadruple marker</li><li>\u2022 Option A (AFP), Option B (beta hCG) and Option C (Estriol) are all components of the Quadruple marker</li><li>\u2022 Option A</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Triple and Quadruple test are 2 nd trimester biochemical screening tests for Down Syndrome and are done between 15 \u2013 21 weeks.</li><li>\u27a4 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein. Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u27a4 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein.</li><li>\u27a4 Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u27a4 Ref: Page no 284, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no 284, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "576cd3a7",
      "audio": ""
    },
    {
      "text": "A 23-year primigravida is diagnosed to have Down syndrome of her fetus at 18 weeks. If a triple test was done, what would have been the report?",
      "options": [
        {
          "label": "A",
          "text": "High HCG, low ue3, low AFP",
          "correct": true
        },
        {
          "label": "B",
          "text": "Low HCG, high ue3, high AFP",
          "correct": false
        },
        {
          "label": "C",
          "text": "High HCG, high ue3, low AFP",
          "correct": false
        },
        {
          "label": "D",
          "text": "Low HCG, low uE3, high AFP",
          "correct": false
        }
      ],
      "correct_answer": "A. High HCG, low ue3, low AFP",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/screenshot-2024-01-09-185442_TtgJ5L7.jpg"
      ],
      "explanation": "<p><strong>Ans. A) High HCG, low ue3, low AFP</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The Triple and Quadruple test are done between 15 \u2013 21 weeks.</li><li>\u2022 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein. Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u2022 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein.</li><li>\u2022 Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u2022 *Easy to remember: B for B ig; so in Down\u2019s syndrome; B eta hCG and Inhi B in A: B ig/ Increased</li><li>\u2022 B</li><li>\u2022 B</li><li>\u2022 B</li><li>\u2022 B</li><li>\u2022 B</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Triple and Quadruple test are 2 nd trimester biochemical screening tests for Down Syndrome and are done between 15 \u2013 21 weeks.</li><li>\u27a4 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein. Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u27a4 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein.</li><li>\u27a4 Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u27a4 Page no 284, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Page no 284, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d4072b17",
      "audio": ""
    },
    {
      "text": "Which of the following is done for screening of Down\u2019s syndrome in the first trimester?",
      "options": [
        {
          "label": "A",
          "text": "Beta HCG and PAPP-A",
          "correct": true
        },
        {
          "label": "B",
          "text": "Unconjugated estradiol and PAPPA",
          "correct": false
        },
        {
          "label": "C",
          "text": "AFP and Inhibin A",
          "correct": false
        },
        {
          "label": "D",
          "text": "AFP and Beta HCG",
          "correct": false
        }
      ],
      "correct_answer": "A. Beta HCG and PAPP-A",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/screenshot-2024-01-09-185858.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Beta HCG and PAPP-A</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 1 st trimester (11-14 weeks) serum analytes for Down\u2019s syndrome screening are: Beta hCG and PAPP-A.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 1 st trimester (11-14 weeks) serum analytes for Down\u2019s syndrome screening are: Beta hCG and PAPP-A. This is called the Dual marker/ Double marker</li><li>\u27a4 1 st trimester (11-14 weeks) serum analytes for Down\u2019s syndrome screening are: Beta hCG and PAPP-A.</li><li>\u27a4 This is called the Dual marker/ Double marker</li><li>\u27a4 Page no 281, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Page no 281, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f8d898b2",
      "audio": ""
    },
    {
      "text": "A couple presents in the 1 st trimester and ask about Down syndrome screening. They are very concerned as a relative in the family has Down syndrome. What is the ideal time for doing a Quadruple test?",
      "options": [
        {
          "label": "A",
          "text": "15-18 weeks",
          "correct": true
        },
        {
          "label": "B",
          "text": "10-12 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "12-14weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "8-10 weeks",
          "correct": false
        }
      ],
      "correct_answer": "A. 15-18 weeks",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/screenshot-2024-01-09-124505.jpg"
      ],
      "explanation": "<p><strong>Ans. A) 15 \u2013 18 weeks</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Both the triple and the quadruple marker are performed between 15 \u2013 21 weeks gestation but exact gestational age ranges vary according to laboratories.</li><li>\u2022 The Triple and Quadruple test are done between 15 \u2013 21 weeks.</li><li>\u2022 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein. Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u2022 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein.</li><li>\u2022 Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u2022 *Easy to remember: B for B ig; so in Down\u2019s syndrome; B eta hCG and Inhi B in A: B ig/ Increased</li><li>\u2022 B</li><li>\u2022 B</li><li>\u2022 B</li><li>\u2022 B</li><li>\u2022 B</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Triple and Quadruple test are 2 nd trimester biochemical screening tests for Down Syndrome and are done between 15 \u2013 21 weeks.</li><li>\u27a4 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein. Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u27a4 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein.</li><li>\u27a4 Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u27a4 Page no 282, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Page no 282, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c47718e7",
      "audio": ""
    },
    {
      "text": "Non-Invasive Prenatal Testing (NIPT) is?",
      "options": [
        {
          "label": "A",
          "text": "Amniocentesis for evaluation of fetal chromosomal anomalies",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pre-conceptional gene testing of an ova",
          "correct": false
        },
        {
          "label": "C",
          "text": "Maternal serum for evaluation of Down syndrome",
          "correct": true
        },
        {
          "label": "D",
          "text": "Testing of maternal tissue",
          "correct": false
        }
      ],
      "correct_answer": "C. Maternal serum for evaluation of Down syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Maternal serum for evaluation of Down syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 NIPT or cell free DNA screening: Salient features:</li><li>\u2022 Introduced in 2011 It is a screening test (NOT DIAGNOSTIC) In 2020 (Oct), ACOG guidelines state that along with serum analytes and NT, cell free DNA can be offered to all women as the initial screening modality for Down syndrome. Prior to this the indications were Age \u2265 35 y A positive 1 st /2 nd trimester analyte-based screening test USG with minor (soft) aneuploidy marker Prior pregnancy with autosomal trisomy Known carriage of a balanced translocation Identification of DNA fragments that are derived primarily from apoptotic trophoblasts. Done after 9 \u2013 10 weeks Results in 7 \u2013 10 days 99% Detection rate for Down syndrome Limitations: Cost The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u2022 Introduced in 2011</li><li>\u2022 It is a screening test (NOT DIAGNOSTIC)</li><li>\u2022 In 2020 (Oct), ACOG guidelines state that along with serum analytes and NT, cell free DNA can be offered to all women as the initial screening modality for Down syndrome. Prior to this the indications were Age \u2265 35 y A positive 1 st /2 nd trimester analyte-based screening test USG with minor (soft) aneuploidy marker Prior pregnancy with autosomal trisomy Known carriage of a balanced translocation</li><li>\u2022 Age \u2265 35 y A positive 1 st /2 nd trimester analyte-based screening test USG with minor (soft) aneuploidy marker Prior pregnancy with autosomal trisomy Known carriage of a balanced translocation</li><li>\u2022 Age \u2265 35 y</li><li>\u2022 A positive 1 st /2 nd trimester analyte-based screening test</li><li>\u2022 USG with minor (soft) aneuploidy marker</li><li>\u2022 Prior pregnancy with autosomal trisomy</li><li>\u2022 Known carriage of a balanced translocation</li><li>\u2022 Identification of DNA fragments that are derived primarily from apoptotic trophoblasts.</li><li>\u2022 Done after 9 \u2013 10 weeks</li><li>\u2022 Results in 7 \u2013 10 days</li><li>\u2022 99% Detection rate for Down syndrome</li><li>\u2022 Limitations: Cost The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u2022 Cost The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u2022 Cost</li><li>\u2022 The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u2022 Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u2022 Placental mosaicism</li><li>\u2022 Early demise of an aneuploid twin</li><li>\u2022 Maternal mosaicism</li><li>\u2022 Occult maternal malignancy</li><li>\u2022 Limited role in multiple pregnancy</li><li>\u2022 In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A. Amniocentesis for evaluation of fetal chromosomal anomalies: Amniocentesis is a diagnostic method for fetal chromosomal anomalies. It is preferably done after 15 weeks of gestation. Option B. Preconceptional gene testing for an ova: There is no such thing; however preimplantation genetic testing can be done of an embryo in IVF, prior to embryo transfer. Option D. Testing of maternal tissue: This is not a test for screening or diagnosis of Down syndrome</li><li>\u2022 Option A. Amniocentesis for evaluation of fetal chromosomal anomalies: Amniocentesis is a diagnostic method for fetal chromosomal anomalies. It is preferably done after 15 weeks of gestation.</li><li>\u2022 Option A.</li><li>\u2022 Option B. Preconceptional gene testing for an ova: There is no such thing; however preimplantation genetic testing can be done of an embryo in IVF, prior to embryo transfer.</li><li>\u2022 Option B.</li><li>\u2022 Option D. Testing of maternal tissue: This is not a test for screening or diagnosis of Down syndrome</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 NIPT or cell free DNA screening: Salient features:</li><li>\u27a4 Introduced in 2011 It is a screening test (NOT DIAGNOSTIC) In 2020 (Oct), ACOG guidelines state that along with serum analytes and NT, cell free DNA can be offered to all women as the initial screening modality for Down syndrome. Prior to this the indications were Age \u2265 35 y A positive 1 st /2 nd trimester analyte-based screening test USG with minor (soft) aneuploidy marker Prior pregnancy with autosomal trisomy Known carriage of a balanced translocation Identification of DNA fragments that are derived primarily from apoptotic trophoblasts. Done after 9 \u2013 10 weeks Results in 7 \u2013 10 days 99% Detection rate for Down syndrome Limitations: Cost The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u27a4 Introduced in 2011</li><li>\u27a4 It is a screening test (NOT DIAGNOSTIC)</li><li>\u27a4 In 2020 (Oct), ACOG guidelines state that along with serum analytes and NT, cell free DNA can be offered to all women as the initial screening modality for Down syndrome. Prior to this the indications were Age \u2265 35 y A positive 1 st /2 nd trimester analyte-based screening test USG with minor (soft) aneuploidy marker Prior pregnancy with autosomal trisomy Known carriage of a balanced translocation</li><li>\u27a4 Age \u2265 35 y A positive 1 st /2 nd trimester analyte-based screening test USG with minor (soft) aneuploidy marker Prior pregnancy with autosomal trisomy Known carriage of a balanced translocation</li><li>\u27a4 Age \u2265 35 y</li><li>\u27a4 A positive 1 st /2 nd trimester analyte-based screening test</li><li>\u27a4 USG with minor (soft) aneuploidy marker</li><li>\u27a4 Prior pregnancy with autosomal trisomy</li><li>\u27a4 Known carriage of a balanced translocation</li><li>\u27a4 Identification of DNA fragments that are derived primarily from apoptotic trophoblasts.</li><li>\u27a4 Done after 9 \u2013 10 weeks</li><li>\u27a4 Results in 7 \u2013 10 days</li><li>\u27a4 99% Detection rate for Down syndrome</li><li>\u27a4 Limitations: Cost The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u27a4 Cost The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u27a4 Cost</li><li>\u27a4 The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy</li><li>\u27a4 Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy</li><li>\u27a4 Placental mosaicism</li><li>\u27a4 Early demise of an aneuploid twin</li><li>\u27a4 Maternal mosaicism</li><li>\u27a4 Occult maternal malignancy</li><li>\u27a4 Limited role in multiple pregnancy</li><li>\u27a4 In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u27a4 Ref: Page No 284, 285; William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page No 284, 285; William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c778cdcc",
      "audio": ""
    },
    {
      "text": "Which of the following aneuploidies is most likely to be missed in prenatal screening?",
      "options": [
        {
          "label": "A",
          "text": "Trisomy 21",
          "correct": false
        },
        {
          "label": "B",
          "text": "Trisomy 18",
          "correct": false
        },
        {
          "label": "C",
          "text": "Turner Syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Klinefelter Syndrome",
          "correct": true
        }
      ],
      "correct_answer": "D. Klinefelter Syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Klinefelter Syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Let\u2019s Discuss all the Options</li><li>\u2022 Let\u2019s Discuss all the Options</li><li>\u2022 Option A and B. Prenatal aneuploidy screening is primarily used to detect Down syndrome (Trisomy 21). It can also detect Trisomy 18 (Edward) and Trisomy 13 (Patau). Option C. Turner Syndrome: Nuchal Translucency (NT) is used in prenatal aneuploidy screening and is increased in several conditions other than Down syndrome, and this includes Turner\u2019s syndrome. Turner syndrome also has several other ultrasound features like Cystic hygroma Non-immune fetal hydrops Cardiac anomalies (mostly compromising the left outflow tract - CoA, HLHS, bicuspid aortic valve) Renal anomalies Pleural effusions Brachycephaly IUGR Option D. Klinefelter\u2019s syndrome does not have any significant USG finding especially in the 1 st and 2 nd trimesters and hence potentially can be easily missed on prenatal screening.</li><li>\u2022 Option A and B. Prenatal aneuploidy screening is primarily used to detect Down syndrome (Trisomy 21). It can also detect Trisomy 18 (Edward) and Trisomy 13 (Patau).</li><li>\u2022 Option A and B.</li><li>\u2022 Option C. Turner Syndrome: Nuchal Translucency (NT) is used in prenatal aneuploidy screening and is increased in several conditions other than Down syndrome, and this includes Turner\u2019s syndrome. Turner syndrome also has several other ultrasound features like Cystic hygroma Non-immune fetal hydrops Cardiac anomalies (mostly compromising the left outflow tract - CoA, HLHS, bicuspid aortic valve) Renal anomalies Pleural effusions Brachycephaly IUGR</li><li>\u2022 Option C. Turner Syndrome:</li><li>\u2022 Nuchal Translucency (NT) is used in prenatal aneuploidy screening and is increased in several conditions other than Down syndrome, and this includes Turner\u2019s syndrome. Turner syndrome also has several other ultrasound features like Cystic hygroma Non-immune fetal hydrops Cardiac anomalies (mostly compromising the left outflow tract - CoA, HLHS, bicuspid aortic valve) Renal anomalies Pleural effusions Brachycephaly IUGR</li><li>\u2022 Nuchal Translucency (NT) is used in prenatal aneuploidy screening and is increased in several conditions other than Down syndrome, and this includes Turner\u2019s syndrome.</li><li>\u2022 Turner syndrome also has several other ultrasound features like Cystic hygroma Non-immune fetal hydrops Cardiac anomalies (mostly compromising the left outflow tract - CoA, HLHS, bicuspid aortic valve) Renal anomalies Pleural effusions Brachycephaly IUGR</li><li>\u2022 Cystic hygroma Non-immune fetal hydrops Cardiac anomalies (mostly compromising the left outflow tract - CoA, HLHS, bicuspid aortic valve) Renal anomalies Pleural effusions Brachycephaly IUGR</li><li>\u2022 Cystic hygroma</li><li>\u2022 Non-immune fetal hydrops</li><li>\u2022 Cardiac anomalies (mostly compromising the left outflow tract - CoA, HLHS, bicuspid aortic valve)</li><li>\u2022 Renal anomalies</li><li>\u2022 Pleural effusions</li><li>\u2022 Brachycephaly</li><li>\u2022 IUGR</li><li>\u2022 Option D. Klinefelter\u2019s syndrome does not have any significant USG finding especially in the 1 st and 2 nd trimesters and hence potentially can be easily missed on prenatal screening.</li><li>\u2022 Option D.</li><li>\u2022 Ref: Page No 282, William\u2019s Obstetrics 25 th edition</li><li>\u2022 Ref: Page No 282, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "aa20ccc2",
      "audio": ""
    },
    {
      "text": "All are true regarding amniocentesis except?",
      "options": [
        {
          "label": "A",
          "text": "It is the most commonly performed prenatal diagnostic procedure",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chromosomal microarray can be performed on uncultured amniocytes",
          "correct": false
        },
        {
          "label": "C",
          "text": "Blood-tinged amniotic fluid is seen in transplacental passage of the needle",
          "correct": false
        },
        {
          "label": "D",
          "text": "Procedure related loss rate is 1 -2% when performed by an experienced provider",
          "correct": true
        }
      ],
      "correct_answer": "D. Procedure related loss rate is 1 -2% when performed by an experienced provider",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Procedure related loss rate is 1-2 % when performed by an experienced provider</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Let\u2019s Discuss all Options:</li><li>\u2022 Let\u2019s Discuss all Options:</li><li>\u2022 Option A. Amniocentesis is the most common prenatal diagnostic procedure. Option B. Chromosomal microarray can be performed on uncultured amniocytes: Following amniocentesis, analysis can be done using</li><li>\u2022 Option A. Amniocentesis is the most common prenatal diagnostic procedure.</li><li>\u2022 Option A.</li><li>\u2022 Option B. Chromosomal microarray can be performed on uncultured amniocytes: Following amniocentesis, analysis can be done using</li><li>\u2022 Option B.</li><li>\u2022 Chromosomal microarray (CMA) \u2013 to assess copy number gains or losses: can be performed directly on uncultured amniocytes Karyotype analysis for aneuploidy: requires cultures amniocytes FISH to identify gain or loss of specific chromosomes.</li><li>\u2022 Chromosomal microarray (CMA) \u2013 to assess copy number gains or losses: can be performed directly on uncultured amniocytes</li><li>\u2022 Karyotype analysis for aneuploidy: requires cultures amniocytes</li><li>\u2022 FISH to identify gain or loss of specific chromosomes.</li><li>\u2022 Option C. Anterior placentation seen in 60% and blood-tinged fluid is more frequent if there is transplacental passage of the needle. Option D. Procedure related loss: 0.1 \u2013 0.3 % when performed by an experienced provider. Early amniocentesis (11-14 weeks): significant higher rate of procedure related complications; like clubfoot, amnionic fluid leakage and fetal loss. Not done anymore.</li><li>\u2022 Option C. Anterior placentation seen in 60% and blood-tinged fluid is more frequent if there is transplacental passage of the needle.</li><li>\u2022 Option C.</li><li>\u2022 Option D. Procedure related loss: 0.1 \u2013 0.3 % when performed by an experienced provider. Early amniocentesis (11-14 weeks): significant higher rate of procedure related complications; like clubfoot, amnionic fluid leakage and fetal loss. Not done anymore.</li><li>\u2022 Option D.</li><li>\u2022 Procedure related loss: 0.1 \u2013 0.3 % when performed by an experienced provider. Early amniocentesis (11-14 weeks): significant higher rate of procedure related complications; like clubfoot, amnionic fluid leakage and fetal loss. Not done anymore.</li><li>\u2022 Procedure related loss: 0.1 \u2013 0.3 % when performed by an experienced provider.</li><li>\u2022 Early amniocentesis (11-14 weeks): significant higher rate of procedure related complications; like clubfoot, amnionic fluid leakage and fetal loss. Not done anymore.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Amniocentesis is the most common prenatal diagnostic procedure. Indications for amniocentesis include: Diagnosis of fetal genetic disorders Diagnosis of Congenital infection Evaluation of anemia in Rh alloimmunization Determination of Fetal lung maturity Following amniocentesis, analysis can be done using</li><li>\u27a4 Amniocentesis is the most common prenatal diagnostic procedure.</li><li>\u27a4 Indications for amniocentesis include: Diagnosis of fetal genetic disorders Diagnosis of Congenital infection Evaluation of anemia in Rh alloimmunization Determination of Fetal lung maturity</li><li>\u27a4 Diagnosis of fetal genetic disorders Diagnosis of Congenital infection Evaluation of anemia in Rh alloimmunization Determination of Fetal lung maturity</li><li>\u27a4 Diagnosis of fetal genetic disorders</li><li>\u27a4 Diagnosis of Congenital infection</li><li>\u27a4 Evaluation of anemia in Rh alloimmunization</li><li>\u27a4 Determination of Fetal lung maturity</li><li>\u27a4 Following amniocentesis, analysis can be done using</li><li>\u27a4 Chromosomal microarray (CMA) \u2013 to assess copy number gains or losses: can be performed directly on uncultured amniocytes Karyotype analysis for aneuploidy: requires cultures amniocytes FISH to identify gain or loss of specific chromosomes.</li><li>\u27a4 Chromosomal microarray (CMA) \u2013 to assess copy number gains or losses: can be performed directly on uncultured amniocytes</li><li>\u27a4 Karyotype analysis for aneuploidy: requires cultures amniocytes</li><li>\u27a4 FISH to identify gain or loss of specific chromosomes.</li><li>\u27a4 Procedure: Ultrasound guided Done between 15- 20weeks Anterior placentation seen in 60% and blood-tinged fluid is more frequent if there is transplacental passage of the needle. For fetal karyotype, about 20 -30 ml withdrawn. Procedure related loss: 0.1 \u2013 0.3 % when performed by an experienced provider. Early amniocentesis (11-14 weeks): significant higher rate of procedure related complications; like clubfoot, amnionic fluid leakage and fetal loss. Not done anymore.</li><li>\u27a4 Procedure: Ultrasound guided Done between 15- 20weeks Anterior placentation seen in 60% and blood-tinged fluid is more frequent if there is transplacental passage of the needle. For fetal karyotype, about 20 -30 ml withdrawn.</li><li>\u27a4 Ultrasound guided Done between 15- 20weeks Anterior placentation seen in 60% and blood-tinged fluid is more frequent if there is transplacental passage of the needle. For fetal karyotype, about 20 -30 ml withdrawn.</li><li>\u27a4 Ultrasound guided</li><li>\u27a4 Done between 15- 20weeks</li><li>\u27a4 Anterior placentation seen in 60% and blood-tinged fluid is more frequent if there is transplacental passage of the needle.</li><li>\u27a4 For fetal karyotype, about 20 -30 ml withdrawn.</li><li>\u27a4 Procedure related loss: 0.1 \u2013 0.3 % when performed by an experienced provider.</li><li>\u27a4 Early amniocentesis (11-14 weeks): significant higher rate of procedure related complications; like clubfoot, amnionic fluid leakage and fetal loss. Not done anymore.</li><li>\u27a4 Ref: Page No 292, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page No 292, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3e9d5930",
      "audio": ""
    },
    {
      "text": "Which amongst these prenatal screening tests has the least detection rate for Down Syndrome?",
      "options": [
        {
          "label": "A",
          "text": "Combined Test",
          "correct": false
        },
        {
          "label": "B",
          "text": "Nuchal Translucency",
          "correct": true
        },
        {
          "label": "C",
          "text": "Quadruple Test",
          "correct": false
        },
        {
          "label": "D",
          "text": "Triple Marker",
          "correct": false
        }
      ],
      "correct_answer": "B. Nuchal Translucency",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/screenshot-2024-01-09-132755.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/10201.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Nuchal Translucency</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page No 282, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page No 282, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "19457af4",
      "audio": ""
    },
    {
      "text": "A couple opts for Non-Invasive Prenatal Testing (NIPT) for Down syndrome screening. Which is NOT a drawback of this test?",
      "options": [
        {
          "label": "A",
          "text": "High cost",
          "correct": false
        },
        {
          "label": "B",
          "text": "Low Detection Rate",
          "correct": true
        },
        {
          "label": "C",
          "text": "Low detection of free DNA in 5% of samples",
          "correct": false
        },
        {
          "label": "D",
          "text": "Limited role in multiple pregnancy",
          "correct": false
        }
      ],
      "correct_answer": "B. Low Detection Rate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Low Detection Rate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Let\u2019s Discuss all the Options:</li><li>\u2022 Let\u2019s Discuss all the Options:</li><li>\u2022 Option A. NIPT is a costly test Option B. NIPT is a screening test for Down syndrome with the highest detection rate (99%) Option C. In 5% of samples, the fetal fraction of DNA may be low so it may not be possible to do the test Option D. NIPT has a limited role in multiple pregnancy</li><li>\u2022 Option A. NIPT is a costly test</li><li>\u2022 Option A.</li><li>\u2022 Option B. NIPT is a screening test for Down syndrome with the highest detection rate (99%)</li><li>\u2022 Option B.</li><li>\u2022 Option C. In 5% of samples, the fetal fraction of DNA may be low so it may not be possible to do the test</li><li>\u2022 Option C.</li><li>\u2022 Option D. NIPT has a limited role in multiple pregnancy</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 NIPT or cell free DNA screening: Salient features:</li><li>\u27a4 Introduced in 2011 It is a screening test (NOT DIAGNOSTIC) In 2020 (Oct), ACOG guidelines state that along with serum analytes and NT, cell free DNA can be offered to all women as the initial screening modality for Down syndrome. Prior to this the indications were Age \u2265 35 y A positive 1 st /2 nd trimester analyte-based screening test USG with minor (soft) aneuploidy marker Prior pregnancy with autosomal trisomy Known carriage of a balanced translocation Identification of DNA fragments that are derived primarily from apoptotic trophoblasts. Done after 9 \u2013 10 weeks Results in 7 \u2013 10 days 99% Detection rate for Down syndrome Limitations: Cost The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u27a4 Introduced in 2011</li><li>\u27a4 It is a screening test (NOT DIAGNOSTIC)</li><li>\u27a4 In 2020 (Oct), ACOG guidelines state that along with serum analytes and NT, cell free DNA can be offered to all women as the initial screening modality for Down syndrome. Prior to this the indications were Age \u2265 35 y A positive 1 st /2 nd trimester analyte-based screening test USG with minor (soft) aneuploidy marker Prior pregnancy with autosomal trisomy Known carriage of a balanced translocation</li><li>\u27a4 Age \u2265 35 y A positive 1 st /2 nd trimester analyte-based screening test USG with minor (soft) aneuploidy marker Prior pregnancy with autosomal trisomy Known carriage of a balanced translocation</li><li>\u27a4 Age \u2265 35 y</li><li>\u27a4 A positive 1 st /2 nd trimester analyte-based screening test</li><li>\u27a4 USG with minor (soft) aneuploidy marker</li><li>\u27a4 Prior pregnancy with autosomal trisomy</li><li>\u27a4 Known carriage of a balanced translocation</li><li>\u27a4 Identification of DNA fragments that are derived primarily from apoptotic trophoblasts.</li><li>\u27a4 Done after 9 \u2013 10 weeks</li><li>\u27a4 Results in 7 \u2013 10 days</li><li>\u27a4 99% Detection rate for Down syndrome</li><li>\u27a4 Limitations: Cost The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u27a4 Cost The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u27a4 Cost</li><li>\u27a4 The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy</li><li>\u27a4 Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy</li><li>\u27a4 Placental mosaicism</li><li>\u27a4 Early demise of an aneuploid twin</li><li>\u27a4 Maternal mosaicism</li><li>\u27a4 Occult maternal malignancy</li><li>\u27a4 Limited role in multiple pregnancy</li><li>\u27a4 In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u27a4 Ref: Page No 284, 285; William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page No 284, 285; William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2a01a625",
      "audio": ""
    },
    {
      "text": "All are true regarding prenatal Down syndrome screening except?",
      "options": [
        {
          "label": "A",
          "text": "The risk of a woman carrying a Down syndrome baby is about 1 in 70 at 40 years",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ultrasound features of Down syndrome at 11 \u2013 14 weeks include increased NT and an absent nasal bone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Combined test includes an NT measurement and the dual marker",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ultrasound at 18 \u2013 20 weeks will miss about 50% of Down syndrome fetuses",
          "correct": true
        }
      ],
      "correct_answer": "D. Ultrasound at 18 \u2013 20 weeks will miss about 50% of Down syndrome fetuses",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Ultrasound at 18 \u2013 20 weeks will miss about 50% of Down syndrome fetuses</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Let\u2019s Discuss all the Options</li><li>\u2022 Let\u2019s Discuss all the Options</li><li>\u2022 Option A. The risk of Down syndrome increases with maternal age. At the age of 40y, the risk os about 1 in 70 Option B. At 11-14 weeks, ultrasound features of Down syndrome include An increased nuchal translucency An absent nasal bone Tricuspid regurgitation An abnormal flow in the ductus venosus Option C. Combined test refers to a combination of the NT and Dual marker Option D. An ultrasound at 18-20 weeks will detect upto 70% of Down syndrome babies. Hence this option is correct</li><li>\u2022 Option A. The risk of Down syndrome increases with maternal age. At the age of 40y, the risk os about 1 in 70</li><li>\u2022 Option A.</li><li>\u2022 Option B. At 11-14 weeks, ultrasound features of Down syndrome include An increased nuchal translucency An absent nasal bone Tricuspid regurgitation An abnormal flow in the ductus venosus</li><li>\u2022 Option B.</li><li>\u2022 An increased nuchal translucency An absent nasal bone Tricuspid regurgitation An abnormal flow in the ductus venosus</li><li>\u2022 An increased nuchal translucency</li><li>\u2022 An absent nasal bone</li><li>\u2022 Tricuspid regurgitation</li><li>\u2022 An abnormal flow in the ductus venosus</li><li>\u2022 Option C. Combined test refers to a combination of the NT and Dual marker</li><li>\u2022 Option C.</li><li>\u2022 Option D. An ultrasound at 18-20 weeks will detect upto 70% of Down syndrome babies. Hence this option is correct</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Screening of Down Syndrome: Trisomy 21 (Down syndrome); is the most common non-lethal trisomy Background risk is based on age (At 25 y: 1 in 5000, 30 y: 1 in 1000, 33 y: 1 in 500, 35 y: 1 in 250, 40 y: 1 in 70, 45 y: 1 in 20) Ultrasound at 11 \u2013 14 weeks: Features of Down Syndrome include: Increased NT Absent nasal bone Abnormal flow in the Ductus venosus Tricuspid Regurgitation 1 st trimester screening for Down Syndrome includes the Dual marker and the NT. Detection rate for Down Syndrome by a 2 nd trimester ultrasound is 70%</li><li>\u27a4 Screening of Down Syndrome:</li><li>\u27a4 Trisomy 21 (Down syndrome); is the most common non-lethal trisomy</li><li>\u27a4 Background risk is based on age (At 25 y: 1 in 5000, 30 y: 1 in 1000, 33 y: 1 in 500, 35 y: 1 in 250, 40 y: 1 in 70, 45 y: 1 in 20)</li><li>\u27a4 Ultrasound at 11 \u2013 14 weeks: Features of Down Syndrome include: Increased NT Absent nasal bone Abnormal flow in the Ductus venosus Tricuspid Regurgitation</li><li>\u27a4 Increased NT Absent nasal bone Abnormal flow in the Ductus venosus Tricuspid Regurgitation</li><li>\u27a4 Increased NT</li><li>\u27a4 Absent nasal bone</li><li>\u27a4 Abnormal flow in the Ductus venosus</li><li>\u27a4 Tricuspid Regurgitation</li><li>\u27a4 1 st trimester screening for Down Syndrome includes the Dual marker and the NT.</li><li>\u27a4 Detection rate for Down Syndrome by a 2 nd trimester ultrasound is 70%</li><li>\u27a4 Ref: Page no 282, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 282, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "33661b71",
      "audio": ""
    },
    {
      "text": "All are serum analytes used in prenatal screening for Down Syndrome in the 2 nd trimester except?",
      "options": [
        {
          "label": "A",
          "text": "Alpha Feto Protein",
          "correct": false
        },
        {
          "label": "B",
          "text": "Beta hCG",
          "correct": false
        },
        {
          "label": "C",
          "text": "Inhibin A",
          "correct": false
        },
        {
          "label": "D",
          "text": "PAPP-A",
          "correct": true
        }
      ],
      "correct_answer": "D. PAPP-A",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) PAPP-A</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Serum analytes used in prenatal screening of Down syndrome are: 1 st trimester (11 \u2013 14 weeks): Dual marker: \u03b2 hCG ( \u2191 ) and PAPP-A ( \u2193 ) 2 nd trimester (15 \u2013 21 weeks): Triple marker: \u03b2 hCG ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 ) Quadruple marker: \u03b2 hCG ( \u2191 ), Inhibin \u2013 A ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 )</li><li>\u2022 Serum analytes used in prenatal screening of Down syndrome are: 1 st trimester (11 \u2013 14 weeks): Dual marker: \u03b2 hCG ( \u2191 ) and PAPP-A ( \u2193 ) 2 nd trimester (15 \u2013 21 weeks): Triple marker: \u03b2 hCG ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 ) Quadruple marker: \u03b2 hCG ( \u2191 ), Inhibin \u2013 A ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 )</li><li>\u2022 1 st trimester (11 \u2013 14 weeks): Dual marker: \u03b2 hCG ( \u2191 ) and PAPP-A ( \u2193 ) 2 nd trimester (15 \u2013 21 weeks): Triple marker: \u03b2 hCG ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 ) Quadruple marker: \u03b2 hCG ( \u2191 ), Inhibin \u2013 A ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 )</li><li>\u2022 1 st trimester (11 \u2013 14 weeks): Dual marker: \u03b2 hCG ( \u2191 ) and PAPP-A ( \u2193 )</li><li>\u2022 2 nd trimester (15 \u2013 21 weeks): Triple marker: \u03b2 hCG ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 ) Quadruple marker: \u03b2 hCG ( \u2191 ), Inhibin \u2013 A ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 )</li><li>\u2022 Triple marker: \u03b2 hCG ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 ) Quadruple marker: \u03b2 hCG ( \u2191 ), Inhibin \u2013 A ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 )</li><li>\u2022 Triple marker: \u03b2 hCG ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 )</li><li>\u2022 Quadruple marker: \u03b2 hCG ( \u2191 ), Inhibin \u2013 A ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 )</li><li>\u2022 Thus, Option D) PAPP-A is not used in the second trimester.</li><li>\u2022 Thus, Option D) PAPP-A is not used in the second trimester.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Serum analytes used in prenatal screening of Down syndrome are: 1 st trimester (11 \u2013 14 weeks): Dual marker: \u03b2 hCG ( \u2191 ) and PAPP-A ( \u2193 ) 2 nd trimester (15 \u2013 21 weeks): Triple marker: \u03b2 hCG ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 ) Quadruple marker: \u03b2 hCG ( \u2191 ), Inhibin \u2013 A ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 )</li><li>\u27a4 Serum analytes used in prenatal screening of Down syndrome are: 1 st trimester (11 \u2013 14 weeks): Dual marker: \u03b2 hCG ( \u2191 ) and PAPP-A ( \u2193 ) 2 nd trimester (15 \u2013 21 weeks): Triple marker: \u03b2 hCG ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 ) Quadruple marker: \u03b2 hCG ( \u2191 ), Inhibin \u2013 A ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 )</li><li>\u27a4 1 st trimester (11 \u2013 14 weeks): Dual marker: \u03b2 hCG ( \u2191 ) and PAPP-A ( \u2193 ) 2 nd trimester (15 \u2013 21 weeks): Triple marker: \u03b2 hCG ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 ) Quadruple marker: \u03b2 hCG ( \u2191 ), Inhibin \u2013 A ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 )</li><li>\u27a4 1 st trimester (11 \u2013 14 weeks): Dual marker: \u03b2 hCG ( \u2191 ) and PAPP-A ( \u2193 )</li><li>\u27a4 2 nd trimester (15 \u2013 21 weeks): Triple marker: \u03b2 hCG ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 ) Quadruple marker: \u03b2 hCG ( \u2191 ), Inhibin \u2013 A ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 )</li><li>\u27a4 Triple marker: \u03b2 hCG ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 ) Quadruple marker: \u03b2 hCG ( \u2191 ), Inhibin \u2013 A ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 )</li><li>\u27a4 Triple marker: \u03b2 hCG ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 )</li><li>\u27a4 Quadruple marker: \u03b2 hCG ( \u2191 ), Inhibin \u2013 A ( \u2191 ), unconjugated Estriol uE3 ( \u2193 ) and Maternal serum Alpha fetoprotein \u2013 MSAFP ( \u2193 )</li><li>\u27a4 Ref: Page no 282, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 282, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c62e8298",
      "audio": ""
    },
    {
      "text": "The following are prenatal diagnostic tests except?",
      "options": [
        {
          "label": "A",
          "text": "Early Amniocentesis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cell free DNA",
          "correct": true
        },
        {
          "label": "C",
          "text": "Chorionic Villous Sampling",
          "correct": false
        },
        {
          "label": "D",
          "text": "Percutaneous Umbilical Blood Sampling",
          "correct": false
        }
      ],
      "correct_answer": "B. Cell free DNA",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Cell free DNA</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Prenatal Diagnostic techniques include: Amniocentesis (including early amniocentesis) Chorionic Villous sampling Cordocentesis (aka Percutaneous umbilical vein sampling or fetal blood sampling) Cell free DNA or NIPT is a prenatal SCREENING test (Not a diagnostic test).</li><li>\u2022 Prenatal Diagnostic techniques include:</li><li>\u2022 Amniocentesis (including early amniocentesis)</li><li>\u2022 Chorionic Villous sampling</li><li>\u2022 Cordocentesis (aka Percutaneous umbilical vein sampling or fetal blood sampling)</li><li>\u2022 Cell free DNA or NIPT is a prenatal SCREENING test (Not a diagnostic test).</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Prenatal Diagnostic techniques include:</li><li>\u27a4 Amniocentesis (including early amniocentesis) Chorionic Villous sampling Cordocentesis (aka Percutaneous umbilical vein sampling or fetal blood sampling)</li><li>\u27a4 Amniocentesis (including early amniocentesis)</li><li>\u27a4 Chorionic Villous sampling</li><li>\u27a4 Cordocentesis (aka Percutaneous umbilical vein sampling or fetal blood sampling)</li><li>\u27a4 Page no 292, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Page no 292, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3c97bec9",
      "audio": ""
    },
    {
      "text": "The image below shows the Nuchal translucency (NT) on Ultrasound. A high NT is associated with fetal aneuploidies and poor perinatal outcome. At what gestational period is the NT measured?",
      "options": [
        {
          "label": "A",
          "text": "10 \u2013 13 weeks",
          "correct": false
        },
        {
          "label": "B",
          "text": "10 weeks 6 days \u2013 13 weeks 6 days",
          "correct": false
        },
        {
          "label": "C",
          "text": "12 \u2013 14 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "11 weeks \u2013 13 weeks 6 days",
          "correct": true
        }
      ],
      "correct_answer": "D. 11 weeks \u2013 13 weeks 6 days",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/picture1_HFXaEOk.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/picture2_QO5PDrg.jpg"
      ],
      "explanation": "<p><strong>Ans. D) 11 weeks \u2013 13 weeks 6 days</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Nuchal Translucency (NT):</li><li>\u2022 Component of first trimester aneuploidy screening Represents maximum thickness of the subcutaneous translucent area between the skin and soft tissue overlying the fetal spine at the back of the neck. If NT increased, risk for Fetal aneuploidy Various structural anomalies: CVS, hydrops, cystic hygroma Measured between 11 weeks \u2013 13 weeks 6 days (or 11- 14 weeks)</li><li>\u2022 Component of first trimester aneuploidy screening</li><li>\u2022 Represents maximum thickness of the subcutaneous translucent area between the skin and soft tissue overlying the fetal spine at the back of the neck.</li><li>\u2022 If NT increased, risk for Fetal aneuploidy Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u2022 Fetal aneuploidy Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u2022 Fetal aneuploidy</li><li>\u2022 Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u2022 Measured between 11 weeks \u2013 13 weeks 6 days (or 11- 14 weeks)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Component of first trimester aneuploidy screening Represents maximum thickness of the subcutaneous translucent area between the skin and soft tissue overlying the fetal spine at the back of the neck. If NT increased, risk for Fetal aneuploidy Various structural anomalies: CVS, hydrops, cystic hygroma Measured between 11 weeks \u2013 13 weeks 6 days (or 11- 14 weeks) Criteria to measure the NT CRL between 45 \u2013 84 mm Fetus in mid sagittal plane Fetus in neutral position Image must be magnified Widest space should be measured The amnion must be seen separately The \u2018+\u2019 calipers must be placed on the inner borders of the nuchal space</li><li>\u27a4 Component of first trimester aneuploidy screening</li><li>\u27a4 Represents maximum thickness of the subcutaneous translucent area between the skin and soft tissue overlying the fetal spine at the back of the neck.</li><li>\u27a4 If NT increased, risk for Fetal aneuploidy Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u27a4 Fetal aneuploidy Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u27a4 Fetal aneuploidy</li><li>\u27a4 Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u27a4 Measured between 11 weeks \u2013 13 weeks 6 days (or 11- 14 weeks)</li><li>\u27a4 Criteria to measure the NT CRL between 45 \u2013 84 mm Fetus in mid sagittal plane Fetus in neutral position Image must be magnified Widest space should be measured The amnion must be seen separately The \u2018+\u2019 calipers must be placed on the inner borders of the nuchal space</li><li>\u27a4 CRL between 45 \u2013 84 mm Fetus in mid sagittal plane Fetus in neutral position Image must be magnified Widest space should be measured The amnion must be seen separately The \u2018+\u2019 calipers must be placed on the inner borders of the nuchal space</li><li>\u27a4 CRL between 45 \u2013 84 mm</li><li>\u27a4 Fetus in mid sagittal plane</li><li>\u27a4 Fetus in neutral position</li><li>\u27a4 Image must be magnified</li><li>\u27a4 Widest space should be measured</li><li>\u27a4 The amnion must be seen separately</li><li>\u27a4 The \u2018+\u2019 calipers must be placed on the inner borders of the nuchal space</li><li>\u27a4 NT alone of used: 65% detection rate for Down Syndrome Combined test: NT + Dual marker (beta hCG + PAPP-A): 80% Detection rate NT > 3 mm/ > 99 th percentile: Significant</li><li>\u27a4 NT alone of used: 65% detection rate for Down Syndrome</li><li>\u27a4 Combined test: NT + Dual marker (beta hCG + PAPP-A): 80% Detection rate</li><li>\u27a4 NT > 3 mm/ > 99 th percentile: Significant</li><li>\u27a4 Ref: Page no 186, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 186, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8bc1718c",
      "audio": ""
    },
    {
      "text": "The below ultrasound done at 12 weeks shows what measurement being taken?",
      "options": [
        {
          "label": "A",
          "text": "Deepest vertical pocket of amniotic fluid",
          "correct": false
        },
        {
          "label": "B",
          "text": "Measurement of cystic hygroma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Nuchal fold thickness",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nuchal translucency",
          "correct": true
        }
      ],
      "correct_answer": "D. Nuchal translucency",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/picture3_flYIkgq.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/picture4_0A4nerg.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Nuchal Translucency</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Let\u2019s Discuss all the Options:</li><li>\u2022 Let\u2019s Discuss all the Options:</li><li>\u2022 Option A: Deepest pocket of amniotic fluid: This measurement is used to determine the amniotic fluid volume. A normal DVP is 2-8 cm Option B: Measurement of cystic hygroma: A cystic hygroma is a large neck swelling seen in the fetus and is seen in Turner syndrome fetuses Option C: Nuchal fold thickness: This is a measurement taken at the level 2 scan and is seen in various anomalies and chromosomal aneuploidies Option D: The measurement shown here is the nuchal translucency. An increased NT is a marker of fetal aneuploidies and various fetal structural anomalies</li><li>\u2022 Option A: Deepest pocket of amniotic fluid: This measurement is used to determine the amniotic fluid volume. A normal DVP is 2-8 cm</li><li>\u2022 Option A:</li><li>\u2022 Option B: Measurement of cystic hygroma: A cystic hygroma is a large neck swelling seen in the fetus and is seen in Turner syndrome fetuses</li><li>\u2022 Option B:</li><li>\u2022 Option C: Nuchal fold thickness: This is a measurement taken at the level 2 scan and is seen in various anomalies and chromosomal aneuploidies</li><li>\u2022 Option C:</li><li>\u2022 Option D: The measurement shown here is the nuchal translucency. An increased NT is a marker of fetal aneuploidies and various fetal structural anomalies</li><li>\u2022 Option D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Nuchal Translucency (NT):</li><li>\u27a4 Nuchal Translucency (NT):</li><li>\u27a4 Component of first trimester aneuploidy screening Represents maximum thickness of the subcutaneous translucent area between the skin and soft tissue overlying the fetal spine at the back of the neck. If NT increased, risk for Fetal aneuploidy Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u27a4 Component of first trimester aneuploidy screening</li><li>\u27a4 Represents maximum thickness of the subcutaneous translucent area between the skin and soft tissue overlying the fetal spine at the back of the neck.</li><li>\u27a4 If NT increased, risk for Fetal aneuploidy Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u27a4 Fetal aneuploidy Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u27a4 Fetal aneuploidy</li><li>\u27a4 Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u27a4 Measured between 11 weeks \u2013 13 weeks 6 days (or 11- 14 weeks) Criteria to measure the NT CRL between 45 \u2013 84 mm Fetus in mid sagittal plane Fetus in neutral position Image must be magnified Widest space should be measured The amnion must be seen separately The \u2018+\u2019 calipers must be placed on the inner borders of the nuchal space</li><li>\u27a4 Measured between 11 weeks \u2013 13 weeks 6 days (or 11- 14 weeks)</li><li>\u27a4 Criteria to measure the NT CRL between 45 \u2013 84 mm Fetus in mid sagittal plane Fetus in neutral position Image must be magnified Widest space should be measured The amnion must be seen separately The \u2018+\u2019 calipers must be placed on the inner borders of the nuchal space</li><li>\u27a4 CRL between 45 \u2013 84 mm Fetus in mid sagittal plane Fetus in neutral position Image must be magnified Widest space should be measured The amnion must be seen separately The \u2018+\u2019 calipers must be placed on the inner borders of the nuchal space</li><li>\u27a4 CRL between 45 \u2013 84 mm</li><li>\u27a4 Fetus in mid sagittal plane</li><li>\u27a4 Fetus in neutral position</li><li>\u27a4 Image must be magnified</li><li>\u27a4 Widest space should be measured</li><li>\u27a4 The amnion must be seen separately</li><li>\u27a4 The \u2018+\u2019 calipers must be placed on the inner borders of the nuchal space</li><li>\u27a4 NT alone of used: 65% detection rate for Down Syndrome Combined test: NT + Dual marker (beta hCG + PAPP-A): 80% Detection rate NT > 3 mm/ > 99 th percentile: Significant</li><li>\u27a4 NT alone of used: 65% detection rate for Down Syndrome</li><li>\u27a4 Combined test: NT + Dual marker (beta hCG + PAPP-A): 80% Detection rate</li><li>\u27a4 NT > 3 mm/ > 99 th percentile: Significant</li><li>\u27a4 Ref: Page no 186, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 186, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "814dc059",
      "audio": ""
    },
    {
      "text": "What is this procedure?",
      "options": [
        {
          "label": "A",
          "text": "Amniocentesis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Chorionic Villous Sampling",
          "correct": false
        },
        {
          "label": "C",
          "text": "Percutaneous Umbilical Vein Sampling",
          "correct": false
        },
        {
          "label": "D",
          "text": "Measuring cell free DNA",
          "correct": false
        }
      ],
      "correct_answer": "A. Amniocentesis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/picture5_ID7nB74.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/picture6_Z9W1rIy.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/screenshot-2024-01-09-161235.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Amniocentesis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The image shows an amniocentesis. Amniocentesis is aspiration of the amniotic fluid for therapeutic or diagnostic procedures</li><li>\u2022 The image shows an amniocentesis. Amniocentesis is aspiration of the amniotic fluid for therapeutic or diagnostic procedures</li><li>\u2022 The image shows an amniocentesis. Amniocentesis is aspiration of the amniotic fluid for therapeutic or diagnostic procedures</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option B: Chorionic villous sampling is as shown below. It is a procedure done between 10-13 weeks for diagnosis of chromosomal and genetic abnormalities</li><li>\u2022 Option B: Chorionic villous sampling is as shown below. It is a procedure done between 10-13 weeks for diagnosis of chromosomal and genetic abnormalities</li><li>\u2022 Option B:</li><li>\u2022 Option C: Percutaneous blood sampling or cordocentesis: This is as shown in the image below and is aspiration of blood from the umbilical vein for diagnostic or therapeutic purposes. It can be done > 18 weeks.</li><li>\u2022 Option C: Percutaneous blood sampling or cordocentesis: This is as shown in the image below and is aspiration of blood from the umbilical vein for diagnostic or therapeutic purposes. It can be done > 18 weeks.</li><li>\u2022 Option C:</li><li>\u2022 Option D: Measuring cell free DNA: This is a screening test for Down syndrome wherein a maternal blood sample is taken and fetal DNA is extracted.</li><li>\u2022 Option D: Measuring cell free DNA: This is a screening test for Down syndrome wherein a maternal blood sample is taken and fetal DNA is extracted.</li><li>\u2022 Option D: Measuring cell free DNA:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Amniocentesis:</li><li>\u27a4 Most Commonly performed prenatal diagnostic procedure Done at 15 \u2013 20 weeks for prenatal diagnosis but can be done later also Indications: Diagnosis of fetal genetic disorders (prenatal diagnosis) Diagnosis of congenital infections Rh alloimmunization (measurement of amniotic fluid bilirubin to determine severity of fetal anemia) Assessment of fetal lung maturity (Lecithin/ Sphingomyelin ratio and measurement of amniotic fluid phosphatidyl glycerol in the amniotic fluid)</li><li>\u27a4 Most Commonly performed prenatal diagnostic procedure</li><li>\u27a4 Done at 15 \u2013 20 weeks for prenatal diagnosis but can be done later also</li><li>\u27a4 Indications: Diagnosis of fetal genetic disorders (prenatal diagnosis) Diagnosis of congenital infections Rh alloimmunization (measurement of amniotic fluid bilirubin to determine severity of fetal anemia) Assessment of fetal lung maturity (Lecithin/ Sphingomyelin ratio and measurement of amniotic fluid phosphatidyl glycerol in the amniotic fluid)</li><li>\u27a4 Diagnosis of fetal genetic disorders (prenatal diagnosis) Diagnosis of congenital infections Rh alloimmunization (measurement of amniotic fluid bilirubin to determine severity of fetal anemia) Assessment of fetal lung maturity (Lecithin/ Sphingomyelin ratio and measurement of amniotic fluid phosphatidyl glycerol in the amniotic fluid)</li><li>\u27a4 Diagnosis of fetal genetic disorders (prenatal diagnosis)</li><li>\u27a4 Diagnosis of congenital infections</li><li>\u27a4 Rh alloimmunization (measurement of amniotic fluid bilirubin to determine severity of fetal anemia)</li><li>\u27a4 Assessment of fetal lung maturity (Lecithin/ Sphingomyelin ratio and measurement of amniotic fluid phosphatidyl glycerol in the amniotic fluid)</li><li>\u27a4 Technique: 20 \u2013 22 -gauge spinal needle Ultrasound guidance Needle inserted into amniotic fluid pocket Avoid umbilical cord, fetal parts Aspirate 10 \u2013 20 ml if sending for fetal karyotype/FISH or chromosomal microarray Discard initial 1-2 ml (may be contamination with maternal blood) If Rh D negative: and unsensitized: Give Anti-D Complications: Procedure related loss: 0.1-0.3% Amniotic fluid leakage Vaginal spotting Early amniocentesis 11- 14 weeks Higher procedure related loss, increased incidence of talipes equinovarus (clubfoot) Not done now</li><li>\u27a4 Technique: 20 \u2013 22 -gauge spinal needle Ultrasound guidance Needle inserted into amniotic fluid pocket Avoid umbilical cord, fetal parts Aspirate 10 \u2013 20 ml if sending for fetal karyotype/FISH or chromosomal microarray Discard initial 1-2 ml (may be contamination with maternal blood) If Rh D negative: and unsensitized: Give Anti-D</li><li>\u27a4 20 \u2013 22 -gauge spinal needle Ultrasound guidance Needle inserted into amniotic fluid pocket Avoid umbilical cord, fetal parts Aspirate 10 \u2013 20 ml if sending for fetal karyotype/FISH or chromosomal microarray Discard initial 1-2 ml (may be contamination with maternal blood) If Rh D negative: and unsensitized: Give Anti-D</li><li>\u27a4 20 \u2013 22 -gauge spinal needle</li><li>\u27a4 Ultrasound guidance</li><li>\u27a4 Needle inserted into amniotic fluid pocket</li><li>\u27a4 Avoid umbilical cord, fetal parts</li><li>\u27a4 Aspirate 10 \u2013 20 ml if sending for fetal karyotype/FISH or chromosomal microarray</li><li>\u27a4 Discard initial 1-2 ml (may be contamination with maternal blood)</li><li>\u27a4 If Rh D negative: and unsensitized: Give Anti-D</li><li>\u27a4 Complications: Procedure related loss: 0.1-0.3% Amniotic fluid leakage Vaginal spotting</li><li>\u27a4 Procedure related loss: 0.1-0.3% Amniotic fluid leakage Vaginal spotting</li><li>\u27a4 Procedure related loss: 0.1-0.3%</li><li>\u27a4 Amniotic fluid leakage</li><li>\u27a4 Vaginal spotting</li><li>\u27a4 Early amniocentesis 11- 14 weeks Higher procedure related loss, increased incidence of talipes equinovarus (clubfoot) Not done now</li><li>\u27a4 11- 14 weeks Higher procedure related loss, increased incidence of talipes equinovarus (clubfoot) Not done now</li><li>\u27a4 11- 14 weeks</li><li>\u27a4 Higher procedure related loss, increased incidence of talipes equinovarus (clubfoot)</li><li>\u27a4 Not done now</li><li>\u27a4 Ref: Page No 291, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page No 291, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "07993970",
      "audio": ""
    },
    {
      "text": "Identify this procedure:",
      "options": [
        {
          "label": "A",
          "text": "Artificial rupture of membranes",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chorionic villous sampling",
          "correct": true
        },
        {
          "label": "C",
          "text": "Cordocentesis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Early amniocentesis",
          "correct": false
        }
      ],
      "correct_answer": "B. Chorionic villous sampling",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/picture8_2sPzrI0.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/picture9_Ds5xTJr.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/screenshot-2024-01-09-161235_GISXBBV.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/picture11_jHzAcVF.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Chorionic Villous Sampling</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 This is an image showing Chorionic Villous Sampling (CVS). This is a procedure done between 10 \u2013 13 weeks wherein chorionic villi obtained via transabdominal or transcervical route for diagnosis of fetal chromosomal or genetic abnormalities</li><li>\u2022 This is an image showing</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A. Artificial Rupture of membranes (ARM): is a procedure as shown below. In this, the membranes are ruptured for induction of labor or augmentation of labor</li><li>\u2022 Option A.</li><li>\u2022 Option C. Cordocentesis: This is as shown in the image below and is aspiration of blood from the umbilical vein for diagnostic or therapeutic purposes. It can be done > 18 weeks.</li><li>\u2022 Option C. Cordocentesis: This is as shown in the image below and is aspiration of blood from the umbilical vein for diagnostic or therapeutic purposes. It can be done > 18 weeks.</li><li>\u2022 Option C. Cordocentesis:</li><li>\u2022 \u200b\u200b\u200b\u200b\u200b\u200b</li><li>\u2022 Indications: Diagnosis of fetal genetic disorders (prenatal diagnosis) Diagnosis of congenital infections Rh alloimmunization (measurement of amniotic fluid bilirubin to determine severity of fetal anemia) Assessment of fetal lung maturity (Lecithin/ Sphingomyelin ratio and measurement of amniotic fluid phosphatidyl glycerol in the amniotic fluid)</li><li>\u2022 Indications: Diagnosis of fetal genetic disorders (prenatal diagnosis) Diagnosis of congenital infections Rh alloimmunization (measurement of amniotic fluid bilirubin to determine severity of fetal anemia) Assessment of fetal lung maturity (Lecithin/ Sphingomyelin ratio and measurement of amniotic fluid phosphatidyl glycerol in the amniotic fluid)</li><li>\u2022 Diagnosis of fetal genetic disorders (prenatal diagnosis) Diagnosis of congenital infections Rh alloimmunization (measurement of amniotic fluid bilirubin to determine severity of fetal anemia) Assessment of fetal lung maturity (Lecithin/ Sphingomyelin ratio and measurement of amniotic fluid phosphatidyl glycerol in the amniotic fluid)</li><li>\u2022 Diagnosis of fetal genetic disorders (prenatal diagnosis)</li><li>\u2022 Diagnosis of congenital infections</li><li>\u2022 Rh alloimmunization (measurement of amniotic fluid bilirubin to determine severity of fetal anemia)</li><li>\u2022 Assessment of fetal lung maturity (Lecithin/ Sphingomyelin ratio and measurement of amniotic fluid phosphatidyl glycerol in the amniotic fluid)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Chorionic Villous sampling is done between 10-13 weeks wherein chorionic villi obtained via transabdominal or transcervical route for diagnosis of fetal chromosomal or genetic abnormalities</li><li>\u27a4 Chorionic Villous sampling is done between 10-13 weeks wherein chorionic villi obtained via transabdominal or transcervical route for diagnosis of fetal chromosomal or genetic abnormalities</li><li>\u27a4 Advantage: do not have to wait till 15 weeks for amniocentesis, results quicker Complications Overall loss rate: higher than amniocentesis because of background losses Procedure related loss: same as amniocentesis (0.1 -0.3%) If done < 7 weeks: limb reduction defects & oro mandibular defects Vaginal spotting</li><li>\u27a4 Advantage: do not have to wait till 15 weeks for amniocentesis, results quicker</li><li>\u27a4 Complications Overall loss rate: higher than amniocentesis because of background losses Procedure related loss: same as amniocentesis (0.1 -0.3%) If done < 7 weeks: limb reduction defects & oro mandibular defects Vaginal spotting</li><li>\u27a4 Overall loss rate: higher than amniocentesis because of background losses Procedure related loss: same as amniocentesis (0.1 -0.3%) If done < 7 weeks: limb reduction defects & oro mandibular defects Vaginal spotting</li><li>\u27a4 Overall loss rate: higher than amniocentesis because of background losses</li><li>\u27a4 Procedure related loss: same as amniocentesis (0.1 -0.3%)</li><li>\u27a4 If done < 7 weeks: limb reduction defects & oro mandibular defects</li><li>\u27a4 Vaginal spotting</li><li>\u27a4 Ref: Page no 293, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 293, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2483545d",
      "audio": ""
    },
    {
      "text": "Match the prenatal screening test with their detection rates:",
      "options": [
        {
          "label": "A",
          "text": "A2 B3 C1 D4",
          "correct": false
        },
        {
          "label": "B",
          "text": "A3 B4 C2 D1",
          "correct": false
        },
        {
          "label": "C",
          "text": "A4 B3 C1 D2",
          "correct": true
        },
        {
          "label": "D",
          "text": "A4 B2 C1 D3",
          "correct": false
        }
      ],
      "correct_answer": "C. A4 B3 C1 D2",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/screenshot-2024-01-09-192208.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/55.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/44.jpg"
      ],
      "explanation": "<p><strong>Ans. C) A4 B3 C1 D2</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page No 282, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page No 282, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1d5bb8a3",
      "audio": ""
    },
    {
      "text": "Maternal serum AFP is increased in all except?",
      "options": [
        {
          "label": "A",
          "text": "Fetus with Down syndrome",
          "correct": true
        },
        {
          "label": "B",
          "text": "Fetus with renal anomaly",
          "correct": false
        },
        {
          "label": "C",
          "text": "Fetus with cystic hygroma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Fetus with intestinal obstruction",
          "correct": false
        }
      ],
      "correct_answer": "A. Fetus with Down syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Fetus with Down Syndrome</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Fetal Conditions associated with an increased MSAFP</li><li>\u27a4 Neural tube defect Gastroschisis, Omphalocele Cystic hygroma Esophageal or intestinal obstruction Liver necrosis Renal anomalies Cloacal dystrophy Osteogenesis imperfecta Sacrococcygeal teratoma</li><li>\u27a4 Neural tube defect</li><li>\u27a4 Gastroschisis, Omphalocele</li><li>\u27a4 Cystic hygroma</li><li>\u27a4 Esophageal or intestinal obstruction</li><li>\u27a4 Liver necrosis</li><li>\u27a4 Renal anomalies</li><li>\u27a4 Cloacal dystrophy</li><li>\u27a4 Osteogenesis imperfecta</li><li>\u27a4 Sacrococcygeal teratoma</li><li>\u27a4 Maternal Conditions associated with an increased MSAFP:</li><li>\u27a4 Underestimated maternal age Placental abruption Oligohydramnios Preeclampsia Fetal growth restriction</li><li>\u27a4 Underestimated maternal age</li><li>\u27a4 Placental abruption</li><li>\u27a4 Oligohydramnios</li><li>\u27a4 Preeclampsia</li><li>\u27a4 Fetal growth restriction</li><li>\u27a4 Conditions associated with a decreased MSAFP</li><li>\u27a4 Obesity Diabetes Trisomy 21 GTD Fetal death Overestimated gestational age</li><li>\u27a4 Obesity</li><li>\u27a4 Diabetes</li><li>\u27a4 Trisomy 21</li><li>\u27a4 GTD</li><li>\u27a4 Fetal death</li><li>\u27a4 Overestimated gestational age</li><li>\u27a4 Ref: page no 283, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: page no 283, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8012ef35",
      "audio": ""
    },
    {
      "text": "In Edwards syndrome, the triple marker will show the following report:",
      "options": [
        {
          "label": "A",
          "text": "\u2191 \u03b2hCG, \u2191 MSAFP, \u2191 uE3",
          "correct": false
        },
        {
          "label": "B",
          "text": "\u2193 \u03b2hCG, \u2191 MSAFP \u2191 uE3",
          "correct": false
        },
        {
          "label": "C",
          "text": "\u2191 \u03b2hCG, \u2193 MSAFP \u2193 uE3",
          "correct": false
        },
        {
          "label": "D",
          "text": "\u2193 \u03b2hCG, \u2193 MSAFP, \u2193 uE3",
          "correct": true
        }
      ],
      "correct_answer": "D. \u2193 \u03b2hCG, \u2193 MSAFP, \u2193 uE3",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/22.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/11_jk5VRxf.jpg"
      ],
      "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Both the triple and the quadruple marker are performed between 15 \u2013 21 weeks gestation but exact gestational age ranges vary according to laboratories.</li><li>\u2022 The triple and Quadruple test are done between 15 \u2013 21 weeks.</li><li>\u2022 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein. Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u2022 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein.</li><li>\u2022 Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u2022 *Easy to remember: B for B ig; so in Down\u2019s syndrome; B eta hCG and Inhi B in A: B ig/ Increased</li><li>\u2022 B</li><li>\u2022 B</li><li>\u2022 B</li><li>\u2022 B</li><li>\u2022 B</li><li>\u2022 *King Edward Abdicated his throne so all levels are decreased</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Triple and Quadruple test are done between 15 \u2013 21 weeks.</li><li>\u27a4 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein. Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u27a4 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein.</li><li>\u27a4 Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u27a4 *Easy to remember: B for B ig; so in Down\u2019s syndrome; B eta hCG and Inhi B in A: B ig/ Increased</li><li>\u27a4 B</li><li>\u27a4 B</li><li>\u27a4 B</li><li>\u27a4 B</li><li>\u27a4 B</li><li>\u27a4 *King Edward Abdicated his throne so all levels are decreased</li><li>\u27a4 Ref: Page no 282, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 282, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "662980b7",
      "audio": ""
    },
    {
      "text": "A 37 y primigravida is 8 weeks pregnant. She is worried about the risk of her having a baby with Down syndrome as she read that increased age is associated with a higher risk. She has also read that screening can be done once she is pregnant. She wants to opt for a test that has the highest detection rate. What screening test would you recommend?",
      "options": [
        {
          "label": "A",
          "text": "Amniocentesis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cell free DNA",
          "correct": true
        },
        {
          "label": "C",
          "text": "Integrated test",
          "correct": false
        },
        {
          "label": "D",
          "text": "Quadruple test",
          "correct": false
        }
      ],
      "correct_answer": "B. Cell free DNA",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/000.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Cell free DNA</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Cell free DNA (NIPT) has the highest detection rate amongst all screening tests (99%)</li><li>\u2022 Cell free DNA (NIPT) has the highest detection rate amongst all screening tests (99%)</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A. Amniocentesis is a diagnostic test Option C. Integrated test: This has a detection rate of about 95% Option D. Quadruple marker: This has a detection rate of 80%</li><li>\u2022 Option A. Amniocentesis is a diagnostic test</li><li>\u2022 Option A.</li><li>\u2022 Option C. Integrated test: This has a detection rate of about 95%</li><li>\u2022 Option C.</li><li>\u2022 Option D. Quadruple marker: This has a detection rate of 80%</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page No 282, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page No 282, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "eb21f499",
      "audio": ""
    },
    {
      "text": "False statement regarding MSAFP is:",
      "options": [
        {
          "label": "A",
          "text": "It is a component of the dual marker",
          "correct": true
        },
        {
          "label": "B",
          "text": "It\u2019s concentration in fetal plasma is 50000 times that in maternal plasma",
          "correct": false
        },
        {
          "label": "C",
          "text": "It is increased in defects in fetal integument",
          "correct": false
        },
        {
          "label": "D",
          "text": "Using an upper limit of MSAFP > 2.5 MoM, the detection rate of anencephaly is 90%",
          "correct": false
        }
      ],
      "correct_answer": "A. It is a component of the dual marker",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Dual marker consists of \u03b2hCG and PAPP-A</li><li>\u2022 Dual marker consists of \u03b2hCG and PAPP-A</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option B. The concentration of MSAFP in fetal plasma is 50000 times greater than in maternal plasma Option C. It is increased in defect s in fetal integument like open neural tube defects (NTD\u2019s) and defects of ventral wall (Gastroschisis and omphalocele) Option D. Using an upper limit of MSAFP > 2.5 MoM, the detection rate of anencephaly is 90%</li><li>\u2022 Option B. The concentration of MSAFP in fetal plasma is 50000 times greater than in maternal plasma</li><li>\u2022 Option B.</li><li>\u2022 Option C. It is increased in defect s in fetal integument like open neural tube defects (NTD\u2019s) and defects of ventral wall (Gastroschisis and omphalocele)</li><li>\u2022 Option C.</li><li>\u2022 Option D. Using an upper limit of MSAFP > 2.5 MoM, the detection rate of anencephaly is 90%</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 MSAFP: Usually measured between 15 \u2013 20 weeks It is increased in defects of fetal integument like open neural tube defects (NTD\u2019s) and defects of ventral wall (Gastroschisis and omphalocele) It is the major protein in the fetal plasma Concentration is 50000 times that in maternal serum Using an MSAFP of > 2.5 MoM as the upper limit of normal, the NTD detection rate is 90% for anencephaly and 80% for spina bifida.</li><li>\u27a4 MSAFP: Usually measured between 15 \u2013 20 weeks It is increased in defects of fetal integument like open neural tube defects (NTD\u2019s) and defects of ventral wall (Gastroschisis and omphalocele) It is the major protein in the fetal plasma Concentration is 50000 times that in maternal serum Using an MSAFP of > 2.5 MoM as the upper limit of normal, the NTD detection rate is 90% for anencephaly and 80% for spina bifida.</li><li>\u27a4 Usually measured between 15 \u2013 20 weeks It is increased in defects of fetal integument like open neural tube defects (NTD\u2019s) and defects of ventral wall (Gastroschisis and omphalocele) It is the major protein in the fetal plasma Concentration is 50000 times that in maternal serum Using an MSAFP of > 2.5 MoM as the upper limit of normal, the NTD detection rate is 90% for anencephaly and 80% for spina bifida.</li><li>\u27a4 Usually measured between 15 \u2013 20 weeks</li><li>\u27a4 It is increased in defects of fetal integument like open neural tube defects (NTD\u2019s) and defects of ventral wall (Gastroschisis and omphalocele)</li><li>\u27a4 It is the major protein in the fetal plasma</li><li>\u27a4 Concentration is 50000 times that in maternal serum</li><li>\u27a4 Using an MSAFP of > 2.5 MoM as the upper limit of normal, the NTD detection rate is 90% for anencephaly and 80% for spina bifida.</li><li>\u27a4 Ref: page no 283, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: page no 283, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f4bd1e31",
      "audio": ""
    },
    {
      "text": "The following biochemical predictors are decreased in a woman at high risk of developing preeclampsia except:",
      "options": [
        {
          "label": "A",
          "text": "PAPP-A",
          "correct": false
        },
        {
          "label": "B",
          "text": "PlGF",
          "correct": false
        },
        {
          "label": "C",
          "text": "S Eng",
          "correct": true
        },
        {
          "label": "D",
          "text": "VEGF",
          "correct": false
        }
      ],
      "correct_answer": "C. S Eng",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/1024.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/01200000.jpg"
      ],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 S eng (soluble endoglin) is increased in women at risk of developing preeclampsia</li><li>\u2022 S eng (soluble endoglin) is increased in women at risk of developing preeclampsia</li><li>\u2022 S eng (soluble endoglin) is increased in women at risk of developing preeclampsia</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 PAPP-A, PlGF and VEGF: All are decreased in women at risk of developing preeclampsia</li><li>\u2022 PAPP-A, PlGF and VEGF: All are decreased in women at risk of developing preeclampsia</li><li>\u2022 PAPP-A, PlGF and VEGF: All are decreased in women at risk of developing preeclampsia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Screening of preeclampsia is based on history (Risk factors), Mean arterial pressure, Uterine artery Doppler at 11-14 weeks and biochemical factors.</li><li>\u27a4 Screening of preeclampsia is based on history (Risk factors), Mean arterial pressure, Uterine artery Doppler at 11-14 weeks and biochemical factors.</li><li>\u27a4 Risk Factors</li><li>\u27a4 Risk Factors</li><li>\u27a4 Other predictors of preeclampsia:</li><li>\u27a4 Other predictors of preeclampsia:</li><li>\u27a4 Biophysical markers: Raised PI in the uterine Artery (11 \u2013 14 weeks); notching of uterine Artery waveform (mid trimester). Biochemical markers:</li><li>\u27a4 Biophysical markers: Raised PI in the uterine Artery (11 \u2013 14 weeks); notching of uterine Artery waveform (mid trimester).</li><li>\u27a4 Biochemical markers:</li><li>\u27a4 Women at high risk of developing pre-eclampsia based on these parameters should be started on Low dose aspirin 75-150 mg before 16 weeks.</li><li>\u27a4 Women at high risk of developing pre-eclampsia based on these parameters should be started on Low dose aspirin 75-150 mg before 16 weeks.</li><li>\u27a4 Ref: Page no 726, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 726, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7a30303a",
      "audio": ""
    },
    {
      "text": "All are high risk factors for preeclampsia except?",
      "options": [
        {
          "label": "A",
          "text": "Antiphospholipid Antibody syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chronic Hypertension",
          "correct": false
        },
        {
          "label": "C",
          "text": "Multiple pregnancy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pregestational Diabetes mellitus",
          "correct": false
        }
      ],
      "correct_answer": "C. Multiple pregnancy",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/777.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/6666_sL2wxz9.jpg"
      ],
      "explanation": "<p><strong>Ans. C) Multiple Pregnancy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Risk factors of pre-eclampsia are as shown in the table</li><li>\u2022 Risk factors of pre-eclampsia are as shown in the table</li><li>\u2022 Thus options A,B and D are high risk factors for pre-eclampsia.</li><li>\u2022 Thus options A,B and D are high risk factors for pre-eclampsia.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Risk factors for pre-eclampsia are:</li><li>\u27a4 Risk factors for pre-eclampsia are:</li><li>\u27a4 Ref: NICE guidelines on HTN in pregnancy 2019</li><li>\u27a4 Ref: NICE guidelines on HTN in pregnancy 2019</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "abd8be51",
      "audio": ""
    },
    {
      "text": "A raised uterine pulsatility index at 11-14 weeks on uterine artery doppler is a predictor for?",
      "options": [
        {
          "label": "A",
          "text": "Down Syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gestational Diabetes",
          "correct": false
        },
        {
          "label": "C",
          "text": "Placenta previa",
          "correct": false
        },
        {
          "label": "D",
          "text": "Preeclampsia",
          "correct": true
        }
      ],
      "correct_answer": "D. Preeclampsia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Preeclampsia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Uterine artery blood flow is estimated to rise from 50ml/min early in gestation to 500-700 ml/ min by term Doppler waveform of the uterine artery shows high diastolic flow velocity and markedly turbulent flow. Greater resistance to flow (High PI) and diastolic notching on a uterine artery Doppler at 11-14 weeks are predictors of Preeclampsia Gestational HTN Fetal growth restriction</li><li>\u2022 Uterine artery blood flow is estimated to rise from 50ml/min early in gestation to 500-700 ml/ min by term</li><li>\u2022 Doppler waveform of the uterine artery shows high diastolic flow velocity and markedly turbulent flow.</li><li>\u2022 Greater resistance to flow (High PI) and diastolic notching on a uterine artery Doppler at 11-14 weeks are predictors of Preeclampsia Gestational HTN Fetal growth restriction</li><li>\u2022 Preeclampsia Gestational HTN Fetal growth restriction</li><li>\u2022 Preeclampsia</li><li>\u2022 Gestational HTN</li><li>\u2022 Fetal growth restriction</li><li>\u2022 Thus, option D) Pre-eclampsia is correct.</li><li>\u2022 Thus, option D) Pre-eclampsia is correct.</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 A raised uterine PI is not related to gestational diabetes, Down syndrome or placenta previa</li><li>\u2022 A raised uterine PI is not related to gestational diabetes, Down syndrome or placenta previa</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Greater resistance to flow (High PI) and diastolic notching  on a uterine artery Doppler at 11-14 weeks are predictors of Preeclampsia Gestational HTN Fetal growth restriction</li><li>\u27a4 Greater resistance to flow (High PI) and diastolic notching  on a uterine artery Doppler at 11-14 weeks are predictors of Preeclampsia Gestational HTN Fetal growth restriction</li><li>\u27a4 Preeclampsia Gestational HTN Fetal growth restriction</li><li>\u27a4 Preeclampsia</li><li>\u27a4 Gestational HTN</li><li>\u27a4 Fetal growth restriction</li><li>\u27a4 Ref: Page no 214, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 214, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c13aa563",
      "audio": ""
    },
    {
      "text": "Nuchal translucency for anomaly scan on USG is usually detected at which week of gestation?",
      "options": [
        {
          "label": "A",
          "text": "8-10 weeks",
          "correct": false
        },
        {
          "label": "B",
          "text": "12-13 weeks",
          "correct": true
        },
        {
          "label": "C",
          "text": "18-20 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "20-22 weeks",
          "correct": false
        }
      ],
      "correct_answer": "B. 12-13 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) 12-13 weeks</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Nuchal Translucency is done between 11 \u2013 14 weeks (more exactly 11 -13weeks 6 days) The best option in these choices is therefore B (12 \u2013 13 weeks) It is a component of first trimester aneuploidy screening Represents maximum thickness of the subcutaneous translucent area between the skin and soft tissue overlying the fetal spine at the back of the neck. If NT increased, risk for Fetal aneuploidy Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u2022 Nuchal Translucency is done between 11 \u2013 14 weeks (more exactly 11 -13weeks 6 days)</li><li>\u2022 The best option in these choices is therefore B (12 \u2013 13 weeks)</li><li>\u2022 It is a component of first trimester aneuploidy screening</li><li>\u2022 Represents maximum thickness of the subcutaneous translucent area between the skin and soft tissue overlying the fetal spine at the back of the neck.</li><li>\u2022 If NT increased, risk for Fetal aneuploidy Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u2022 Fetal aneuploidy Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u2022 Fetal aneuploidy</li><li>\u2022 Various structural anomalies: CVS, hydrops, cystic hygroma</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Nuchal Translucency is a parameter seen on ultrasound done between 11 \u2013 14 weeks An increased value is seen in Down syndrome, ither chromosomal aneuploidies and in several fetal structural abnormalities</li><li>\u27a4 Nuchal Translucency is a parameter seen on ultrasound done between 11 \u2013 14 weeks</li><li>\u27a4 An increased value is seen in Down syndrome, ither chromosomal aneuploidies and in several fetal structural abnormalities</li><li>\u27a4 Ref: Page 282, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 282, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6f2a0640",
      "audio": ""
    },
    {
      "text": "A 26-year-old primigravida presents to the antenatal OPD for her first visit at 16 weeks. She opts for the triple screen. Her report shows an elevated maternal serum AFP level. An elevated maternal serum AFP level puts her at an increased risk for which of the following?",
      "options": [
        {
          "label": "A",
          "text": "Down syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gastroschisis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Gestational diabetes",
          "correct": false
        },
        {
          "label": "D",
          "text": "Intra uterine death",
          "correct": false
        }
      ],
      "correct_answer": "B. Gastroschisis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Gastroschisis</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Fetal Conditions associated with an increased MSAFP</li><li>\u27a4 Neural tube defect Gastroschisis, Omphalocele Cystic hygroma Esophageal or intestinal obstruction Liver necrosis Renal anomalies Cloacal dystrophy Osteogenesis imperfecta Sacrococcygeal teratoma</li><li>\u27a4 Neural tube defect</li><li>\u27a4 Gastroschisis, Omphalocele</li><li>\u27a4 Cystic hygroma</li><li>\u27a4 Esophageal or intestinal obstruction</li><li>\u27a4 Liver necrosis</li><li>\u27a4 Renal anomalies</li><li>\u27a4 Cloacal dystrophy</li><li>\u27a4 Osteogenesis imperfecta</li><li>\u27a4 Sacrococcygeal teratoma</li><li>\u27a4 Maternal conditions associated with an increased MSAFP:</li><li>\u27a4 Underestimated maternal age Placental abruption Oligohydramnios Preeclampsia Fetal growth restriction</li><li>\u27a4 Underestimated maternal age</li><li>\u27a4 Placental abruption</li><li>\u27a4 Oligohydramnios</li><li>\u27a4 Preeclampsia</li><li>\u27a4 Fetal growth restriction</li><li>\u27a4 Conditions associated with a decreased MSAFP</li><li>\u27a4 Obesity Diabetes Trisomy 21 GTD Fetal death Overestimated gestational age</li><li>\u27a4 Obesity</li><li>\u27a4 Diabetes</li><li>\u27a4 Trisomy 21</li><li>\u27a4 GTD</li><li>\u27a4 Fetal death</li><li>\u27a4 Overestimated gestational age</li><li>\u27a4 Ref: Page no 284, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 284, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0a96956e",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman in her first trimester presents for prenatal care. She inquires about prenatal screening for chromosomal abnormalities. What is the most appropriate initial screening test for assessing chromosomal abnormalities in the first trimester?",
      "options": [
        {
          "label": "A",
          "text": "Alpha-fetoprotein (AFP) screening",
          "correct": false
        },
        {
          "label": "B",
          "text": "Noninvasive prenatal testing (NIPT)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chorionic villus sampling (CVS)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nuchal translucency ultrasound",
          "correct": true
        }
      ],
      "correct_answer": "D. Nuchal translucency ultrasound",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Nuchal translucency ultrasound</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Other Options</li><li>\u2022 Other Options</li><li>\u2022 Option A: AFP is usually done at16-18 weeks for detecting neural tube defects in the fetus as it is high in such patients. Option B: Noninvasive prenatal testing (NIPT) or cell free DNA is a screening test with a very high detection rate for fetal genetic abnormalities. It can be done after 9 weeks of pregnancy. However, it is usually not prescribed as an initial test due to its expense. In women who are elderly (> 35y) or other risk factors, it can be offered as a preliminary test Option C: Chorionic villous sampling: This is a diagnostic test for fetal genetic abnormalities done between 11-13 weeks.</li><li>\u2022 Option A: AFP is usually done at16-18 weeks for detecting neural tube defects in the fetus as it is high in such patients.</li><li>\u2022 Option A:</li><li>\u2022 Option B: Noninvasive prenatal testing (NIPT) or cell free DNA is a screening test with a very high detection rate for fetal genetic abnormalities. It can be done after 9 weeks of pregnancy. However, it is usually not prescribed as an initial test due to its expense. In women who are elderly (> 35y) or other risk factors, it can be offered as a preliminary test</li><li>\u2022 Option B:</li><li>\u2022 Option C: Chorionic villous sampling: This is a diagnostic test for fetal genetic abnormalities done between 11-13 weeks.</li><li>\u2022 Option C:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The initial tests prescribed in a low risk pregnant woman for screening for chromosomal abnormalities include Nuchal translucency (11-14 weeks) Dual marker (\u03b2hCG and PAPP-A) Combined marker (NT + Dual marker) NIPT after 9 weeks (Can be offered as an initial test but is expensive so usually offered in elderly mothers or any other risk factor)</li><li>\u27a4 The initial tests prescribed in a low risk pregnant woman for screening for chromosomal abnormalities include Nuchal translucency (11-14 weeks) Dual marker (\u03b2hCG and PAPP-A) Combined marker (NT + Dual marker) NIPT after 9 weeks (Can be offered as an initial test but is expensive so usually offered in elderly mothers or any other risk factor)</li><li>\u27a4 Nuchal translucency (11-14 weeks) Dual marker (\u03b2hCG and PAPP-A) Combined marker (NT + Dual marker) NIPT after 9 weeks (Can be offered as an initial test but is expensive so usually offered in elderly mothers or any other risk factor)</li><li>\u27a4 Nuchal translucency (11-14 weeks)</li><li>\u27a4 Dual marker (\u03b2hCG and PAPP-A)</li><li>\u27a4 Combined marker (NT + Dual marker)</li><li>\u27a4 NIPT after 9 weeks (Can be offered as an initial test but is expensive so usually offered in elderly mothers or any other risk factor)</li><li>\u27a4 Ref: Page no 281, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 281, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "868760ff",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman presents for her first prenatal visit. She is concerned about the risk of chromosomal abnormalities due to her advanced maternal age. Which of the following prenatal screening tests is specifically recommended for women aged 35 and older?",
      "options": [
        {
          "label": "A",
          "text": "Alpha-fetoprotein (AFP) screening",
          "correct": false
        },
        {
          "label": "B",
          "text": "Amniocentesis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chorionic villus sampling (CVS)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Noninvasive prenatal testing (NIPT)",
          "correct": true
        }
      ],
      "correct_answer": "D. Noninvasive prenatal testing (NIPT)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Noninvasive prenatal testing (NIPT)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A: AFP is for detecting neural tube defects where it is found to be raised. Done between 16-18 weeks Option B & Option C: Amniocentesis and CVS are diagnostic tests and are advised if a screening test is positive.</li><li>\u2022 Option A: AFP is for detecting neural tube defects where it is found to be raised. Done between 16-18 weeks</li><li>\u2022 Option A:</li><li>\u2022 Option B & Option C: Amniocentesis and CVS are diagnostic tests and are advised if a screening test is positive.</li><li>\u2022 Option B & Option C:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The initial tests prescribed in a low risk pregnant woman for screening for chromosomal abnormalities include</li><li>\u27a4 Nuchal translucency (11-14 weeks) Dual marker (\u03b2hCG and PAPP-A) Combined marker (NT + Dual marker) NIPT after 9 weeks (Can be offered as an initial test but is expensive so usually offered in elderly mothers or any other risk factor)</li><li>\u27a4 Nuchal translucency (11-14 weeks)</li><li>\u27a4 Dual marker (\u03b2hCG and PAPP-A)</li><li>\u27a4 Combined marker (NT + Dual marker)</li><li>\u27a4 NIPT after 9 weeks (Can be offered as an initial test but is expensive so usually offered in elderly mothers or any other risk factor)</li><li>\u27a4 Ref: Page no , William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no , William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "becf8ae5",
      "audio": ""
    },
    {
      "text": "A 28-year-old pregnant woman is at her second trimester prenatal visit. She inquires about screening for neural tube defects. Which prenatal screening test is used to assess the risk of neural tube defects, such as spina bifida, in the second trimester?",
      "options": [
        {
          "label": "A",
          "text": "Alpha-fetoprotein (AFP) screening",
          "correct": true
        },
        {
          "label": "B",
          "text": "Nuchal translucency ultrasound",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chorionic villus sampling (CVS)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Amniocentesis",
          "correct": false
        }
      ],
      "correct_answer": "A. Alpha-fetoprotein (AFP) screening",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Alpha-fetoprotein (AFP) screening</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option B: Nuchal Translucency (NT): Done at 11-14 weeks as screening for Down syndrome. It is increased in fetuses with Down syndrome and also increased in other chromosomal abnormalities and congenital abnormalities like cardiac diseases. Option C & Option D: CVS and Amniocentesis are diagnostic techniques for detecting chromosomal abnormalities.</li><li>\u2022 Option B: Nuchal Translucency (NT): Done at 11-14 weeks as screening for Down syndrome. It is increased in fetuses with Down syndrome and also increased in other chromosomal abnormalities and congenital abnormalities like cardiac diseases.</li><li>\u2022 Option B:</li><li>\u2022 Option C & Option D: CVS and Amniocentesis are diagnostic techniques for detecting chromosomal abnormalities.</li><li>\u2022 Option C & Option D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page no 273, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 273, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "86fdc65f",
      "audio": ""
    },
    {
      "text": "A 32-year-old pregnant woman presents for her first prenatal visit. She is concerned about her risk of carrying a baby with a genetic disorder due to a family history of cystic fibrosis. What prenatal screening test should be offered to assess the risk of cystic fibrosis in this pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Chorionic villus sampling (CVS)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Non-invasive prenatal testing (NIPT)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Carrier screening for cystic fibrosis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Amniocentesis",
          "correct": false
        }
      ],
      "correct_answer": "C. Carrier screening for cystic fibrosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Carrier screening for cystic fibrosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Cystic fibrosis is an autosomal recessive disease. Cystic Fibrosis is caused due to a mutation in the CFTR gene located on chromosome 7 and affects chloride channels. To assess the risk of carrying a baby with cystic fibrosis, carrier screening for cystic fibrosis is appropriate. This test analyzes the parents' carrier status for the cystic fibrosis gene mutations and provides information about the risk of having an affected child. If both parents are carriers, invasive tests such as CVS and amniocentesis should be offered.</li><li>\u2022 Cystic fibrosis is an autosomal recessive disease.</li><li>\u2022 Cystic Fibrosis is caused due to a mutation in the CFTR gene located on chromosome 7 and affects chloride channels.</li><li>\u2022 To assess the risk of carrying a baby with cystic fibrosis, carrier screening for cystic fibrosis is appropriate.</li><li>\u2022 This test analyzes the parents' carrier status for the cystic fibrosis gene mutations and provides information about the risk of having an affected child.</li><li>\u2022 If both parents are carriers, invasive tests such as CVS and amniocentesis should be offered.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cystic fibrosis has an autosomal recessive pattern of inheritance and hence only if both partners are carriers, is diagnostic testing (CVS or amniocentesis) warranted</li><li>\u27a4 Cystic fibrosis has an autosomal recessive pattern of inheritance and hence only if both partners are carriers, is diagnostic testing (CVS or amniocentesis) warranted</li><li>\u27a4 Ref: Page no 289, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 289, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1c394bfb",
      "audio": ""
    },
    {
      "text": "A 35-year-old pregnant woman with a family history of a genetic disorder is considering invasive prenatal testing. What are the two common invasive prenatal diagnostic tests that can provide definitive information about chromosomal or genetic abnormalities in the fetus?",
      "options": [
        {
          "label": "A",
          "text": "Alpha-fetoprotein (AFP) screening and nuchal translucency ultrasound",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chorionic villus sampling (CVS) and noninvasive prenatal testing (NIPT)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Amniocentesis and nuchal translucency ultrasound",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chorionic villus sampling (CVS) and amniocentesis",
          "correct": true
        }
      ],
      "correct_answer": "D. Chorionic villus sampling (CVS) and amniocentesis",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/15/prenatal-screening-ca-3.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/15/prenatal-screening-ca-4.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Chorionic villus sampling (CVS) and amniocentesis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Prenatal Diagnostic Tests:</li><li>\u2022 Prenatal Diagnostic Tests:</li><li>\u2022 Amniocentesis Chorionic Villous Sampling Fetal blood sampling/ Cordocentesis/ Percutaneous Umbilical Vein Sampling</li><li>\u2022 Amniocentesis</li><li>\u2022 Amniocentesis</li><li>\u2022 Chorionic Villous Sampling</li><li>\u2022 Chorionic Villous Sampling</li><li>\u2022 Fetal blood sampling/ Cordocentesis/ Percutaneous Umbilical Vein Sampling</li><li>\u2022 Fetal blood sampling/ Cordocentesis/ Percutaneous Umbilical Vein Sampling</li><li>\u2022 1. Amniocentesis:</li><li>\u2022 1. Amniocentesis:</li><li>\u2022 Most Commonly performed prenatal diagnostic procedure Done at 15 \u2013 20 weeks for prenatal diagnosis but can be done later also Indications: Diagnosis of fetal genetic disorders (prenatal diagnosis) Diagnosis of congenital infections Rh alloimmunization (measurement of amniotic fluid bilirubin to determine severity of fetal anemia Assessment of fetal lung maturity (Lecithin/ Sphingomyelin ratio and measurement of amniotic fluid phosphatidyl glycerol in the amniotic fluid) Complications : Procedure related loss: 0.1-0.3% Amniotic fluid leakage Vaginal spotting</li><li>\u2022 Most Commonly performed prenatal diagnostic procedure</li><li>\u2022 Done at 15 \u2013 20 weeks for prenatal diagnosis but can be done later also</li><li>\u2022 Indications: Diagnosis of fetal genetic disorders (prenatal diagnosis) Diagnosis of congenital infections Rh alloimmunization (measurement of amniotic fluid bilirubin to determine severity of fetal anemia Assessment of fetal lung maturity (Lecithin/ Sphingomyelin ratio and measurement of amniotic fluid phosphatidyl glycerol in the amniotic fluid)</li><li>\u2022 Indications:</li><li>\u2022 Diagnosis of fetal genetic disorders (prenatal diagnosis) Diagnosis of congenital infections Rh alloimmunization (measurement of amniotic fluid bilirubin to determine severity of fetal anemia Assessment of fetal lung maturity (Lecithin/ Sphingomyelin ratio and measurement of amniotic fluid phosphatidyl glycerol in the amniotic fluid)</li><li>\u2022 Diagnosis of fetal genetic disorders (prenatal diagnosis)</li><li>\u2022 Diagnosis of congenital infections</li><li>\u2022 Rh alloimmunization (measurement of amniotic fluid bilirubin to determine severity of fetal anemia</li><li>\u2022 Assessment of fetal lung maturity (Lecithin/ Sphingomyelin ratio and measurement of amniotic fluid phosphatidyl glycerol in the amniotic fluid)</li><li>\u2022 Complications : Procedure related loss: 0.1-0.3% Amniotic fluid leakage Vaginal spotting</li><li>\u2022 Complications</li><li>\u2022 Procedure related loss: 0.1-0.3% Amniotic fluid leakage Vaginal spotting</li><li>\u2022 Procedure related loss: 0.1-0.3%</li><li>\u2022 Amniotic fluid leakage</li><li>\u2022 Vaginal spotting</li><li>\u2022 2. Chorionic Villous Sampling</li><li>\u2022 2. Chorionic Villous Sampling</li><li>\u2022 Done at 10 \u2013 13 weeks Chorionic villi obtained via transabdominal or transcervical route Advantage: do not have to wait till 15 weeks for amniocentesis, results quicker Complications Overall loss rate: higher than amniocentesis because of background losses Procedure related loss: same as amniocentesis (0.1 -0.3%) If done < 7 weeks: limb reduction defects & oro mandibular defects Vaginal spotting</li><li>\u2022 Done at 10 \u2013 13 weeks</li><li>\u2022 Chorionic villi obtained via transabdominal or transcervical route</li><li>\u2022 Advantage: do not have to wait till 15 weeks for amniocentesis, results quicker</li><li>\u2022 Complications Overall loss rate: higher than amniocentesis because of background losses Procedure related loss: same as amniocentesis (0.1 -0.3%) If done < 7 weeks: limb reduction defects & oro mandibular defects Vaginal spotting</li><li>\u2022 Overall loss rate: higher than amniocentesis because of background losses Procedure related loss: same as amniocentesis (0.1 -0.3%) If done < 7 weeks: limb reduction defects & oro mandibular defects Vaginal spotting</li><li>\u2022 Overall loss rate: higher than amniocentesis because of background losses</li><li>\u2022 Overall loss rate:</li><li>\u2022 Procedure related loss: same as amniocentesis (0.1 -0.3%)</li><li>\u2022 Procedure related loss:</li><li>\u2022 If done < 7 weeks: limb reduction defects & oro mandibular defects</li><li>\u2022 If done < 7 weeks:</li><li>\u2022 Vaginal spotting</li><li>\u2022 Other options:</li><li>\u2022 Other options:</li><li>\u2022 AFP is a noninvasive test (blood sample) for detection of neural tube defects Nuchal translucency is a screening test for Down syndrome done by ultrasound NIPT is cell free DNA. It is a screening test done after 9 weeks for fetal chromosomal abnormalities</li><li>\u2022 AFP is a noninvasive test (blood sample) for detection of neural tube defects</li><li>\u2022 Nuchal translucency is a screening test for Down syndrome done by ultrasound</li><li>\u2022 NIPT is cell free DNA. It is a screening test done after 9 weeks for fetal chromosomal abnormalities</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page no 293, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 293, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d1ec1422",
      "audio": ""
    },
    {
      "text": "Identify the maternal condition that can lead to the findings in the baby as shown below.",
      "options": [
        {
          "label": "A",
          "text": "Pre-gestational diabetes",
          "correct": true
        },
        {
          "label": "B",
          "text": "Gestational diabetes mellites",
          "correct": false
        },
        {
          "label": "C",
          "text": "Effect of valproate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypertensive on ACE inhibitors",
          "correct": false
        }
      ],
      "correct_answer": "A. Pre-gestational diabetes",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/12/picture1.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/12/picture4_Mie1Wml.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Pre \u2013 gestational diabetes</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The image shown is of Sirenomelia/ mermaid syndrome Sirenomelia is the most specific anomaly seen in pregestational (overt) diabetes The most common anomaly seen in pregestational (overt) diabetes is cardiovascular anomalies (VSD).</li><li>\u2022 The image shown is of Sirenomelia/ mermaid syndrome</li><li>\u2022 Sirenomelia is the most specific anomaly seen in pregestational (overt) diabetes</li><li>\u2022 The most common anomaly seen in pregestational (overt) diabetes is cardiovascular anomalies (VSD).</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option B. Gestational diabetes is NOT associated with an increased incidence of fetal anomalies</li><li>\u2022 Option B. Gestational diabetes is NOT associated with an increased incidence of fetal anomalies</li><li>\u2022 Option B.</li><li>\u2022 Option C. Sodium Valproate is an antiepileptic drug (AED) and is associated with orofacial clefting, neural tube defects (NTDs) and cardiac anomalies. Amongst all AEDs, Valproate has the highest incidence of congenital anomalies (4-8-fold higher)</li><li>\u2022 Option C. Sodium Valproate is an antiepileptic drug (AED) and is associated with orofacial clefting, neural tube defects (NTDs) and cardiac anomalies. Amongst all AEDs, Valproate has the highest incidence of congenital anomalies (4-8-fold higher)</li><li>\u2022 Option C.</li><li>\u2022 Option D. ACE inhibitors are associated with fetal renal ischemia and oligohydramnios-pulmonary hypoplasia sequence.</li><li>\u2022 Option D. ACE inhibitors are associated with fetal renal ischemia and oligohydramnios-pulmonary hypoplasia sequence.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The image shown is of Sirenomelia/ mermaid syndrome Sirenomelia is the most specific anomaly seen in pregestational (overt) diabetes The most common anomaly seen in pregestational (overt) diabetes is cardiovascular anomalies (VSD). Gestational diabetes is NOT associated with an increased incidence of fetal anomalies</li><li>\u27a4 The image shown is of Sirenomelia/ mermaid syndrome</li><li>\u27a4 Sirenomelia is the most specific anomaly seen in pregestational (overt) diabetes</li><li>\u27a4 The most common anomaly seen in pregestational (overt) diabetes is cardiovascular anomalies (VSD).</li><li>\u27a4 Gestational diabetes is NOT associated with an increased incidence of fetal anomalies</li><li>\u27a4 Ref: Page no 1100, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 1100, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "af503c22",
      "audio": ""
    },
    {
      "text": "What could be a possible teratogenic agent that has caused this anomaly?",
      "options": [
        {
          "label": "A",
          "text": "Doxycycline",
          "correct": false
        },
        {
          "label": "B",
          "text": "Methotrexate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Phenytoin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Thalidomide",
          "correct": true
        }
      ],
      "correct_answer": "D. Thalidomide",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/12/picture2_WM3QPRH.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/12/picture3_n3tCxVW.jpg"
      ],
      "explanation": "<p><strong>Ans. D. Thalidomide</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The characteristic anomaly caused by Thalidomide is phocomelia (Absence of 1 or more long bone): Described in the Thalidomide tragedy in the USA form 1956-1960</li><li>\u2022 The characteristic anomaly caused by Thalidomide is phocomelia (Absence of 1 or more long bone): Described in the Thalidomide tragedy in the USA form 1956-1960</li><li>\u2022 Other options:</li><li>\u2022 Other options:</li><li>\u2022 Methotrexate: Craniosynostosis with a clover leaf skull, wide nasal bridge, low set ears and micrognathia Phenytoin: Fetal hydantoin syndrome (upturned nose, midfacial hypoplasia, distal digital hypoplasia) Doxycycline: tetracyclines: yellowish-brownish discoloration of deciduous teeth when used after 25 weeks of gestation</li><li>\u2022 Methotrexate: Craniosynostosis with a clover leaf skull, wide nasal bridge, low set ears and micrognathia</li><li>\u2022 Phenytoin: Fetal hydantoin syndrome (upturned nose, midfacial hypoplasia, distal digital hypoplasia)</li><li>\u2022 Doxycycline: tetracyclines: yellowish-brownish discoloration of deciduous teeth when used after 25 weeks of gestation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The characteristic anomaly caused by Thalidomide is phocomelia (Absence of 1 or more long bone): Described in the Thalidomide tragedy in the USA form 1956-1960</li><li>\u27a4 The characteristic anomaly caused by Thalidomide is phocomelia (Absence of 1 or more long bone): Described in the Thalidomide tragedy in the USA form 1956-1960</li><li>\u27a4 Ref: Page no 246, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 246, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "237570f1",
      "audio": ""
    },
    {
      "text": "Which of the following medication should never be used in pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Methotrexate",
          "correct": true
        },
        {
          "label": "B",
          "text": "Cyclosporine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chloroquine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pyrazinamide",
          "correct": false
        }
      ],
      "correct_answer": "A. Methotrexate",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/12/screenshot-2024-01-12-155559.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Methotrexate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Methotrexate is a folic acid antagonist and is potent teratogen</li><li>\u2022 Methotrexate is a folic acid antagonist and is potent teratogen</li><li>\u2022 Methotrexate causes craniosynostosis with a clover leaf skull, wide nasal bridge, low set ears and micrognathia.</li><li>\u2022 Methotrexate causes craniosynostosis with a clover leaf skull, wide nasal bridge, low set ears and micrognathia.</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Chloroquine use should not be withheld where indicated on account of pregnancy. Cyclosporine and pyrazinamide are category C in pregnancy (should be used only when benefits outweigh the risks)</li><li>\u2022 Chloroquine use should not be withheld where indicated on account of pregnancy.</li><li>\u2022 Cyclosporine and pyrazinamide are category C in pregnancy (should be used only when benefits outweigh the risks)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Teratogenic Drugs</li><li>\u27a4 Teratogenic Drugs</li><li>\u27a4 Ref: Page no 246, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 246, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "66c9fd66",
      "audio": ""
    },
    {
      "text": "Maternal use of which of the following hormone may cause hypospadias in a male child?",
      "options": [
        {
          "label": "A",
          "text": "Tolbutamide",
          "correct": false
        },
        {
          "label": "B",
          "text": "Clomiphene",
          "correct": false
        },
        {
          "label": "C",
          "text": "Diethylstilbesterol",
          "correct": true
        },
        {
          "label": "D",
          "text": "Clonazepam",
          "correct": false
        }
      ],
      "correct_answer": "C. Diethylstilbesterol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Diethylstilbesterol</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Diethylstilbestrol (DES) is a synthetic nonsteroidal estrogen that was used to prevent miscarriage and other pregnancy complications between 1938 and 1971 In the United States. In 1971, the U.S. Food and Drug Administration issued a warning about the use of DES during pregnancy after a relationship between DES and the development of clear cell adenocarcinoma of the vagina and cervix was found in women whose mothers had taken diethylstilbestrol while they were pregnant. Effects of DES exposure in utero on girls Cervix: hypoplastic cervix, Cockscomb cervix, cervical collar, pseudo polyp Vagina: Clear cell adenocarcinoma, adenosis Uterus: T-shaped uterus Effects of DES exposure in utero on boys: Epididymal cysts Microphallus Undescended testes and small testes. Hypospadias</li><li>\u2022 Diethylstilbestrol (DES) is a synthetic nonsteroidal estrogen that was used to prevent miscarriage and other pregnancy complications between 1938 and 1971</li><li>\u2022 In the United States. In 1971, the U.S. Food and Drug Administration issued a warning about the use of DES during pregnancy after a relationship between DES and the development of clear cell adenocarcinoma of the vagina and cervix was found in women whose mothers had taken diethylstilbestrol while they were pregnant.</li><li>\u2022 Effects of DES exposure in utero on girls Cervix: hypoplastic cervix, Cockscomb cervix, cervical collar, pseudo polyp Vagina: Clear cell adenocarcinoma, adenosis Uterus: T-shaped uterus</li><li>\u2022 Cervix: hypoplastic cervix, Cockscomb cervix, cervical collar, pseudo polyp Vagina: Clear cell adenocarcinoma, adenosis Uterus: T-shaped uterus</li><li>\u2022 Cervix: hypoplastic cervix, Cockscomb cervix, cervical collar, pseudo polyp</li><li>\u2022 Vagina: Clear cell adenocarcinoma, adenosis</li><li>\u2022 Uterus: T-shaped uterus</li><li>\u2022 Effects of DES exposure in utero on boys: Epididymal cysts Microphallus Undescended testes and small testes. Hypospadias</li><li>\u2022 Epididymal cysts Microphallus Undescended testes and small testes. Hypospadias</li><li>\u2022 Epididymal cysts</li><li>\u2022 Microphallus</li><li>\u2022 Undescended testes and small testes.</li><li>\u2022 Hypospadias</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A. Tolbutamide: Insufficient studies; no major teratogenic effect noted till now Option B. Clomiphene: Some association with defects like NTDs and hypospadias has been found but larger studies are required. Option D. Clonazepam: Associated with orofacial clefts</li><li>\u2022 Option A. Tolbutamide: Insufficient studies; no major teratogenic effect noted till now</li><li>\u2022 Option A.</li><li>\u2022 Option B. Clomiphene: Some association with defects like NTDs and hypospadias has been found but larger studies are required.</li><li>\u2022 Option B.</li><li>\u2022 Option D. Clonazepam: Associated with orofacial clefts</li><li>\u2022 Option D.</li><li>\u2022 *Hence the answer to this question should be DES and not Clomiphene as the evidence for DES causing hypospadias is higher</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Diethylstilbestrol (DES) is a synthetic nonsteroidal estrogen that was used to prevent miscarriage and other pregnancy complications between 1938 and 1971</li><li>\u27a4 In the United States. In 1971, the U.S. Food and Drug Administration issued a warning about the use of DES during pregnancy after a relationship between DES and the development of clear cell adenocarcinoma of the vagina and cervix was found in women whose mothers had taken diethylstilbestrol while they were pregnant. Effects of DES exposure in utero on girls Cervix: hypoplastic cervix, Cockscomb cervix, cervical collar, pseudo polyp Vagina: Clear cell adenocarcinoma, adenosis Uterus: T-shaped uterus Effects of DES exposure in utero on boys: Epididymal cysts Microphallus Undescended testes and small testes. Hypospadias</li><li>\u27a4 In the United States. In 1971, the U.S. Food and Drug Administration issued a warning about the use of DES during pregnancy after a relationship between DES and the development of clear cell adenocarcinoma of the vagina and cervix was found in women whose mothers had taken diethylstilbestrol while they were pregnant.</li><li>\u27a4 Effects of DES exposure in utero on girls Cervix: hypoplastic cervix, Cockscomb cervix, cervical collar, pseudo polyp Vagina: Clear cell adenocarcinoma, adenosis Uterus: T-shaped uterus</li><li>\u27a4 Cervix: hypoplastic cervix, Cockscomb cervix, cervical collar, pseudo polyp Vagina: Clear cell adenocarcinoma, adenosis Uterus: T-shaped uterus</li><li>\u27a4 Cervix: hypoplastic cervix, Cockscomb cervix, cervical collar, pseudo polyp</li><li>\u27a4 Vagina: Clear cell adenocarcinoma, adenosis</li><li>\u27a4 Uterus: T-shaped uterus</li><li>\u27a4 Effects of DES exposure in utero on boys: Epididymal cysts Microphallus Undescended testes and small testes. Hypospadias</li><li>\u27a4 Epididymal cysts Microphallus Undescended testes and small testes. Hypospadias</li><li>\u27a4 Epididymal cysts</li><li>\u27a4 Microphallus</li><li>\u27a4 Undescended testes and small testes.</li><li>\u27a4 Hypospadias</li><li>\u27a4 Ref: Page no 244, William\u2019s Obstetrics 25 th edition; AAFP 2004: DES exposure</li><li>\u27a4 Ref: Page no 244, William\u2019s Obstetrics 25 th edition; AAFP 2004: DES exposure</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fe9a9d90",
      "audio": ""
    },
    {
      "text": "Mobius syndrome in fetus may be caused by maternal intake of",
      "options": [
        {
          "label": "A",
          "text": "Mifepristone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Misoprostol",
          "correct": true
        },
        {
          "label": "C",
          "text": "Dinoprostone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Methotrexate",
          "correct": false
        }
      ],
      "correct_answer": "B. Misoprostol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Misoprostol</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 M\u00f6bius syndrome is:</li><li>\u2022 M\u00f6bius syndrome is:</li><li>\u2022 A rare congenital neurological disorder Characterized by facial paralysis and the inability to move the eyes from side to side Most people with M\u00f6bius syndrome are born with complete facial paralysis and cannot close their eyes or form facial expressions. Limb and chest wall abnormalities sometimes occur with the syndrome. Associated with prenatal exposure to misoprostol and thalidomide</li><li>\u2022 A rare congenital neurological disorder</li><li>\u2022 Characterized by facial paralysis and the inability to move the eyes from side to side</li><li>\u2022 Most people with M\u00f6bius syndrome are born with complete facial paralysis and cannot close their eyes or form facial expressions.</li><li>\u2022 Limb and chest wall abnormalities sometimes occur with the syndrome.</li><li>\u2022 Associated with prenatal exposure to misoprostol and thalidomide</li><li>\u2022 Other options:</li><li>\u2022 Other options:</li><li>\u2022 Methotrexate is a folic acid antagonist and is a potent teratogen; Methotrexate can cause craniosynostosis with a clover leaf skull, wide nasal bridge, low set ears and micrognathia. Mifepristone is not teratogenic. However, in early pregnancy it can lead to abortions and is also used for induction of labor at term Dinoprostone is Prostaglandin E2; it is not teratogenic and is used for induction of labor at term</li><li>\u2022 Methotrexate is a folic acid antagonist and is a potent teratogen; Methotrexate can cause craniosynostosis with a clover leaf skull, wide nasal bridge, low set ears and micrognathia.</li><li>\u2022 Mifepristone is not teratogenic. However, in early pregnancy it can lead to abortions and is also used for induction of labor at term</li><li>\u2022 Dinoprostone is Prostaglandin E2; it is not teratogenic and is used for induction of labor at term</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 M\u00f6bius syndrome is:</li><li>\u27a4 M\u00f6bius syndrome is:</li><li>\u27a4 A rare congenital neurological disorder Characterized by facial paralysis and the inability to move the eyes from side to side Most people with M\u00f6bius syndrome are born with complete facial paralysis and cannot close their eyes or form facial expressions. Limb and chest wall abnormalities sometimes occur with the syndrome. Associated with prenatal exposure to misoprostol and thalidomide</li><li>\u27a4 A rare congenital neurological disorder</li><li>\u27a4 Characterized by facial paralysis and the inability to move the eyes from side to side</li><li>\u27a4 Most people with M\u00f6bius syndrome are born with complete facial paralysis and cannot close their eyes or form facial expressions.</li><li>\u27a4 Limb and chest wall abnormalities sometimes occur with the syndrome.</li><li>\u27a4 Associated with prenatal exposure to misoprostol and thalidomide</li><li>\u27a4 Ref: Neuromuscular disorders of infancy, childhood and adolescence,2 nd edition chapter 46, pg922-957, Page no 244, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Neuromuscular disorders of infancy, childhood and adolescence,2 nd edition chapter 46, pg922-957, Page no 244, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5350cc10",
      "audio": ""
    },
    {
      "text": "Fetal hydantoin syndrome is seen due to antenatal exposure to which drug?",
      "options": [
        {
          "label": "A",
          "text": "Amlodipine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Metformin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Phenytoin",
          "correct": true
        },
        {
          "label": "D",
          "text": "Retinoic acid",
          "correct": false
        }
      ],
      "correct_answer": "C. Phenytoin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Phenytoin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Phenytoin Is associated with a 3-fold increase in fetal malformations Fetal hydantoin syndrome: Upturned nose Midfacial hypoplasia Distal digital hypoplasia</li><li>\u2022 Phenytoin Is associated with a 3-fold increase in fetal malformations Fetal hydantoin syndrome: Upturned nose Midfacial hypoplasia Distal digital hypoplasia</li><li>\u2022 Is associated with a 3-fold increase in fetal malformations Fetal hydantoin syndrome: Upturned nose Midfacial hypoplasia Distal digital hypoplasia</li><li>\u2022 Is associated with a 3-fold increase in fetal malformations</li><li>\u2022 Fetal hydantoin syndrome: Upturned nose Midfacial hypoplasia Distal digital hypoplasia</li><li>\u2022 Upturned nose Midfacial hypoplasia Distal digital hypoplasia</li><li>\u2022 Upturned nose</li><li>\u2022 Midfacial hypoplasia</li><li>\u2022 Distal digital hypoplasia</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Amlodipine is not associated with increased incidence of fetal malformations Metformin is not associated with increased incidence of fetal malformations</li><li>\u2022 Amlodipine is not associated with increased incidence of fetal malformations</li><li>\u2022 Metformin is not associated with increased incidence of fetal malformations</li><li>\u2022 Retinoic acid: Retinoic acid embryopathy: Ventriculomegaly, maldevelopment of facial bone or cranium, microtia or anotia, micrognathia, cleft palate, conotruncal heart defects and thymic aplasia</li><li>\u2022 Retinoic acid: Retinoic acid embryopathy: Ventriculomegaly, maldevelopment of facial bone or cranium, microtia or anotia, micrognathia, cleft palate, conotruncal heart defects and thymic aplasia</li><li>\u2022 Ref: Page no 240, William\u2019s Obstetrics 25 th edition</li><li>\u2022 Ref: Page no 240, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "40c0b32b",
      "audio": ""
    },
    {
      "text": "A woman comes for pre-conceptional counselling. She is a known hypertensive and is taking losartan. She is explained that she needs to change the antihypertensive to a safer non teratogenic drug. She asks you what the possible effects of losartan on the fetus are.",
      "options": [
        {
          "label": "A",
          "text": "Cardiovascular anomalies",
          "correct": false
        },
        {
          "label": "B",
          "text": "Neural tube defects",
          "correct": false
        },
        {
          "label": "C",
          "text": "Renal anomalies",
          "correct": true
        },
        {
          "label": "D",
          "text": "Skeletal abnormalities",
          "correct": false
        }
      ],
      "correct_answer": "C. Renal anomalies",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Renal anomalies</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 ACE inhibitors and ARBs cause:</li><li>\u2022 Fetal renal hypoperfusion leading to subsequent ischemia and anuria. This leads to oligohydramnios and pulmonary hypoplasia. This leads to: limb contractures, calvarium maldevelopment and Fetal growth restriction.</li><li>\u2022 Fetal renal hypoperfusion leading to subsequent ischemia and anuria. This leads to oligohydramnios and pulmonary hypoplasia.</li><li>\u2022 This leads to: limb contractures, calvarium maldevelopment and Fetal growth restriction.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 ACE inhibitors and ARBs cause:</li><li>\u27a4 Fetal renal hypoperfusion leading to subsequent ischemia and anuria. This leads to oligohydramnios and pulmonary hypoplasia. This leads to: limb contractures, calvarium maldevelopment and Fetal growth restriction.</li><li>\u27a4 Fetal renal hypoperfusion leading to subsequent ischemia and anuria. This leads to oligohydramnios and pulmonary hypoplasia.</li><li>\u27a4 This leads to: limb contractures, calvarium maldevelopment and Fetal growth restriction.</li><li>\u27a4 Ref: Page 241, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 241, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a5800352",
      "audio": ""
    },
    {
      "text": "A 26-year-old Primigravida presents at 33 weeks in preterm labor. All the following can be given as tocolysis except?",
      "options": [
        {
          "label": "A",
          "text": "Atosiban",
          "correct": false
        },
        {
          "label": "B",
          "text": "Indomethacin",
          "correct": true
        },
        {
          "label": "C",
          "text": "Nifedipine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Magnesium sulfate",
          "correct": false
        }
      ],
      "correct_answer": "B. Indomethacin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Indomethacin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Indomethacin is a tocolytic but may cause constriction of the fetal ductus arteriosus and subsequent pulmonary hypoplasia.</li><li>\u2022 Indomethacin is a tocolytic but may cause constriction of the fetal ductus arteriosus and subsequent pulmonary hypoplasia.</li><li>\u2022 Risk of closure is higher is taken after 32 weeks for > 72 hours Hence, beyond 32 weeks, indomethacin is not given for tocolysis.</li><li>\u2022 Risk of closure is higher is taken after 32 weeks for > 72 hours</li><li>\u2022 Hence, beyond 32 weeks, indomethacin is not given for tocolysis.</li><li>\u2022 Other options A) Atosiban, C) Nifedipine and D) Magnesium sulphate can be safely given in this case.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Indomethacin is a tocolytic but may cause constriction of the fetal ductus arteriosus and subsequent pulmonary hypoplasia.</li><li>\u27a4 Indomethacin is a tocolytic but may cause constriction of the fetal ductus arteriosus and subsequent pulmonary hypoplasia.</li><li>\u27a4 Risk of closure is higher is taken after 32 weeks for > 72 hours Hence, beyond 32 weeks, indomethacin is not given for tocolysis.</li><li>\u27a4 Risk of closure is higher is taken after 32 weeks for > 72 hours</li><li>\u27a4 Hence, beyond 32 weeks, indomethacin is not given for tocolysis.</li><li>\u27a4 Ref: Page no 241, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 241, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3760b0bc",
      "audio": ""
    },
    {
      "text": "Lithium in pregnancy is associated with an increased incidence of?",
      "options": [
        {
          "label": "A",
          "text": "Orofacial clefting",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ebstein anomaly",
          "correct": true
        },
        {
          "label": "C",
          "text": "Neurobehavioral abnormalities",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cardiovascular anomalies",
          "correct": false
        }
      ],
      "correct_answer": "B. Ebstein anomaly",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Ebstein anomaly</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Lithium has been associated with Ebstein anomaly</li><li>\u2022 Lithium has been associated with Ebstein anomaly</li><li>\u2022 This is an otherwise rare anomaly but has a 3% risk in women on Lithium. Fetal ECHO is indicated in women on Lithium</li><li>\u2022 This is an otherwise rare anomaly but has a 3% risk in women on Lithium.</li><li>\u2022 Fetal ECHO is indicated in women on Lithium</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Lithium has been associated with Ebstein anomaly</li><li>\u27a4 Lithium has been associated with Ebstein anomaly</li><li>\u27a4 This is an otherwise rare anomaly but has a 3% risk in women on Lithium. Fetal ECHO is indicated in women on Lithium</li><li>\u27a4 This is an otherwise rare anomaly but has a 3% risk in women on Lithium.</li><li>\u27a4 Fetal ECHO is indicated in women on Lithium</li><li>\u27a4 Ref: Page no 245, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 245, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fb4fac9b",
      "audio": ""
    },
    {
      "text": "A pregnant woman with a known cardiac disease presents to you in the first trimester. She gives a history of warfarin intake. What should be advised now?",
      "options": [
        {
          "label": "A",
          "text": "Continue warfarin throughout pregnancy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Give coumarin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Stop warfarin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Replace warfarin with heparin in the 1 st trimester",
          "correct": true
        }
      ],
      "correct_answer": "D. Replace warfarin with heparin in the 1 st trimester",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Replace Warfarin with heparin in the 1sttrimester</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 A patient who is on warfarin is at risk of warfarin embryopathy so she should be shifted to heparin in the 1 st trimester. In the 2 nd trimester, warfarin can be re-started. In the 3 rd trimester, we again must shift to heparin.</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Option A. Continue warfarin throughout pregnancy: Warfarin is unsafe in the 1 st trimester (risk of warfarin embryopathy) and in the 3 rd trimester (Risk of intra-cranial hemorrhage in the fetus) Option B. Give coumarin: Warfarin is a coumarin Option C. Stop warfarin: This will increase her risk of thrombo-embolism so it should not be stopped</li><li>\u2022 Option A. Continue warfarin throughout pregnancy: Warfarin is unsafe in the 1 st trimester (risk of warfarin embryopathy) and in the 3 rd trimester (Risk of intra-cranial hemorrhage in the fetus)</li><li>\u2022 Option A. Continue warfarin throughout pregnancy:</li><li>\u2022 Option B. Give coumarin: Warfarin is a coumarin</li><li>\u2022 Option B. Give coumarin:</li><li>\u2022 Option C. Stop warfarin: This will increase her risk of thrombo-embolism so it should not be stopped</li><li>\u2022 Option C. Stop warfarin:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Warfarin is known to crosses the placenta and is teratogenic and causes warfarin embryopathy Warfarin embryopathy - stippled epiphysis and nasal hypoplasia It can also cause CNS defects and developmental delay Results from fetal exposure between the 6 th and 9 th weeks In the 3 rd trimester there is a risk of hemorrhage into fetal structures Hence, switch over to heparin preconceptionally or in the first trimester and then again in the third trimester.</li><li>\u27a4 Warfarin is known to crosses the placenta and is teratogenic and causes warfarin embryopathy</li><li>\u27a4 Warfarin embryopathy - stippled epiphysis and nasal hypoplasia</li><li>\u27a4 It can also cause CNS defects and developmental delay</li><li>\u27a4 Results from fetal exposure between the 6 th and 9 th weeks</li><li>\u27a4 In the 3 rd trimester there is a risk of hemorrhage into fetal structures</li><li>\u27a4 Hence, switch over to heparin preconceptionally or in the first trimester and then again in the third trimester.</li><li>\u27a4 Ref: Page no 247, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 247, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fc17f97a",
      "audio": ""
    },
    {
      "text": "Tobacco in pregnancy is associated with all the following birth defects except",
      "options": [
        {
          "label": "A",
          "text": "Cardiac anomalies",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cleft lip and palate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Poland sequence",
          "correct": false
        },
        {
          "label": "D",
          "text": "Renal anomalies",
          "correct": true
        }
      ],
      "correct_answer": "D. Renal anomalies",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Renal anomalies</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Renal anomalies are unlikely to be seen in tobacco and cigarette smoking</li><li>\u2022 Tobacco and cigarette smoking have been associated with the following adverse effects:</li><li>\u2022 Poland sequence (2-fold higher risk): unilateral aplasia of chest wall muscles and webbed fingers Cardiac anomalies Hydrocephaly, microcephaly Omphalocele, gastroschisis Cleft lip and palate Hand abnormalities Fetal growth restriction Preterm birth Placenta previa Abruptio placentae Spontaneous abortion Sudden infant death syndrome (SIDS) Increased risk of childhood asthma and obesity</li><li>\u2022 Poland sequence (2-fold higher risk): unilateral aplasia of chest wall muscles and webbed fingers</li><li>\u2022 Cardiac anomalies</li><li>\u2022 Hydrocephaly, microcephaly</li><li>\u2022 Omphalocele, gastroschisis</li><li>\u2022 Cleft lip and palate</li><li>\u2022 Hand abnormalities</li><li>\u2022 Fetal growth restriction</li><li>\u2022 Preterm birth</li><li>\u2022 Placenta previa</li><li>\u2022 Abruptio placentae</li><li>\u2022 Spontaneous abortion</li><li>\u2022 Sudden infant death syndrome (SIDS)</li><li>\u2022 Increased risk of childhood asthma and obesity</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Tobacco and cigarette smoking have been associated with the following adverse effects:</li><li>\u27a4 Poland sequence (2-fold higher risk): unilateral aplasia of chest wall muscles and webbed fingers Cardiac anomalies Hydrocephaly, microcephaly Omphalocele, gastroschisis Cleft lip and palate Hand abnormalities Fetal growth restriction Preterm birth Placenta previa Abruptio placentae Spontaneous abortion Sudden infant death syndrome (SIDS) Increased risk of childhood asthma and obesity</li><li>\u27a4 Poland sequence (2-fold higher risk): unilateral aplasia of chest wall muscles and webbed fingers</li><li>\u27a4 Cardiac anomalies</li><li>\u27a4 Hydrocephaly, microcephaly</li><li>\u27a4 Omphalocele, gastroschisis</li><li>\u27a4 Cleft lip and palate</li><li>\u27a4 Hand abnormalities</li><li>\u27a4 Fetal growth restriction</li><li>\u27a4 Preterm birth</li><li>\u27a4 Placenta previa</li><li>\u27a4 Abruptio placentae</li><li>\u27a4 Spontaneous abortion</li><li>\u27a4 Sudden infant death syndrome (SIDS)</li><li>\u27a4 Increased risk of childhood asthma and obesity</li><li>\u27a4 Ref: Page no 249, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 249, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "671b8acc",
      "audio": ""
    },
    {
      "text": "A 23-year woman has been taking isotretinoin for acne. She now is recently married and is planning conception. After how long of stopping isotretinoin should she conceive?",
      "options": [
        {
          "label": "A",
          "text": "3 days",
          "correct": false
        },
        {
          "label": "B",
          "text": "3 weeks",
          "correct": true
        },
        {
          "label": "C",
          "text": "3 months",
          "correct": false
        },
        {
          "label": "D",
          "text": "3 years",
          "correct": false
        }
      ],
      "correct_answer": "B. 3 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. 3 weeks</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Isotretinoin is contraindicated during pregnancy as one of the stronger teratogen Retinoic acid embryopathy\u2014  involve the CNS, face, heart, and thymus. Specific anomalies may include ventriculomegaly, maldevelopment of the facial bones or cranium, microtia or anotia, micrognathia, cleft palate, conotruncal heart defects, and thymic aplasia or hypoplasia Two reliable forms of birth control must be used at the same time (unless abstinence is the chosen method) for 1 month before, during, and for at least 1 month after concluding treatment with isotretinoin. The most recent, and most stringent, system aimed to avoid exposure to isotretinoin is an Internet-based, performance-linked system called iPLEDGE Isotretinoin and its active metabolites cross the human placenta. Isotretinoin is one of the strongest human teratogens known today. The prevalence of birth defects after exposure during embryogenesis is as high as 30%.</li><li>\u27a4 Isotretinoin is contraindicated during pregnancy as one of the stronger teratogen</li><li>\u27a4 Retinoic acid embryopathy\u2014  involve the CNS, face, heart, and thymus.</li><li>\u27a4 Specific anomalies may include ventriculomegaly, maldevelopment of the facial bones or cranium, microtia or anotia, micrognathia, cleft palate, conotruncal heart defects, and thymic aplasia or hypoplasia</li><li>\u27a4 Two reliable forms of birth control must be used at the same time (unless abstinence is the chosen method) for 1 month before, during, and for at least 1 month after concluding treatment with isotretinoin.</li><li>\u27a4 The most recent, and most stringent, system aimed to avoid exposure to isotretinoin is an Internet-based, performance-linked system called iPLEDGE</li><li>\u27a4 Isotretinoin and its active metabolites cross the human placenta. Isotretinoin is one of the strongest human teratogens known today.</li><li>\u27a4 The prevalence of birth defects after exposure during embryogenesis is as high as 30%.</li><li>\u27a4 Ref: Page no 245, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 245, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "46493f25",
      "audio": ""
    },
    {
      "text": "A 34-year primi is started on sertraline for depression at 24 weeks gestation. She is worried about the risks the fetus can have because of the drug. What can the fetus develop?",
      "options": [
        {
          "label": "A",
          "text": "Congenital diaphragmatic hernia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Congenital pulmonary airway malformation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Primary pulmonary HTN",
          "correct": true
        },
        {
          "label": "D",
          "text": "Tracheo-esophageal fistula",
          "correct": false
        }
      ],
      "correct_answer": "C. Primary pulmonary HTN",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Primary pulmonary HTN</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 SSRIs are known to cause:</li><li>\u27a4 Primary pulmonary hypertension if started late in pregnancy. Neonatal behavioral syndrome Paroxetine is associated with fetal cardiac anomalies like VSD</li><li>\u27a4 Primary pulmonary hypertension if started late in pregnancy.</li><li>\u27a4 Neonatal behavioral syndrome</li><li>\u27a4 Paroxetine is associated with fetal cardiac anomalies like VSD</li><li>\u27a4 Ref: Page no 245, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 245, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f0843b5a",
      "audio": ""
    },
    {
      "text": "A 28-year-old pregnant woman is concerned about potential teratogenic effects on her developing fetus. Which of the following medications, if taken during pregnancy, is associated with an increased risk of CNS defects?",
      "options": [
        {
          "label": "A",
          "text": "Folic acid",
          "correct": false
        },
        {
          "label": "B",
          "text": "Warfarin",
          "correct": true
        },
        {
          "label": "C",
          "text": "Indomethacin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Aspirin",
          "correct": false
        }
      ],
      "correct_answer": "B. Warfarin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Warfarin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Other options:</li><li>\u2022 Other options:</li><li>\u2022 Option A: Folic acid supplementation is used for the prevention of neural tube defects. Option C and D : Indomethacin and aspirin are NSAIDs. Aspirin is not a major risk factor for birth defects. Indomethacin when taken late in pregnancy may cause constriction of the fetal ductus arteriosus and fetal pulmonary hypertension.</li><li>\u2022 Option A: Folic acid supplementation is used for the prevention of neural tube defects.</li><li>\u2022 Option A:</li><li>\u2022 Option C and D : Indomethacin and aspirin are NSAIDs. Aspirin is not a major risk factor for birth defects. Indomethacin when taken late in pregnancy may cause constriction of the fetal ductus arteriosus and fetal pulmonary hypertension.</li><li>\u2022 Option C and D</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Warfarin is an anticoagulant medication that, if taken during pregnancy causes stippled epiphysis and nasal hypoplasia, it is also associated with an increased risk of CNS defects. It should be avoided during pregnancy, and alternative anticoagulation methods should be considered.</li><li>\u27a4 Ref: Page no 247, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 247, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "aecaf7e7",
      "audio": ""
    },
    {
      "text": "A 32-year-old pregnant woman is prescribed a medication for her chronic medical condition. She asks if this medication is a teratogen. The physician explains that this medication can potentially cause limb and ear malformations if taken during pregnancy. Which medication is the physician most likely referring to?",
      "options": [
        {
          "label": "A",
          "text": "Penicillin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Prednisone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Valproic acid",
          "correct": true
        },
        {
          "label": "D",
          "text": "Omeprazole",
          "correct": false
        }
      ],
      "correct_answer": "C. Valproic acid",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Valproic acid</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Other options:</li><li>\u2022 Other options:</li><li>\u2022 Option A, B and D: (penicillin, prednisone, omeprazole) are generally considered safer choices during pregnancy.</li><li>\u2022 Option A, B and D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Valproic acid, an antiepileptic medication, is associated with an increased risk of limb and ear malformations when taken during pregnancy. It is considered a teratogen, and alternative medications should be considered for pregnant women with epilepsy.</li><li>\u27a4 Valproic acid, an antiepileptic medication, is associated with an increased risk of limb and ear malformations when taken during pregnancy.</li><li>\u27a4 It is considered a teratogen, and alternative medications should be considered for pregnant women with epilepsy.</li><li>\u27a4 Ref: Page no 240, William\u2019s Obstetrics 25th edition</li><li>\u27a4 Ref: Page no 240, William\u2019s Obstetrics 25th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "29f9fb56",
      "audio": ""
    },
    {
      "text": "A 26-year-old pregnant woman presents for her first prenatal visit. She is a healthcare worker and asks about the potential teratogenic effects of her occupational exposure to radiation. What is the most critical period during pregnancy when exposure to ionizing radiation poses the highest risk of teratogenic effects?",
      "options": [
        {
          "label": "A",
          "text": "First trimester",
          "correct": true
        },
        {
          "label": "B",
          "text": "Third trimester",
          "correct": false
        },
        {
          "label": "C",
          "text": "Any trimester",
          "correct": false
        },
        {
          "label": "D",
          "text": "Only during labor and delivery",
          "correct": false
        }
      ],
      "correct_answer": "A. First trimester",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. First trimester</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Exposure to ionizing radiation during the first trimester of pregnancy poses the highest risk of teratogenic effects</li><li>\u27a4 Exposure to ionizing radiation during the first trimester of pregnancy poses the highest risk of teratogenic effects</li><li>\u27a4 Ref: Page no 906, William\u2019s Obstetrics 25th edition</li><li>\u27a4 Ref: Page no 906, William\u2019s Obstetrics 25th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0820ea91",
      "audio": ""
    },
    {
      "text": "A 30-year-old pregnant woman seeks advice about alcohol consumption during pregnancy. What is the most appropriate recommendation regarding alcohol use during pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Occasional moderate alcohol consumption is safe during pregnancy.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Heavy alcohol use is safe in the first trimester.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Alcohol consumption should be completely avoided during pregnancy.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Alcohol is safe to consume after the first trimester.",
          "correct": false
        }
      ],
      "correct_answer": "C. Alcohol consumption should be completely avoided during pregnancy.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Alcohol consumption should be completely avoided during pregnancy.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The most appropriate recommendation regarding alcohol use during pregnancy is that it should be completely avoided. Prenatal alcohol exposure can lead to a range of developmental and behavioral issues, collectively known as fetal alcohol spectrum disorders (FASD). These include defects of the cardiac, skeletal, renal system as well as eye and ear defects.</li><li>\u2022 The most appropriate recommendation regarding alcohol use during pregnancy is that it should be completely avoided.</li><li>\u2022 Prenatal alcohol exposure can lead to a range of developmental and behavioral issues, collectively known as fetal alcohol spectrum disorders (FASD). These include defects of the cardiac, skeletal, renal system as well as eye and ear defects.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Prenatal alcohol exposure can lead to a range of developmental and behavioral issues, collectively known as fetal alcohol spectrum disorders (FASD). These include defects of the cardiac, skeletal, renal system as well as eye and ear defects.</li><li>\u27a4 Prenatal alcohol exposure can lead to a range of developmental and behavioral issues, collectively known as fetal alcohol spectrum disorders (FASD). These include defects of the cardiac, skeletal, renal system as well as eye and ear defects.</li><li>\u27a4 Ref: Page no 239, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 239, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "37a244ed",
      "audio": ""
    },
    {
      "text": "A 35-year-old pregnant woman with a history of uncontrolled diabetes is concerned about the potential teratogenic effects of her condition on her developing fetus. What is the common teratogenic risk associated with maternal diabetes during pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Cardiac malformations",
          "correct": true
        },
        {
          "label": "B",
          "text": "Limb deformities",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cleft lip and palate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Eye abnormalities",
          "correct": false
        }
      ],
      "correct_answer": "A. Cardiac malformations",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Cardiac malformations</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Maternal diabetes during pregnancy is associated with an increased risk of cardiac malformations in the developing fetus. The most common anomaly seen in pregestational (overt) diabetes is cardiovascular anomalies (VSD). Poorly controlled maternal blood glucose levels can lead to structural heart defects, making it important to manage diabetes rigorously during pregnancy to reduce this risk.</li><li>\u2022 Maternal diabetes during pregnancy is associated with an increased risk of cardiac malformations in the developing fetus.</li><li>\u2022 The most common anomaly seen in pregestational (overt) diabetes is cardiovascular anomalies (VSD).</li><li>\u2022 Poorly controlled maternal blood glucose levels can lead to structural heart defects, making it important to manage diabetes rigorously during pregnancy to reduce this risk.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The most common anomaly seen in pregestational (overt) diabetes is cardiovascular anomalies (VSD).</li><li>\u27a4 The most common anomaly seen in pregestational (overt) diabetes is cardiovascular anomalies (VSD).</li><li>\u27a4 Ref: Page no 1100, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 1100, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4ff353da",
      "audio": ""
    },
    {
      "text": "A 22-year-old pregnant woman of 13 weeks gestation age informs about accidental exposure to radiation during chest X-ray at 7 weeks of gestation. What should be the next step advised to her?",
      "options": [
        {
          "label": "A",
          "text": "Continue pregnancy",
          "correct": true
        },
        {
          "label": "B",
          "text": "Terminate pregnancy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pre-invasive diagnostic test",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chromosome screening",
          "correct": false
        }
      ],
      "correct_answer": "A. Continue pregnancy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Continue pregnancy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Most diagnostic radiographic procedures are associated with minimal fetal risk and hence pregnancy can be continued in the case given</li><li>\u2022 Most diagnostic radiographic procedures are associated with minimal fetal risk and hence pregnancy can be continued in the case given</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option B: Termination of pregnancy is not required as the exposure of radiation in a chest X Ray is negligible and will not cause fetal harm Option C: Pre-invasive diagnostic test: This is not indicated unless a screening test is positive Option D: Chromosome screening: Is indicated as usual in all pregnant women and not specifically for women with a Chest X Ray exposure. Also, this is done routinely between 11-14 weeks (combined screening)</li><li>\u2022 Option B: Termination of pregnancy is not required as the exposure of radiation in a chest X Ray is negligible and will not cause fetal harm</li><li>\u2022 Option B:</li><li>\u2022 Termination of pregnancy</li><li>\u2022 Option C: Pre-invasive diagnostic test: This is not indicated unless a screening test is positive</li><li>\u2022 Option C:</li><li>\u2022 Pre-invasive diagnostic test:</li><li>\u2022 Option D: Chromosome screening: Is indicated as usual in all pregnant women and not specifically for women with a Chest X Ray exposure. Also, this is done routinely between 11-14 weeks (combined screening)</li><li>\u2022 Option D:</li><li>\u2022 Chromosome screening:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ionizing radiation: Max energy is in X rays and gamma rays Can cause structural change in DNA \u2013 risk of Abortion Malformations Fetal growth restriction Increased incidence of childhood cancers NOAEL (No observed adverse effect level): 0.05 Gy; Below this level: No Effects on Pregnancy (To reach this level, about 500 Chest X Rays are required. Chest Xray: < 0.0001 Gy / view IVP: increased exposure: 7 - 14 mGy Increased exposure with CT scans USG \u2013 safe MRI \u2013 safe (does not use ionizing radiation) Gadolinium (contrast) in MRI is contraindicated.</li><li>\u27a4 Ionizing radiation: Max energy is in X rays and gamma rays</li><li>\u27a4 Can cause structural change in DNA \u2013 risk of Abortion Malformations Fetal growth restriction Increased incidence of childhood cancers</li><li>\u27a4 Abortion Malformations Fetal growth restriction Increased incidence of childhood cancers</li><li>\u27a4 Abortion</li><li>\u27a4 Malformations</li><li>\u27a4 Fetal growth restriction</li><li>\u27a4 Increased incidence of childhood cancers</li><li>\u27a4 NOAEL (No observed adverse effect level): 0.05 Gy; Below this level: No Effects on Pregnancy (To reach this level, about 500 Chest X Rays are required.</li><li>\u27a4 Chest Xray: < 0.0001 Gy / view</li><li>\u27a4 IVP: increased exposure: 7 - 14 mGy</li><li>\u27a4 Increased exposure with CT scans</li><li>\u27a4 USG \u2013 safe</li><li>\u27a4 MRI \u2013 safe (does not use ionizing radiation)</li><li>\u27a4 Gadolinium (contrast) in MRI is contraindicated.</li><li>\u27a4 Ref: ACOG Committee Opinion on Guidelines for Diagnostic Imaging During Pregnancy and Lactation 2017</li><li>\u27a4 Ref: ACOG Committee Opinion on Guidelines for Diagnostic Imaging During Pregnancy and Lactation 2017</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1097f317",
      "audio": ""
    },
    {
      "text": "All are features of a true sac except:",
      "options": [
        {
          "label": "A",
          "text": "Intra-decidual sign is negative",
          "correct": true
        },
        {
          "label": "B",
          "text": "It is eccentric in position",
          "correct": false
        },
        {
          "label": "C",
          "text": "Peripheral vascularity is seen",
          "correct": false
        },
        {
          "label": "D",
          "text": "Yolk sac is seen at 5.5 weeks",
          "correct": false
        }
      ],
      "correct_answer": "A. Intra-decidual sign is negative",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/screenshot-2024-01-11-172027.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Intra-decidual sign is negative</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Intra-decidual sign is seen in a true sac</li><li>\u2022 Intra-decidual sign is seen in a true sac</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option B: A true sac is eccentric in position Option C: Peripheral vascularity is seen in a true gestational sac Option D: Yolk sac is seen at 5.5 weeks in a TVS</li><li>\u2022 Option B: A true sac is eccentric in position</li><li>\u2022 Option B:</li><li>\u2022 Option C: Peripheral vascularity is seen in a true gestational sac</li><li>\u2022 Option C:</li><li>\u2022 Option D: Yolk sac is seen at 5.5 weeks in a TVS</li><li>\u2022 Option D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page No 186, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page No 186, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dabe56c0",
      "audio": ""
    },
    {
      "text": "Double Decidual Sac sign is seen in:",
      "options": [
        {
          "label": "A",
          "text": "Early intra-uterine pregnancy",
          "correct": true
        },
        {
          "label": "B",
          "text": "Intra-uterine pseudo gestational sac",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tubal ectopic pregnancy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Molar pregnancy",
          "correct": false
        }
      ],
      "correct_answer": "A. Early intra-uterine pregnancy",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/08/untitled-329.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Early Intra \u2013 uterine pregnancy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Double decidual sac sign is seen in an intra-uterine pregnancy.</li><li>\u2022 Other Options</li><li>\u2022 Other Options</li><li>\u2022 Option B: An intra-uterine pseudo sac is seen usually in an ectopic pregnancy, It is fluid collection in the uterus Option C: Tubal ectopic pregnancy: in this a double decidual sac sign wont be seen. USG signs of a tubal pregnancy include bagel sign, blob sign and ring of fire sign Option D: In Molar pregnancy , the characteristic sign seen is the snowstorm appearance</li><li>\u2022 Option B: An intra-uterine pseudo sac is seen usually in an ectopic pregnancy, It is fluid collection in the uterus</li><li>\u2022 Option B:</li><li>\u2022 intra-uterine pseudo sac</li><li>\u2022 Option C: Tubal ectopic pregnancy: in this a double decidual sac sign wont be seen. USG signs of a tubal pregnancy include bagel sign, blob sign and ring of fire sign</li><li>\u2022 Option C:</li><li>\u2022 Tubal ectopic pregnancy:</li><li>\u2022 Option D: In Molar pregnancy , the characteristic sign seen is the snowstorm appearance</li><li>\u2022 Option D:</li><li>\u2022 Molar pregnancy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Double Decidual sac sign:</li><li>\u27a4 Double Decidual sac sign:</li><li>\u27a4 Is a useful feature on early pregnancy ultrasound to confirm an early intrauterine pregnancy (IUP) Especially useful when the yolk sac or embryo is still not visualized. It consists of the decidua parietalis (lining the uterine cavity) and decidua capsularis (lining the gestational sac) It is seen as two concentric rings surrounding an anechoic gestational sac. Where the two adhere is the decidua basalis, and is the site of future placental formation.</li><li>\u27a4 Is a useful feature on early pregnancy ultrasound to confirm an early intrauterine pregnancy (IUP)</li><li>\u27a4 Especially useful when the yolk sac or embryo is still not visualized.</li><li>\u27a4 It consists of the decidua parietalis (lining the uterine cavity) and decidua capsularis (lining the gestational sac)</li><li>\u27a4 It is seen as two concentric rings surrounding an anechoic gestational sac.</li><li>\u27a4 Where the two adhere is the decidua basalis, and is the site of future placental formation.</li><li>\u27a4 Another sign of an intra-uterine pregnancy is the intra-decidual sign.</li><li>\u27a4 Ref: Page no 159, William\u2019s Obstetrics</li><li>\u27a4 Ref: Page no 159, William\u2019s Obstetrics</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3e5c5027",
      "audio": ""
    },
    {
      "text": "Which of the following abnormalities can be diagnosed in the 1 st trimester of pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Anencephaly",
          "correct": true
        },
        {
          "label": "B",
          "text": "Encephalocele",
          "correct": false
        },
        {
          "label": "C",
          "text": "Meningocele",
          "correct": false
        },
        {
          "label": "D",
          "text": "Microcephaly",
          "correct": false
        }
      ],
      "correct_answer": "A. Anencephaly",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Anencephaly</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Most anomalies are detected in the 2 nd trimester. The anomalies that can be detected in the 1 st trimester (11-14 weeks scan) are: Acrania/ Anencephaly Encephalocele Alobar holoprosencephaly Iniencephaly Exomphalos Gastroschisis Body-Stalk anomaly Megacystis Missing Limbs</li><li>\u27a4 Most anomalies are detected in the 2 nd trimester.</li><li>\u27a4 The anomalies that can be detected in the 1 st trimester (11-14 weeks scan) are: Acrania/ Anencephaly Encephalocele Alobar holoprosencephaly Iniencephaly Exomphalos Gastroschisis Body-Stalk anomaly Megacystis Missing Limbs</li><li>\u27a4 Acrania/ Anencephaly Encephalocele Alobar holoprosencephaly Iniencephaly Exomphalos Gastroschisis Body-Stalk anomaly Megacystis Missing Limbs</li><li>\u27a4 Acrania/ Anencephaly</li><li>\u27a4 Encephalocele</li><li>\u27a4 Alobar holoprosencephaly</li><li>\u27a4 Iniencephaly</li><li>\u27a4 Exomphalos</li><li>\u27a4 Gastroschisis</li><li>\u27a4 Body-Stalk anomaly</li><li>\u27a4 Megacystis</li><li>\u27a4 Missing Limbs</li><li>\u27a4 Ref: Page No 186, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page No 186, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cff70348",
      "audio": ""
    },
    {
      "text": "The first structure to appear in an intrauterine gestational sac on ultrasound is?",
      "options": [
        {
          "label": "A",
          "text": "Cardiac activity",
          "correct": false
        },
        {
          "label": "B",
          "text": "Double decidual sac sign",
          "correct": false
        },
        {
          "label": "C",
          "text": "Embryo",
          "correct": false
        },
        {
          "label": "D",
          "text": "Yolk sac",
          "correct": true
        }
      ],
      "correct_answer": "D. Yolk sac",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Yolk sac</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 The yolk sac is the first anatomical structure to appear in an intra-uterine gestational sac. It appears on a TVS at 5.5 weeks.</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A: Cardiac activity in the fetal pole is seen at 6 weeks in TVS or at 7 weeks on a transabdominal scan (TAS)</li><li>\u2022 Option A: Cardiac activity</li><li>\u2022 Option B: This is a sign seen in early pregnancy on ultrasound at about 6 weeks</li><li>\u2022 Option B:</li><li>\u2022 Option C: Embryo: Or fetal pole: This is seen on the TVS at 6 weeks (7 weeks on TAS)</li><li>\u2022 Option C: Embryo:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 About the Yolk sac:</li><li>\u27a4 1 st anatomical structure identified within the g sac (5 weeks) Undetectable after 10 weeks Large yolk sac: (\u2265 6mm) is associated with poor obstetrical outcome</li><li>\u27a4 1 st anatomical structure identified within the g sac (5 weeks)</li><li>\u27a4 Undetectable after 10 weeks Large yolk sac: (\u2265 6mm) is associated with poor obstetrical outcome</li><li>\u27a4 Large yolk sac: (\u2265 6mm) is associated with poor obstetrical outcome</li><li>\u27a4 Large yolk sac: (\u2265 6mm) is associated with poor obstetrical outcome</li><li>\u27a4 Other important points:</li><li>\u27a4 On a Transvaginal Sonogram (TVS): The gestational sac appears at 5 weeks Yolk sac at 5.5 weeks Embryo with cardiac activity at 6 weeks On Transabdominal sonography these appear 1 week later</li><li>\u27a4 On a Transvaginal Sonogram (TVS): The gestational sac appears at 5 weeks Yolk sac at 5.5 weeks Embryo with cardiac activity at 6 weeks</li><li>\u27a4 The gestational sac appears at 5 weeks Yolk sac at 5.5 weeks Embryo with cardiac activity at 6 weeks</li><li>\u27a4 The gestational sac appears at 5 weeks</li><li>\u27a4 Yolk sac at 5.5 weeks</li><li>\u27a4 Embryo with cardiac activity at 6 weeks</li><li>\u27a4 On Transabdominal sonography these appear 1 week later</li><li>\u27a4 Ref: Page no 186, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 186, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "41da3887",
      "audio": ""
    },
    {
      "text": "Identify the condition as shown in the image below:",
      "options": [
        {
          "label": "A",
          "text": "Anterior Placenta Previa (Partial)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Posterior Placenta Previa (Partial)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Ant Placenta Previa (Marginal)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Posterior placenta previa (Marginal)",
          "correct": false
        }
      ],
      "correct_answer": "B. Posterior Placenta Previa (Partial)",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/08/untitled-330_zDnYB0n.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/08/aph-2.jpg"
      ],
      "explanation": "<p><strong>Ans. B. Posterior Placenta Previa \u2013 Partial</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 This is an Obstetric ultrasound showing the lower uterine segment with the bladder anteriorly. The cervix is seen and the placenta is seen posteriorly (as it is opposite to the bladder). It is seen to partially cover the os. So, this is Post placenta previa (partial).</li><li>\u2022 This is an Obstetric ultrasound showing the lower uterine segment with the bladder anteriorly. The cervix is seen and the placenta is seen posteriorly (as it is opposite to the bladder). It is seen to partially cover the os. So, this is Post placenta previa (partial).</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Placenta previa is classified as follows:</li><li>\u27a4 Placenta previa is classified as follows:</li><li>\u27a4 Type 1 ---Mild degree ----- Type 2     Type 3--- Major degree ----- Type 4</li><li>\u27a4 Type 1: Low lying:  implantation in lower uterine segment but not touching the os.</li><li>\u27a4 Type 2: Marginal: placenta is at the edge of the os but not covering it</li><li>\u27a4 Type 3: Partial Placenta Previa: Placenta partially covering the internal os.</li><li>\u27a4 Type 4: Complete Placenta Previa: Placenta completely covering the internal os.</li><li>\u27a4 Placenta previa can also be classified on USG as (Newer system) True placenta previa : the placenta covers the internal os either partially or completely Low lying placenta:  placenta is implanted in the lower uterine segment such that the edge does not reach the os  but remains  outside a 2 cm wide  perimeter around the os.</li><li>\u27a4 Placenta previa can also be classified on USG as (Newer system) True placenta previa : the placenta covers the internal os either partially or completely Low lying placenta:  placenta is implanted in the lower uterine segment such that the edge does not reach the os  but remains  outside a 2 cm wide  perimeter around the os.</li><li>\u27a4 True placenta previa : the placenta covers the internal os either partially or completely Low lying placenta:  placenta is implanted in the lower uterine segment such that the edge does not reach the os  but remains  outside a 2 cm wide  perimeter around the os.</li><li>\u27a4 True placenta previa : the placenta covers the internal os either partially or completely</li><li>\u27a4 Low lying placenta:  placenta is implanted in the lower uterine segment such that the edge does not reach the os  but remains  outside a 2 cm wide  perimeter around the os.</li><li>\u27a4 Ref: Page 774, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 774, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4e0dc875",
      "audio": ""
    },
    {
      "text": "Identify this anomaly:",
      "options": [
        {
          "label": "A",
          "text": "Anencephaly",
          "correct": true
        },
        {
          "label": "B",
          "text": "Cleft lip",
          "correct": false
        },
        {
          "label": "C",
          "text": "Encephalocele",
          "correct": false
        },
        {
          "label": "D",
          "text": "Facial deformity",
          "correct": false
        }
      ],
      "correct_answer": "A. Anencephaly",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/08/untitled-331.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/20.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Anencephaly</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 The anomaly seen is an anencephaly About Anencephaly: Anencephaly is the most severe form of NTD Characterized by an absence of cortical tissue & absence of the cranial vault Detected by USG as early as 11 weeks. Frog face appearance on ultrasound Associated with polyhydramnios If undiagnosed, patient may present with face or breech presentation at term</li><li>\u2022 The anomaly seen is an anencephaly</li><li>\u2022 The anomaly seen is an anencephaly</li><li>\u2022 About Anencephaly: Anencephaly is the most severe form of NTD Characterized by an absence of cortical tissue & absence of the cranial vault Detected by USG as early as 11 weeks. Frog face appearance on ultrasound Associated with polyhydramnios If undiagnosed, patient may present with face or breech presentation at term</li><li>\u2022 Anencephaly is the most severe form of NTD Characterized by an absence of cortical tissue & absence of the cranial vault Detected by USG as early as 11 weeks. Frog face appearance on ultrasound Associated with polyhydramnios If undiagnosed, patient may present with face or breech presentation at term</li><li>\u2022 Anencephaly is the most severe form of NTD</li><li>\u2022 Anencephaly</li><li>\u2022 Characterized by an absence of cortical tissue & absence of the cranial vault</li><li>\u2022 Detected by USG as early as 11 weeks.</li><li>\u2022 Frog face appearance on ultrasound</li><li>\u2022 Associated with polyhydramnios</li><li>\u2022 If undiagnosed, patient may present with face or breech presentation at term</li><li>\u2022 Other options:</li><li>\u2022 Other options:</li><li>\u2022 Option B: Cleft lip: It is an opening in the upper lip due to failure of fusion of tissues forming it. It can occur alone or as a part of a genetic syndrome and may also have an accompanying cleft palate. Ultrasound can be best diagnosed on a 3D scan. Option C: Encephalocele: It is a sac like protrusion of the brain and the membranes covering it through a opening in the skull. Option D: Facial deformities are best seen on a 3D scan</li><li>\u2022 Option B: Cleft lip: It is an opening in the upper lip due to failure of fusion of tissues forming it. It can occur alone or as a part of a genetic syndrome and may also have an accompanying cleft palate. Ultrasound can be best diagnosed on a 3D scan.</li><li>\u2022 Option B: Cleft lip:</li><li>\u2022 Option C: Encephalocele: It is a sac like protrusion of the brain and the membranes covering it through a opening in the skull.</li><li>\u2022 Option C: Encephalocele:</li><li>\u2022 Option D: Facial deformities are best seen on a 3D scan</li><li>\u2022 Option D: Facial deformities</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The anomaly seen is an anencephaly About Anencephaly: Anencephaly is the most severe form of NTD Characterized by an absence of cortical tissue & absence of the cranial vault Detected by USG as early as 11 weeks. Frog face appearance on ultrasound Associated with polyhydramnios If undiagnosed, patient may present with face or breech presentation at term</li><li>\u27a4 The anomaly seen is an anencephaly</li><li>\u27a4 The anomaly seen is an anencephaly</li><li>\u27a4 About Anencephaly: Anencephaly is the most severe form of NTD Characterized by an absence of cortical tissue & absence of the cranial vault Detected by USG as early as 11 weeks. Frog face appearance on ultrasound Associated with polyhydramnios If undiagnosed, patient may present with face or breech presentation at term</li><li>\u27a4 Anencephaly is the most severe form of NTD Characterized by an absence of cortical tissue & absence of the cranial vault Detected by USG as early as 11 weeks. Frog face appearance on ultrasound Associated with polyhydramnios If undiagnosed, patient may present with face or breech presentation at term</li><li>\u27a4 Anencephaly is the most severe form of NTD</li><li>\u27a4 Anencephaly</li><li>\u27a4 Characterized by an absence of cortical tissue & absence of the cranial vault</li><li>\u27a4 Detected by USG as early as 11 weeks.</li><li>\u27a4 Frog face appearance on ultrasound</li><li>\u27a4 Associated with polyhydramnios</li><li>\u27a4 If undiagnosed, patient may present with face or breech presentation at term</li><li>\u27a4 Ref: Page no 186, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 186, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4203c588",
      "audio": ""
    },
    {
      "text": "A 34-year primi presents at 8 weeks pregnancy, The ultrasound shows an anembryonic pregnancy. An anembryonic pregnancy is when, on ultrasound, the embryo is not seen at a Mean Sac Diameter (MSD) of:",
      "options": [
        {
          "label": "A",
          "text": "\u2265 20 mm",
          "correct": false
        },
        {
          "label": "B",
          "text": "\u2265 25 mm",
          "correct": true
        },
        {
          "label": "C",
          "text": "\u2265 30 mm",
          "correct": false
        },
        {
          "label": "D",
          "text": "\u2265 35 mm",
          "correct": false
        }
      ],
      "correct_answer": "B. \u2265 25 mm",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. \u2265 25mm</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Absence of an embryo at a MSD \u2265 25 mm \u2013 anembryonic pregnancy Absence of Cardiac activity at a CRL \u2265 7 mm \u2013 non-viable pregnancy</li><li>\u2022 Absence of an embryo at a MSD \u2265 25 mm \u2013 anembryonic pregnancy</li><li>\u2022 Absence of Cardiac activity at a CRL \u2265 7 mm \u2013 non-viable pregnancy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Absence of an embryo at a MSD \u2265 25 mm \u2013 anembryonic pregnancy Absence of Cardiac activity at a CRL \u2265 7 mm \u2013 non-viable pregnancy</li><li>\u27a4 Absence of an embryo at a MSD \u2265 25 mm \u2013 anembryonic pregnancy</li><li>\u27a4 Absence of Cardiac activity at a CRL \u2265 7 mm \u2013 non-viable pregnancy</li><li>\u27a4 Ref: Page no 186, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 186, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "68a7b734",
      "audio": ""
    },
    {
      "text": "On ultrasound, a non-viable pregnancy refers to one in which the cardiac activity has not appeared even when the embryo is:",
      "options": [
        {
          "label": "A",
          "text": "\u2265 5 mm",
          "correct": false
        },
        {
          "label": "B",
          "text": "\u2265 6 mm",
          "correct": false
        },
        {
          "label": "C",
          "text": "\u2265 7 mm",
          "correct": true
        },
        {
          "label": "D",
          "text": "\u2265 8 mm",
          "correct": false
        }
      ],
      "correct_answer": "C. \u2265 7 mm",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. \u2265 7 mm</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Absence of an embryo at a MSD \u2265 25 mm \u2013 anembryonic pregnancy Absence of Cardiac activity at a CRL \u2265 7 mm \u2013 non-viable pregnancy</li><li>\u2022 Absence of an embryo at a MSD \u2265 25 mm \u2013 anembryonic pregnancy</li><li>\u2022 Absence of Cardiac activity at a CRL \u2265 7 mm \u2013 non-viable pregnancy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Absence of an embryo at a MSD \u2265 25 mm \u2013 anembryonic pregnancy Absence of Cardiac activity at a CRL \u2265 7 mm \u2013 non-viable pregnancy</li><li>\u27a4 Absence of an embryo at a MSD \u2265 25 mm \u2013 anembryonic pregnancy</li><li>\u27a4 Absence of Cardiac activity at a CRL \u2265 7 mm \u2013 non-viable pregnancy</li><li>\u27a4 Ref: Page no 186, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 186, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "043cd308",
      "audio": ""
    },
    {
      "text": "The best measurement for estimating gestational age on ultrasound is:",
      "options": [
        {
          "label": "A",
          "text": "Biparietal diameter",
          "correct": false
        },
        {
          "label": "B",
          "text": "Crown \u2013 Rump length",
          "correct": true
        },
        {
          "label": "C",
          "text": "Head circumference",
          "correct": false
        },
        {
          "label": "D",
          "text": "Femur length",
          "correct": false
        }
      ],
      "correct_answer": "B. Crown \u2013 Rump length",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Crown-Rump Length</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 CRL: This is the Crown-Rump Length and is the most accurate method to establish and confirm the gestational age</li><li>\u2022 CRL: This is the Crown-Rump Length and is the most accurate method to establish and confirm the gestational age</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A: Biparietal diameter (BPD): The BPD is a measurement of the fetus done after 14 weeks. It is the most accurate estimation of gestational age after 14 weeks. Option C: Head circumference: The HC is a measurement done after 14 weeks Option D : Femur length is also a fetal biometric measurement done after 14 weeks.</li><li>\u2022 Option A: Biparietal diameter (BPD): The BPD is a measurement of the fetus done after 14 weeks. It is the most accurate estimation of gestational age after 14 weeks.</li><li>\u2022 Option A:</li><li>\u2022 Biparietal diameter (BPD):</li><li>\u2022 Option C: Head circumference: The HC is a measurement done after 14 weeks</li><li>\u2022 Option C:</li><li>\u2022 Head circumference:</li><li>\u2022 Option D : Femur length is also a fetal biometric measurement done after 14 weeks.</li><li>\u2022 Option D</li><li>\u2022 Femur length</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 About Crown Rump Length (CRL)</li><li>\u27a4 Most accurate method to establish/ confirm gestational age It is measured in the mid \u2013 sagittal plane Embryo in neutral position Till 13 weeks: accuracy of 5 \u2013 7 days In the 2 nd trimester the best parameter to estimate gestational age in:  BPD If dolichocephaly/ brachycephaly; HC better Abdominal Circumference (AC): greatest variation</li><li>\u27a4 Most accurate method to establish/ confirm gestational age</li><li>\u27a4 It is measured in the mid \u2013 sagittal plane</li><li>\u27a4 Embryo in neutral position</li><li>\u27a4 Till 13 weeks: accuracy of 5 \u2013 7 days</li><li>\u27a4 In the 2 nd trimester the best parameter to estimate gestational age in:  BPD</li><li>\u27a4 If dolichocephaly/ brachycephaly; HC better</li><li>\u27a4 Abdominal Circumference (AC): greatest variation</li><li>\u27a4 Ref: Page no 159, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 159, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5c910805",
      "audio": ""
    },
    {
      "text": "What measurement is being shown in this image on ultrasound?",
      "options": [
        {
          "label": "A",
          "text": "CRL",
          "correct": true
        },
        {
          "label": "B",
          "text": "AC",
          "correct": false
        },
        {
          "label": "C",
          "text": "BPD",
          "correct": false
        },
        {
          "label": "D",
          "text": "FL",
          "correct": false
        }
      ],
      "correct_answer": "A. CRL",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/08/untitled-325.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. CRL</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 CRL:</li><li>\u27a4 CRL:</li><li>\u27a4 Most accurate method to establish/ confirm gestational age It is measured in the mid \u2013 sagittal plane Embryo in neutral position Till 13 weeks: accuracy of 5 \u2013 7 days</li><li>\u27a4 Most accurate method to establish/ confirm gestational age</li><li>\u27a4 It is measured in the mid \u2013 sagittal plane</li><li>\u27a4 Embryo in neutral position</li><li>\u27a4 Till 13 weeks: accuracy of 5 \u2013 7 days</li><li>\u27a4 Ref: Page no 159, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 159, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "74d536c1",
      "audio": ""
    },
    {
      "text": "All the following are ultrasound features of a Down Syndrome fetus seen at 11-14 weeks scan except:",
      "options": [
        {
          "label": "A",
          "text": "Abnormal flow in the ductus venosus",
          "correct": false
        },
        {
          "label": "B",
          "text": "Absent nasal bone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased nuchal translucency",
          "correct": false
        },
        {
          "label": "D",
          "text": "Limb hypoplasia",
          "correct": true
        }
      ],
      "correct_answer": "D. Limb hypoplasia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Limb hypoplasia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The features seen on an 11-14 weeks ultrasound of a Down syndrome fetus are:</li><li>\u2022 Increased NT Absent nasal bone Abnormal flow in the ductus venosus Tricuspid regurgitation Limb hypoplasia is not a feature of Down syndrome on 11-14 weeks ultrasound</li><li>\u2022 Increased NT</li><li>\u2022 Absent nasal bone</li><li>\u2022 Abnormal flow in the ductus venosus</li><li>\u2022 Tricuspid regurgitation Limb hypoplasia is not a feature of Down syndrome on 11-14 weeks ultrasound</li><li>\u2022 Limb hypoplasia is not a feature of Down syndrome on 11-14 weeks ultrasound</li><li>\u2022 Limb hypoplasia is not a feature of Down syndrome on 11-14 weeks ultrasound</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The features seen on an 11-14 weeks ultrasound of a Down syndrome fetus are:</li><li>\u27a4 Increased NT Absent nasal bone Abnormal flow in the ductus venosus Tricuspid regurgitation</li><li>\u27a4 Increased NT</li><li>\u27a4 Absent nasal bone</li><li>\u27a4 Abnormal flow in the ductus venosus</li><li>\u27a4 Tricuspid regurgitation</li><li>\u27a4 Ref: Page no 282; William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 282; William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "999caae4",
      "audio": ""
    },
    {
      "text": "Congenital Diaphragmatic Hernia can be diagnosed on fetal ultrasound at the following gestational age?",
      "options": [
        {
          "label": "A",
          "text": "9 Weeks",
          "correct": false
        },
        {
          "label": "B",
          "text": "15 Weeks",
          "correct": true
        },
        {
          "label": "C",
          "text": "24 Weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "30 Weeks",
          "correct": false
        }
      ],
      "correct_answer": "B. 15 Weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. 15 weeks</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Congenital diaphragmatic hernia can be diagnosed as early 15 weeks</li><li>\u2022 Congenital diaphragmatic hernia can be diagnosed as early 15 weeks</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Congenital Diaphragmatic hernia:</li><li>\u27a4 Congenital Diaphragmatic hernia:</li><li>\u27a4 Defect in the diaphragm through which abdominal organs herniate into the thorax. Left sided: 75% cases Can be detected as early as 14-15 weeks but some may be undetected till the 3 rd trimester Always look for associated cardiovascular anomalies Amenable to fetal therapy: FETO (Fetal endoscopic tracheal occlusion)</li><li>\u27a4 Defect in the diaphragm through which abdominal organs herniate into the thorax.</li><li>\u27a4 Left sided: 75% cases</li><li>\u27a4 Can be detected as early as 14-15 weeks but some may be undetected till the 3 rd trimester</li><li>\u27a4 Always look for associated cardiovascular anomalies</li><li>\u27a4 Amenable to fetal therapy: FETO (Fetal endoscopic tracheal occlusion)</li><li>\u27a4 Ref: Page no 198, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 198, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b2e7c048",
      "audio": ""
    },
    {
      "text": "This is an image of an ultrasound in twin pregnancy. What is the chorionicity?",
      "options": [
        {
          "label": "A",
          "text": "Dichorionic Diamniotic",
          "correct": true
        },
        {
          "label": "B",
          "text": "Dichorionic Monoamniotic",
          "correct": false
        },
        {
          "label": "C",
          "text": "Monochorionic Diamniotic",
          "correct": false
        },
        {
          "label": "D",
          "text": "Monochorionic Monoamniotic",
          "correct": false
        }
      ],
      "correct_answer": "A. Dichorionic Diamniotic",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/08/untitled-332.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/08/untitled-326.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Dichorionic Diamniotic</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 In this image we can see the lambda or the twin peak sign which is seen in Dichorionic Diamniotic Twins</li><li>\u2022 In this image we can see the lambda or the twin peak sign which is seen in Dichorionic Diamniotic Twins</li><li>\u2022 Other Options</li><li>\u2022 Other Options</li><li>\u2022 Option B: Dichorionic Monoamniotic: There is no such type of twin Option C: Monochorionic Diamniotic: This is a type of monzygotic twinning wherein on ultrasound, an inverted \"T\" sign will be seen Option D: Monochorionic Monoamniotic: This is a type of monozygotic twinning in whch there is a single chorion and amnion and there will not be any inter-twin membrane visible on the ultrasound</li><li>\u2022 Option B: Dichorionic Monoamniotic: There is no such type of twin</li><li>\u2022 Option B:</li><li>\u2022 Dichorionic Monoamniotic:</li><li>\u2022 Option C: Monochorionic Diamniotic: This is a type of monzygotic twinning wherein on ultrasound, an inverted \"T\" sign will be seen</li><li>\u2022 Option C: Monochorionic Diamniotic:</li><li>\u2022 Option D: Monochorionic Monoamniotic: This is a type of monozygotic twinning in whch there is a single chorion and amnion and there will not be any inter-twin membrane visible on the ultrasound</li><li>\u2022 Option D: Monochorionic Monoamniotic:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Determination of chorionicity in twin pregnancy:</li><li>\u27a4 Determined best by ultrasound in the 1 st trimester (8- 10 weeks) Twin peak sign (Lambda sign) \u2013 Dichorionic Diamniotic Twins Inverted T sign \u2013 Monochorionic Diamniotic No intervening membrane in Monochorionic Monoamniotic Twins</li><li>\u27a4 Determined best by ultrasound in the 1 st trimester (8- 10 weeks)</li><li>\u27a4 Twin peak sign (Lambda sign) \u2013 Dichorionic Diamniotic Twins</li><li>\u27a4 Inverted T sign \u2013 Monochorionic Diamniotic</li><li>\u27a4 No intervening membrane in Monochorionic Monoamniotic Twins</li><li>\u27a4 Ref: Page 870, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 870, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "83aaef93",
      "audio": ""
    },
    {
      "text": "What is being measured in this obstetric ultrasound image?",
      "options": [
        {
          "label": "A",
          "text": "Amniotic fluid",
          "correct": true
        },
        {
          "label": "B",
          "text": "Cervical length",
          "correct": false
        },
        {
          "label": "C",
          "text": "Size of placenta",
          "correct": false
        },
        {
          "label": "D",
          "text": "Femur length",
          "correct": false
        }
      ],
      "correct_answer": "A. Amniotic fluid",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/08/untitled-327.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/picture21.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/picture22.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/picture23.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Amniotic Fluid</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Amniotic fluid appears hypoechoic on ultrasound and is as measured in the image.</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option B: Cervical length</li><li>\u2022 Option B: Cervical length</li><li>\u2022 Option B: Cervical length</li><li>\u2022 Option C: Size of placenta:</li><li>\u2022 Option C: Size of placenta:</li><li>\u2022 Option C: Size of placenta:</li><li>\u2022 Option D:</li><li>\u2022 Option D:</li><li>\u2022 Option D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Amniotic fluid is measured on ultrasound by 2 methods</li><li>\u27a4 Deepest vertical pocket (2 \u2013 8 cm) Amniotic Fluid Index (8 \u2013 24 cm) \u2013 the liquor in 4 quadrants are measured and added up.</li><li>\u27a4 Deepest vertical pocket (2 \u2013 8 cm)</li><li>\u27a4 Amniotic Fluid Index (8 \u2013 24 cm) \u2013 the liquor in 4 quadrants are measured and added up.</li><li>\u27a4 Ref: Page 188, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 188, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e2c745bf",
      "audio": ""
    },
    {
      "text": "All are indications for a fetal ECHO except:",
      "options": [
        {
          "label": "A",
          "text": "Gestational Diabetes mellitus",
          "correct": true
        },
        {
          "label": "B",
          "text": "Maternal phenylketonuria",
          "correct": false
        },
        {
          "label": "C",
          "text": "Patient on Lithium therapy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Previous baby with VSD",
          "correct": false
        }
      ],
      "correct_answer": "A. Gestational Diabetes mellitus",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Gestational Diabetes mellitus</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 In gestational diabetes mellitus, there is no additional risk of congenital anomalies, so an ECHO is not required. Only in overt diabetes, there is an increased risk of congenital anomalies, especially cardiovascular anomalies.</li><li>\u2022 In gestational diabetes mellitus, there is no additional risk of congenital anomalies, so an ECHO is not required. Only in overt diabetes, there is an increased risk of congenital anomalies, especially cardiovascular anomalies.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The following are indications for doing a fetal ECHO</li><li>\u27a4 Suspected fetal cardiac anomaly Extracardiac anomaly in the fetus Fetal chromosomal anomaly Fetal arrythmia Fetal Hydrops Thick NT Previous baby with Congenital heart disease (CHD) Either parent with CHD Conception through IVF Maternal anti Ro/ anti La (Congenital heart blocks ) Exposure to Lithium (Ebsteins anomaly) / Anti-epileptic drugs/other teratogenic drugs Pregestational DM/ Overt diabetes Phenylketonuria (associated with co-arctation of aorta, hypoplastic left heart)</li><li>\u27a4 Suspected fetal cardiac anomaly</li><li>\u27a4 Extracardiac anomaly in the fetus</li><li>\u27a4 Fetal chromosomal anomaly</li><li>\u27a4 Fetal arrythmia</li><li>\u27a4 Fetal Hydrops</li><li>\u27a4 Thick NT</li><li>\u27a4 Previous baby with Congenital heart disease (CHD)</li><li>\u27a4 Either parent with CHD</li><li>\u27a4 Conception through IVF</li><li>\u27a4 Maternal anti Ro/ anti La (Congenital heart blocks )</li><li>\u27a4 Exposure to Lithium (Ebsteins anomaly) / Anti-epileptic drugs/other teratogenic drugs</li><li>\u27a4 Pregestational DM/ Overt diabetes</li><li>\u27a4 Pregestational DM/ Overt diabetes</li><li>\u27a4 Phenylketonuria (associated with co-arctation of aorta, hypoplastic left heart)</li><li>\u27a4 Ref: Page no 201, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 201, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "96c5e2d2",
      "audio": ""
    },
    {
      "text": "Magnetic Resonance Imaging is used in obstetrics in all these situations except?",
      "options": [
        {
          "label": "A",
          "text": "Suspected Adherent placenta",
          "correct": false
        },
        {
          "label": "B",
          "text": "Maternal pelvic mass",
          "correct": false
        },
        {
          "label": "C",
          "text": "Contracted pelvis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Fetal anatomic survey",
          "correct": false
        }
      ],
      "correct_answer": "C. Contracted pelvis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Contracted pelvis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 MRI is not useful in diagnosing contracted pelvis. Contracted pelvis is best diagnosed by clinical pelvimetry. Actually, the best test of a pelvis is the fetal head itself.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 MRI in pregnancy:</li><li>\u27a4 MRI is safe in pregnancy Due to cost and as it is not portable and time consuming, its role is limited Benefit in Adjunct to USG in fetal anatomic survey Placental invasion Maternal pelvic masses</li><li>\u27a4 MRI is safe in pregnancy</li><li>\u27a4 Due to cost and as it is not portable and time consuming, its role is limited</li><li>\u27a4 Benefit in Adjunct to USG in fetal anatomic survey Placental invasion Maternal pelvic masses</li><li>\u27a4 Adjunct to USG in fetal anatomic survey Placental invasion Maternal pelvic masses</li><li>\u27a4 Adjunct to USG in fetal anatomic survey</li><li>\u27a4 Placental invasion</li><li>\u27a4 Maternal pelvic masses</li><li>\u27a4 Ref: Page no 215, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 215, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5989e006",
      "audio": ""
    },
    {
      "text": "A 28-year-old pregnant woman with a history of type 1 diabetes is concerned about fetal well-being. Which fetal imaging modality is commonly used to assess placental and fetal blood flow, as well as fetal oxygenation during pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "2D ultrasound",
          "correct": false
        },
        {
          "label": "B",
          "text": "Magnetic resonance imaging (MRI)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Doppler ultrasound",
          "correct": true
        },
        {
          "label": "D",
          "text": "3D ultrasound",
          "correct": false
        }
      ],
      "correct_answer": "C. Doppler ultrasound",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Doppler ultrasound</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Doppler ultrasound is commonly used to assess placental and fetal blood flow, as well as fetal oxygenation during pregnancy. This imaging modality can help monitor fetal well-being, especially in high-risk pregnancies.</li><li>\u2022 Doppler ultrasound is commonly used to assess placental and fetal blood flow, as well as fetal oxygenation during pregnancy.</li><li>\u2022 This imaging modality can help monitor fetal well-being, especially in high-risk pregnancies.</li><li>\u2022 Other Options</li><li>\u2022 Other Options</li><li>\u2022 Option A: 2D ultrasound is routinely used for all ANC patients. This tells us No of fetuses Placental position Growth parameters: BPD, HC, AC and FL Amniotic fluid volume Fetal anomalies Adnexal lesions Option B: MRI is useful for specific indications such as Adjunct to USG in fetal anatomic survey, placental invasion or maternal pelvic masses. Option D: 3D USG is useful in detecting surface anomalies in the fetus like cleft lip. It is alwso very helpful in diagnosing Mullerian anomalies</li><li>\u2022 Option A: 2D ultrasound is routinely used for all ANC patients. This tells us No of fetuses Placental position Growth parameters: BPD, HC, AC and FL Amniotic fluid volume Fetal anomalies Adnexal lesions</li><li>\u2022 Option A:</li><li>\u2022 No of fetuses Placental position Growth parameters: BPD, HC, AC and FL Amniotic fluid volume Fetal anomalies Adnexal lesions</li><li>\u2022 No of fetuses</li><li>\u2022 Placental position</li><li>\u2022 Growth parameters: BPD, HC, AC and FL</li><li>\u2022 Amniotic fluid volume</li><li>\u2022 Fetal anomalies</li><li>\u2022 Adnexal lesions</li><li>\u2022 Option B: MRI is useful for specific indications such as Adjunct to USG in fetal anatomic survey, placental invasion or maternal pelvic masses.</li><li>\u2022 Option B:</li><li>\u2022 Option D: 3D USG is useful in detecting surface anomalies in the fetus like cleft lip. It is alwso very helpful in diagnosing Mullerian anomalies</li><li>\u2022 Option D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Seeing the flow in uterine arteries (Screening for preeclampsia) Flow in the umbilical artery in IUGR, utero-placental insufficiency and antepartum fetal monitoring in high risk pregnancies Flow in the middle cerebral artery (IUGR, Rh isoimmunized fetuses) Screening of Down syndrome at 11-14 weeks (Tricuspid regurgitation, Abnormal ductus venosus)</li><li>\u27a4 Seeing the flow in uterine arteries (Screening for preeclampsia)</li><li>\u27a4 Flow in the umbilical artery in IUGR, utero-placental insufficiency and antepartum fetal monitoring in high risk pregnancies</li><li>\u27a4 Flow in the middle cerebral artery (IUGR, Rh isoimmunized fetuses)</li><li>\u27a4 Screening of Down syndrome at 11-14 weeks (Tricuspid regurgitation, Abnormal ductus venosus)</li></ul>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference:  William\u2019s textbook of Obstetrics 25 th edition page 213-214</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6143d7a7",
      "audio": ""
    },
    {
      "text": "A 35-year-old pregnant woman presents for a fetal ultrasound at 7 weeks of gestation. What is the most appropriate type of ultrasound for dating the pregnancy accurately?",
      "options": [
        {
          "label": "A",
          "text": "Transabdominal ultrasound",
          "correct": false
        },
        {
          "label": "B",
          "text": "3D ultrasound",
          "correct": false
        },
        {
          "label": "C",
          "text": "Transvaginal ultrasound",
          "correct": true
        },
        {
          "label": "D",
          "text": "Color Doppler ultrasound",
          "correct": false
        }
      ],
      "correct_answer": "C. Transvaginal ultrasound",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/11/screenshot-2023-12-11-174709.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Transvaginal ultrasound</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Transvaginal ultrasound is the most appropriate type of ultrasound for dating the pregnancy accurately in the first trimester. It provides better resolution and access to the developing embryo. The CRL is most accurate for estimation of age in the first trimester.</li><li>\u2022 Transvaginal ultrasound is the most appropriate type of ultrasound for dating the pregnancy accurately in the first trimester. It provides better resolution and access to the developing embryo. The CRL is most accurate for estimation of age in the first trimester.</li><li>\u2022 Other Options</li><li>\u2022 Other Options</li><li>\u2022 Option A: Transabdominal ultrasound: Is usually preferred after 12 weeks in pregnancy as the uterus is an abdominal organ after 12 weeks. Option B: 3D USG is useful in detecting surface anomalies in the fetus like cleft lip. It is alwso very helpful in diagnosing Mullerian anomalies Option D: Doppler ultrasound is commonly used to assess placental and fetal blood flow, as well as fetal oxygenation during pregnancy.</li><li>\u2022 Option A: Transabdominal ultrasound: Is usually preferred after 12 weeks in pregnancy as the uterus is an abdominal organ after 12 weeks.</li><li>\u2022 Option A:</li><li>\u2022 Option B: 3D USG is useful in detecting surface anomalies in the fetus like cleft lip. It is alwso very helpful in diagnosing Mullerian anomalies</li><li>\u2022 Option B:</li><li>\u2022 Option D: Doppler ultrasound is commonly used to assess placental and fetal blood flow, as well as fetal oxygenation during pregnancy.</li><li>\u2022 Option D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A transvaginal scan (TVS) is preferred over a transabdominal scan (TAS) in the 1 st trimester A CRL done between 8 to 12 weeks is the best determinant of gestational age In a 1 st trimester scan, the following structures are seen.</li><li>\u27a4 A transvaginal scan (TVS) is preferred over a transabdominal scan (TAS) in the 1 st trimester</li><li>\u27a4 A CRL done between 8 to 12 weeks is the best determinant of gestational age</li><li>\u27a4 In a 1 st trimester scan, the following structures are seen.</li></ul>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference: Williams textbook of Obstetrics 25 th edition page  183.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c557c0bc",
      "audio": ""
    },
    {
      "text": "A 30-year-old pregnant woman in her second trimester presents for a routine prenatal ultrasound. What is the primary purpose of this mid-pregnancy ultrasound?",
      "options": [
        {
          "label": "A",
          "text": "To assess for neural tube defects",
          "correct": false
        },
        {
          "label": "B",
          "text": "To evaluate fetal growth and anatomy",
          "correct": true
        },
        {
          "label": "C",
          "text": "To estimate amniotic fluid volume",
          "correct": false
        },
        {
          "label": "D",
          "text": "To check for placental abnormalities",
          "correct": false
        }
      ],
      "correct_answer": "B. To evaluate fetal growth and anatomy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. To evaluate fetal growth and anatomy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The primary purpose of a mid-pregnancy ultrasound (typically performed between 18-22 weeks) is to evaluate fetal growth and anatomy, including assessing the development of various organs and structures in the fetus. This scan may also be referred to as anomaly scan/ malformation scan/ Targeted imaging for fetal anomaly (TIFFA scan)</li><li>\u2022 The primary purpose of a mid-pregnancy ultrasound (typically performed between 18-22 weeks) is to evaluate fetal growth and anatomy, including assessing the development of various organs and structures in the fetus. This scan may also be referred to as anomaly scan/ malformation scan/ Targeted imaging for fetal anomaly (TIFFA scan)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective: Routine ultrasounds done in pregnancy include</li><li>\u27a4 1 st trimester (6-10 weeks): For confirmation of pregnancy, excluding ectopic pregnancy, number of fetuses, viability, adnexal lesions 11-14 weeks: Level 1 scan: For Down syndrome screening and uterine artery doppler for preeclampsia screening 18-22 weeks: TIFFA scan (Targeted imaging for fetal anomaly) > 28 weeks: Fetal growth and well being, placental localization, amniotic fluid volume, confirming presentation.</li><li>\u27a4 1 st trimester (6-10 weeks): For confirmation of pregnancy, excluding ectopic pregnancy, number of fetuses, viability, adnexal lesions</li><li>\u27a4 1 st trimester (6-10 weeks):</li><li>\u27a4 11-14 weeks: Level 1 scan: For Down syndrome screening and uterine artery doppler for preeclampsia screening</li><li>\u27a4 11-14 weeks:</li><li>\u27a4 18-22 weeks: TIFFA scan (Targeted imaging for fetal anomaly)</li><li>\u27a4 18-22 weeks:</li><li>\u27a4 > 28 weeks: Fetal growth and well being, placental localization, amniotic fluid volume, confirming presentation.</li><li>\u27a4 > 28 weeks:</li></ul>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference: Williams textbook of Obstetrics 25 th edition page 187</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "060444d2",
      "audio": ""
    }
  ]
}